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SUMMARY 
  
Midbrain dopaminergic (MbDA) neurons are located in the ventral tegmental area (VTA) and the 
substantia nigra (SN) and are involved in many brain functions including motor control, reward 
associated behavior and modulation of emotions. This thesis dissects the migratory routes and 
the molecular mechanisms underlying the migration of the subsets of MbDA neurons that form 
the SN and the VTA. Previous attempts to study the migration of MbDA neurons were 
hampered by the lack of markers for migrating SN and VTA neurons and the lack of a system to 
monitor their migration in real time. In this study, different MbDA progenitor populations, which 
give rise to either SN or medial VTA (mVTA) were heritably labeled using a genetic inducible 
fate mapping method and the changing position of their descendants was assesed at several 
stages during their migration phase. To monitor migrating MbDA neurons in real time, an 
organotypic slice culture system of the developing midbrain was established. In this culture 
system the migratory behaviour of distinct MbDN populations was characterized by time-lapse 
imaging of fluorescently labeled fate-mapped SN or mVTA neurons. Furthermore, to assess 
leading edge orientation, the morphology of MbDA neurons was characterized at several 
developmental stages by three dimensional imaging of whole brains.  
The results of this study reveal two distinct modes of MbDA migration: MbDA neurons destined 
for the SN migrate first radially from their progenitor domain to the forming mantle layer and 
subsequently switch to tangential migration to reach their final position in the lateral midbrain. In 
contrast, neurons destined to the mVTA mainly undergo radial migration. The data further show 
that components of the Reelin signaling pathway are specifically expressed in a lateral MbDA 
subpopulation during embryonic development. CXCR4, a chemokine receptor, is expressed in 
medially located MbDA neurons and its ligand, CXCL12, is expressed in the meninges 
surrounding the midbrain. Time-lapse imaging of migrating MbDA neurons in presence of Reelin 
blocking antibody and analysis of mice in which Reelin signaling was inactivated demonstrate 
that Reelin signaling regulates the speed and trajectory of tangentially migrating MbDA neurons 
and the formation of the SN. In contrast, inactivation of CXCR4/CXCL12 signaling leads to 
accumulation of MbDA neurons in dorsal aspects of the MbDA neuronal field suggesting that 
CXCR4/CXCL12 signaling might modulate the radial migration of MbDA neurons.  
This study provides a detailed characterization of the distinct migratory pathways taken by 
MbDA neurons destined for the SN or the mVTA and provides insight into the molecular 
mechanisms that control different modes of MbDA neuronal migration. These mechanistic 
insights might serve as a model that can be applied to understand the formation of other nuclei 
in the ventral brain, where the migration processes are less well understood than in the layered 
structures of the dorsal brain. Moreover, the results of this study might contribute to improving 
the in vitro production of MbDA neurons from induced pluripotent or embryonic stem cells by 
providing markers to identify different subtypes of MbDA neurons during their generation.
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ZUSAMMENFASSUNG  
 
Dopaminerge Mittelhirn-Neurone (MbDA Neurone) befinden sich im ventralen tegmentalen 
Areal (VTA) und der Substantia nigra (SN) und modulieren willkürliche Bewegungen, 
Belohnungsverhalten und Emotionen. Die vorliegende Doktorarbeit analysiert die 
Migrationswege und die molekularen Mechanismen, die für die Migration der Subpopulation von 
MbDA Neuronen wichtig sind, die sich zu der SN und dem VTA entwickeln. Bisherige Versuche, 
die Migration von MbDA Subpopulationen im Detail zu untersuchen, waren nur wenig 
erfolgreich, da weder Marker für migrierende SN und VTA Neurone noch ein experimentelles 
System für die Echtzeit-Beobachtung der MbDA Neurone etabliert waren. 
In der vorliegenden Studie wurden verschiedene MbDA Vorläuferpopulationen, die sich 
entweder zu MbDA Neuronen in der SN oder dem mittleren Teil des VTA entwickeln, mit Hilfe 
einer genetischen Methode zu verschiedenen Entwicklungszeitpunkten markiert. Zunächst 
wurden über mehrer Entwicklungsstadien die sich verändernden Positionen der so markierten 
MbDA Neurone bestimmt, um einen Einblick in ihre Migrationswege zu gewinnen. Um 
migrierende MbDA Neuronen direkt beobachten zu können, wurden organotypische 
Schnittkulturen des embryonalen Mittelhirns etabliert. In diesem Kultursystem wurde das 
Migrationsverhalten von fluoreszenzmarkierten SN oder VTA Neuronen mit Zeitraffer-
Mikroskopie untersucht. Um die Orientierung der migrierenden Neurone zu analysieren, wurde 
die Morphologie von MbDA Neuronen zu mehreren Entwicklungsstadien durch 
dreidimensionale Bildgebung charakterisiert.  
Die Ergebnisse dieser Studie zeigen, dass unterschiedliche MbDA Subpopulationen 
unterschiedliche Migrationsverhalten aufweisen: MbDA Neurone, die sich zur SN entwickeln, 
wandern zuerst radial von ihrer Vorläuferdomäne in die Mantelschicht. Anschließend migrieren 
sie tangential, um ihre endgültige Position im lateralen Mittelhirn zu erreichen. Dagegen 
wandern MbDA Neurone, die sich zum mittleren Teil des VTA entwickeln, hauptsächlich radial. 
Die vorliegenden Daten zeigen weiter, dass während der Embryonalentwicklung Komponenten 
des Reelin Signalwegs spezifisch in einer lateral gelegenen MbDA Population exprimiert sind. 
Hingegen ist CXCR4, ein Chemokinrezeptor, nur in medial gelegenen MbDA Neuronen 
exprimiert. Der CXCR4 Ligand CXCL12 wird in der Pia mater exprimiert, die das Mittelhirn 
umschliesst. Zeitraffer-Mikroskopie von migrierenden MbDA Neuronen in Gegenwart eines 
Reelin-inhibierenden Anitkörpers und die Analyse von Mäusen, in denen der Reelin-Signalweg 
inaktiviert wurde, zeigen, dass das Reelin-Signal die Geschwindigkeit und Bewegungsbahn 
tangential wandernder MbDA Neuronen und die Bildung der SN reguliert. Im Gegensatz dazu 
führt die Inaktivierung des CXCL12/CXCR4 Signalwegs zu einer Ansammlung von MbDA 
Neuronen im dorsalen Bereich des VTA. Diese Ergebnisse deuten darauf hin, dass der 
CXCR4/CXCL12 Signalweg die  radiale Wanderung der MbDA Neuronen moduliert.
ZUSAMMENFASSUNG 
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Diese Studie charakterisiert die Migrationswege der MbDA Neurone, die sich zur SN oder dem 
mittleren Teil des VTA entwickeln und gibt Einblicke in die molekularen Mechanismen, die 
verschiedene Arten der MbDA Migration kontrollieren. Diese mechanistischen Erkenntnisse 
könnten als Modell dienen, um die Entstehung anderer, in Kernen organisierter ventraler 
Gehirnbereiche besser zu verstehen, da bisher Migrationsprozesse in ventralen 
Gehirnbereichen weit weniger gut verstanden werden als im dorsalen Gehirn, wo Neurone in 
Zellschichten organisiert sind. Schließlich könnten die Ergebnisse dieser Studie möglicherweise 
dazu beitragen, die in vitro Erzeugung von MbDA Neuronen aus induzierten pluripotenten oder 
embryonalen Stammzellen zu verbessern, da mit Hilfe der hier identifizierten Markern 
verschiedene Unterarten von MbDA Neuronen schon während ihrer Entstehung identifiziert 
werden könnten.  
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1. INTRODUCTION 
 
The mammalian brain is a precisely organized and complex structure that controls various 
functions of the body. The mammalian brain arises from a simple neuroepithelial structure and 
its complexity is established through the coordinated generation and organization of a vast 
diversity of neural cell types. A key feature in the organization of neural cells is that the cells are 
located in a specific structure or region of the nervous system, within highly organized cell 
cluster and laminae. To reach their specific position in the brain, neurons often have to undergo 
long distance migration from their place of origin. Arriving at the correct final position is 
necessary for the neurons to establish proper neural network, which are essential for 
accomplishing complex brain functions. 
Neuronal migration in the mammalian brain is achieved through very elaborate patterns of cell 
movements. Defects in neuronal migration in humans are implicated in epilepsy, mental 
retardation and severe learning disabilities (Gleeson and Walsh, 2000). Migratory behavior and 
underlying molecular mechanisms have been extensively studied in the dorsal brain, in 
particular in the cerebral and cerebellar cortex, where neurons undergo radial and/or tangential 
migration to organize themselves into neuronal layers (Figure 1A). Neurons in ventral brain 
areas, including midbrain dopaminergic (MbDA) neurons, are rarely organized into layers but 
are arranged into a complex array of neuronal clusters, also called nuclei (Figure 1B). MbDA 
nuclei are involved in many brain functions, such as motor integration, cognition, emotive and 
reward behaviors. Dysfunctions in MbDA system have been linked with many neurological and 
psychiatric disorders, including Parkinson’s disease, depression and schizophrenia. Due to their 
clinical importance, MbDA neurons have been the subject of extensive investigations. However, 
very little is known about the migration events and the molecular mechanism that guide neurons 
to form these neuronal clusters. 
 
1.1 Midbrain dopaminergic neuron diversity in the mammalian brain 
In the central nervous system (CNS), dopaminergic neurons are localized in the olfactory bulb, 
the hypothalamus and the mesencephalon (midbrain). MbDA neurons are located in the ventral 
midbrain and are the main source of dopamine neurotransmitter in the mammalian CNS. The 
development of various histology methods and tracing studies enabled the anatomical mapping 
of the MbDA system. Based on their anatomical position, MbDA neurons are organized into 
three major nuclei: the lateral substantia nigra pars compacta (SN, A9), the medialy ventral 
tegmental area (VTA, A10), and the retrorubral field (RRF, A8) in the posterolateral midbrain 
(Dahlstrom and Fuxe, 1964). These nuclei have distinct projections and functions, which are not 
yet fully understood. 
1. INTRODUCTION 
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Figure 1. Neuronal migration in dorsal brain areas (A) results in formation of neuronal layers, whereas in 
(B) ventral brain areas neurons migrate and form clusters or nuclei. VZ: ventricular zone 
 
The MbDA neurons project to striatal (caudate and putamen nucleus), limbic (nucleus 
accumbens, amygdala, olfactory tubercle, septum) and cortical areas (prefrontal cortex, 
cingulate cortex, perirhinal cortex) (Bentivoglio and Morelli, 2005; Bjorklund and Dunnett, 2007). 
SN and VTA neurons project to distinct areas, but some of their projections are partially 
overlapping. Most SN neurons project to the dorsal-lateral striatum (putamen and caudate 
nucleus) and form the mesostriatal pathway (Figure 2). The SN neurons of the mesostriatal 
pathway are involved in regulation of motor control and their degeneration results in the major 
symptoms of Parkinson’s disease. Some SN neurons also innervate cortical and limbic areas 
(Figure 2). The VTA projection pattern is more complicated. Thus, the posteromedial VTA 
projects to ventromedial striatum (medial olfactory tubercle, medial nucleus accumbens shell); 
most of the anteromedial VTA, lateral VTA and lateralposterior RRF project to ventrolateral 
striatum (nucleus accumbens core, lateral shell and lateral tubercle) and the medial posterior 
VTA projects to ventrolateral striatum (nucleus accumbens shell and core), medial prefrontal 
cortex and basolateral amygdala (Bentivoglio and Morelli, 2005; Ikemoto, 2007; Lammel et al., 
2008; Lammel et al., 2011; Lammel et al., 2012; Sillitoe and Vogel, 2008; Van den Heuvel and 
Pasterkamp, 2008). The VTA neurons form the mesocorticolimbic system and are involved in 
regulation of emotions and reward-associated behavior. Defects in dopaminergic transmission 
within the mesocorticolimbic system have been associated with drug addiction, depression, 
attention deficit hyperactivity disorder and schizophrenia (Chenu et al., 2009; Dailly et al., 2004; 
Sulzer, 2007; Winterer and Weinberger, 2004; Wise, 2009). RRF neurons play a role in 
modulating the nigrostriatal and mesolimbic pathways (Deutch et al., 1988). 
 
8 
 
 
Figure 2. Midbrain dopaminergic (MbDA) system. (A,B) Anatomical localization of MbDA neurons in 
different nuclei and their axonal projections target areas in the human (A) and murine (B) forebrain 
(sagittal view). (C) Coronal view, level of sections indicated in B, ant: anterior, int: intermediate, pos: 
posterior 
 
In addition to anatomical classification into SN, VTA and RRF and functional characterization 
based on their different projection pattern, MbDA neurons were further distinguished based on 
their electrophysiological and molecular properties. By combining retrograde tracing with brain 
slice electrophysiological recording, Lammel and colleagues (2008), revealed different firing 
properties for MbDA neurons projecting to striatal and limbic areas versus cortical areas. 
Moreover, this study revealed that a part of the VTA neurons were missing some of the 
electrophysiological properties, thought before to be specific for MbDA neurons. 
Transcriptome and marker analyses that have been done in MbDA, SN and VTA 
subpopulations in the adult brain, found several receptors, transcription factors and channels to 
be differentially expressed (Barrett et al., 2001; Greene et al., 2005; Simunovic et al., 2008; 
Zhou et al., 2011). For example only SN neurons and few nearby VTA neurons express GIRK2 
(G-protein regulated inward rectifier potassium channel-2) (Reyes et al., 2012; Schein et al., 
1998), whereas most of MbDA neurons of the VTA express Calbindin (Ca2+ binding protein) 
(Alfahel-Kakunda and Silverman, 1997; Pan and Ryan, 2012; Rogers, 1992). It is not well 
understood yet how these molecular and electrophysiological differences contribute to the 
functional diversity of MbDA neurons. 
Moreover, while described anatomical, functional, physiological and molecular diversity of 
MbDA neurons has been established, it remains unclear when and how this diversity is 
1. INTRODUCTION 
 
9 
 
generated during development. A comprehensive understanding of the genetic cues and 
extrinsic signals controlling the fate choice of precursor cells into specific MbDA neurons is 
required.  
1.2 Development of MbDA neurons 
MbDA neurons develop in a complex and continuous multi step process. MbDA neuron 
development starts with midbrain regionalization and cell fate specification, followed by 
differentiation and migration. Later events include growth of axonal processes and synapse 
formation (Figure 3). Various signaling molecules, transcription factors and cell receptor 
molecules tightly control MbDA development. 
 
Figure 3. Timeline of MbDA neuron development. Progenitors in the ventral midbrain are specified to 
MbDA fate between embryonic day (E) 8.5 and E11.5. They differentiate, migrate and form projections 
between E11.5 and E14.5. Subsequently, MbDA neurons establish synaptic contacts with neurons in 
their forebrain target areas, creating a complex and functional circuitry after P0.  
 
1.2.1 Regional specification of MbDA progenitors 
MbDA progenitors are specified along the dorsoventral (DV) and anteroposterior (AP) axes of 
ventral tube at the intersection of two signals: SHH (Sonic hedgehog) expressed along the 
ventral neural tube and FGF8 (Fibroblast Growth Factor 8) locally secreted at MHB (mid-
hindbrain boundary) and anterior hindbrain (Hb) (Ye et al., 1998)(Figure 4 A). SHH and FGF8 
function as organizers, secreted signaling molecules that can induce and pattern a neighboring 
tissue. While, FGF8 acts as a local patterning molecule on the anteroposterior axis, SHH is 
involved in dorsoventral patterning. Forebrain explants that normally do not give rise to MbDA 
neurons, when exposed to FGF8 beads, ectopically start expressing MbDA markers. 
Furthermore, inhibition of SHH with a function-blocking antibody, prevents FGF8 from inducing 
MbDA neurons. Thus, SHH and FGF8 control the fate and position of MbDA neurons along the 
dorsoventral and anteroposterior axis (Ye et al., 1998). FGF8 and SHH signals determines the 
activation of a combination of transcription factors, such as OTX2 (Orthodenticle homeobox 2), 
LMX1A/B (LIM homeobox transcription factor 1 α and β), EN1/2 (Engrailed 1 and 2) in a 
temporal order. FGF8 represses OTX2 (Martinez et al., 1999). Transcription factor OTX2, 
expressed in the anterior part of the brain (forebrain and midbrain) and GBX2 (Gastrulation 
Brain homeobox 2), expressed posteriorly (hindbrain) interact to position the MHB and FGF8 
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expression (Li and Joyner, 2001)(Figure 4 A). In mutants, who ectopically express OTX2 in 
anterior hindbrain the MHB is shifted, leading to an expansion of MbDA progenitor domain 
(Brodski et al., 2003). FGF8 can induce and maintain expression of WNT1 (Wingless-related 
MMTV integration site 1) at the MHB and in the roof plate (Chi et al., 2003; Liu and Joyner, 
2001) (Figure 4 A, C). WNT1 is important for maintaining OTX2 expression, which is required 
for the repression of NKX2.2 (NK2 homebox 2) (Figure 4C). The absence of this repression 
results in generation of 5HT neurons instead of MbDA neurons (Prakash et al., 2006). 
Moreover, in absence of WNT1, SHH and FGF8 are not sufficient to induce MbDA neurons 
(Prakash et al., 2006). WNT1 is also involved in maintaining the expression of EN1/2 genes, 
which are also involved in the induction and maintenance of MbDA neurons (Castelo-Branco et 
al., 2004; Castelo-Branco et al., 2003; Danielian and McMahon, 1996). 
SHH induces FOXA2 (Forkhead box protein A2) expression, by signaling through its receptor 
PTCH1 (Patched-1). The SHH-PTCH binding triggers the release of SMO (Smoothened) 
inhibition by PTCH1 and activation of GLI proteins. SHH signaling induces the generation of a 
transcriptional activator form of GLI2 and suppresses the formation of a GLI3 repressor. GLI2 
activator induces FOXA2 transcription factor in the ventral midline of the floor plate (Hynes et 
al., 1997; Matise et al., 1998). When the floor plate starts to express FOXA2 transcription factor, 
expression of FOXA1 is induced. FOXA1/2 induce SHH expression in the floor plate and also 
attenuate the SHH signaling by binding to and inhibiting the expression of GLI2 transcriptional 
activator (Kittappa et al., 2007; Mavromatakis et al., 2011). FOXA1/2 inhibits the NKX2.2 in 
ventral midbrain progenitors playing a role in neuronal commitment of MbDA progenitors (Lin et 
al., 2009; Mavromatakis et al., 2011). SHH expression ventrally, in the domain that give rise to 
MbDA neurons is flanked by NKX6.1 domain from which red nucleus (RN) progenitors arise, 
which is then followed by the NKX2.2 domain believed to give rise to GABAergic interneurons 
(Ang, 2006). The delineation of MbDA progenitors is controlled by the SHH indirect induction of 
MSX1 (Msh homeobox 1) expression in the ventral midbrain. MSX1 inhibits NKX6.1 (NK6 
homeobox protein1) and restricts its expression to more lateral region of the ventral midbrain 
from where the other neuronal types are generated (Andersson et al., 2006; Fedtsova and 
Turner, 2001). SHH also induce the expression of LMX1A/B (LIM homeobox transcription factor 
1 α and β) (Andersson et al., 2006; Fedtsova and Turner, 2001). LMX1A start to be expressed 
in the ventricular zone of the developing midbrain around E9.0 and forms a regulatory loop with 
WNT1 (Chung et al., 2009; Yan et al., 2011). In postmitotic MbDA progenitors, LMX1A/B 
downregulate the expression of LIM1/2 (LIM homeobox 1 and 2) and BRN3A (brain-specific 
homeobox / POU domain protein 3A), which are markers for neurons of the red nucleus (Ono et 
al., 2007). LMX1A also acts on MSX1, required for the repression of NKX6.1. Repression of 
NKX6.1 at the midline is important to delimit the MDA progenitor domain from the progenitor of 
other neuronal types (Andersson et al., 2006; Fedtsova and Turner, 2001). Subsequently, 
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LMX1A/B is involved in inducing the expression of other transcription factors necessary for 
MbDA neuronal differentiation (Andersson et al., 2006; Chung et al., 2009; Fedtsova and 
Turner, 2001). 
 
Figure 4. The induction of MbDA progenitors and their differentiation into MbDA neurons: MbDA 
progenitors are induced, starting at E8.5 by a combination of factors, the most important ones: SHH 
(Sonic Hedgehog), FGF8 (Fibroblast growth factor 8) and WNT1 (Wingless-type protein 1). The square 
indicates the place of MbDA neurons induction. (B) The MbDA initial domain expressing SHH will express 
MbDA progenitors markers, LMX1A (LIM homeobox transcription factor 1 α), MSX1 (MSH homeobox 1); 
whereas the adjacent domain will express SIM1 (single-minded homolog 1), NKX6.1 (NK6 homeobox 1), 
the red nucleus progenitors. FOXA2 (forkhead box A2) labels both progenitor domains. NKX2.2 (NK2 
homebox 2) is expressed in a precursor domain that is thought to give rise to GABAergic interneurons . 
Modified after (Blaess et al., 2011) (C) Simplified regulatory network of MbDA neuron induction. SHH 
induces the expression of LMX1A, Nkx6.1, Nkx2.2 and regulates FOXA2 expression, and inhibits PAX7 
(paired box gene 7). FOXA2 interacts with FOXA1 and both inhibit NKX2.2. FOXA2 activates NGN2 and 
the markers for differentiated MbDA neruons: TH (Tyrosine Hydroxylase), NURR1 (nuclear receptor 
subfamily 4, group A, member 2) and Pitx3 (paired-like homeodomain transcription factor 3). WNT1 
(wingless-related MMTV integration site 1) negatively regulates SHH and induces OTX2 (orthodenticle 
homolog 2) and LMX1A. LMX1A represses LIM1/2 (LIM homebox protein 1 and 2) and NGN1 
(neurogenin 1), regulates WNT1 and TH, NURR1 and PITX3,  and indirectly activates NGN2 (neurogenin 
2); WNT1. Red arrows: negative regulation, Green arrows: positive regulation  (Andersson et al., 2006; 
Chung et al., 2009; Ferri et al., 2007; Gennet et al.; Joksimovic et al., 2009b; Lin et al., 2009; 
Mavromatakis et al., 2011; Nakatani et al., 2010; Omodei et al., 2008; Ono et al., 2007; Prakash and 
Wurst, 2006; Puelles et al., 2004; Tang et al., 2010).    
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1.2.2 Differentiation of MbDA progenitors into MbDA neurons 
FOXA1/2 and WNT1 activate the expression of the panneural gene NGN2 (neurogenin 2), 
marking the beginning of MbDA neurogenesis (Ferri et al., 2007; Kele et al., 2006; Ono et al., 
2007). WNT1 is further required for the proper differentiation of MbDA progenitors, since in 
WNT1 null mice few TH positive neurons are generated and they do not start to express PITX3 
(paired-like homeodomain transcription factor 3), one of the differentiated MbDA neurons 
markers (Prakash et al., 2006). The WNT1-LMX1A regulatory loop controls the number of the 
cells expressing NURR1 (nuclear receptor subfamily 4, group A, member 2) and TH and their 
position in the floor plate (Andersson et al., 2013). NURR1 is necessary for the proper 
development of MbDA neurons. In absence of NURR1, postmitotic MbDA do not initiate TH, 
VMAT (vesicular monoamine transporter 2) and DAT (dopamine transporter) expression and 
become apoptotic (Perlmann and Wallen-Mackenzie, 2004; Prakash and Wurst, 2006). Thus, 
NURR1 induces the expression of TH, VMAT2 and DAT, which are required for dopamine 
synthesis (Saucedo-Cardenas et al., 1998; Sillitoe and Vogel, 2008; Smidt et al., 2003). 
The first, differentiated MbDA neurons appear between E10.5 and E11.5. MbDA neurons 
continue differentiation in successive waves between E12.5 and E15.5 (Bayer et al., 1995). 
Neurons of SN and dorsal lateral VTA appear first with a peak at E11.5. In contrast, medial VTA 
neurons and more caudal MbDA neurons appear to be born later with a peak at E12.5 (Bayer et 
al., 1995). By E11.5 - E12.5 WNT1 is restricted to a narrow area at the VZ and together with 
LMX1B induces PITX3 expression (Prakash and Wurst, 2006; Smidt et al., 2000). PITX3 is 
expressed in all MbDA neurons and its expression is maintained till adulthood. The lack of 
PITX3 does not affect the formation of MbDA neurons, but leads to the loss of most of SN 
neurons and about 50% of VTA neurons at later stages in development. This suggested that 
PITX3 is important for SN terminal differentiation (Maxwell et al., 2005; Nunes et al., 2003; 
Smidt et al., 2004). PITX3 also cooperate with EN1, which can induce the NURR1 target genes, 
including TH and DAT in the anterior MbDA neurons (Veenvliet et al., 2013). The absence of 
EN1 leads to a similar phenotype to that observed in Pitx3 null embryos (Veenvliet et al., 2013). 
EN1 starts to be expressed in postmitotic MbDA neurons by E11.5 and it has been shown to be 
required for MbDA neurons survival (Simon et al., 2001). Thus, in the En 1/2 null mutants the 
generation of MbDA neurons is diminished and the neurons that are generated die at around 
E14.5. It is belived that their survival depend on signals or trophic support provided by other 
cells that are normally present in the ventral midbrain and which are missing in the En 1/2 null 
mutants (Simon et al., 2001; Simon et al., 2004). EN1/2 can compensate for each other and are 
also required for maintenance of MbDA at later stages.  
 
1.2.3 SHH expressing progenitors give rise to different MbDA neuronal subpopulations 
All MbDA neurons originate from progenitors in the midbrain floor plate that express SHH, 
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FOXA1/2 and LMX1A/B (Ang, 2009; Blaess et al., 2011; Chung et al., 2009; Hayes et al., 2011; 
Nakatani et al., 2010; Yan et al., 2011). However, SHH expression in the ventral midbrain is 
very dynamic (Figure 5). MbDA progenitors respond to SHH signaling between E7.5 and E9.5 
and express SHH between E8.5 and E11.5. SHH is expressed in a narrow medial domain at 
E8.5, which becomes broader by E9.5-E10.5. At E11.5 SHH expression is present even further 
lateral, but ceases medially (Blaess et al., 2011; Hayes et al., 2011) .  
 
Figure 5. SHH expression (yellow) during ventral midbrain development is dynamic: initially (E8.5) it is 
confined to the mesencephalic ventral midline, then expands laterally (E11.5) and at later stages is 
downregulated in the ventral midline (after E12.5).  
 
1.2.3.1 Genetic inducible fate mapping of SHH expressing progenitors 
By employing genetic inducible fate mapping method (GIFM), which heritably marks progenitors 
and their descendants, several authors unraveled the contribution of SHH to MbDA neuron 
subpopulations. GIFM is a lineage tracing method, which establish a relationship between gene 
expression at a specific embryonic time point and cell fate (Joyner and Zervas, 2006). GIFM is 
based on an inducible Cre-loxP system, which uses a fusion protein of DNA recombinase, Cre 
(Causes Recombination) and a mutant estrogen receptor ligand-binding domain (ER) or 
progesterone receptor ligand binding domain. The mutant ER it can only be activated by the 
synthetic estrogen antagonist 4-hydroxy-tamoxifen (TM) and not by the endogenous estrogen 
(Hayashi and McMahon, 2002; Schwenk et al., 1998). The Cre estrogen receptor fusion protein 
(CreER) interacts with chaperone proteins, such as HSP 90 (heat shock protein 90) and forms 
an inactive complex, which is retained in the cytoplasm. When TM binds to the ER, the CreER 
fusion protein dissociates from the chaperones and the nuclear localization signal of the ER is 
exposed. This allows the CreER protein to enter into the nucleus, where it specifically 
recognizes 34 base pairs (bp) sequences named lox P (locus of x over P1). Cre mediates 
cleavage at the loxP sites, with the same orientation and a DNA sequence flanked by two loxP, 
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is deleted upon recombination. Knocking in a CreER cassette into the Shh locus (ShhCreER/ + 
mice) results in CreER expression under the control of Shh specific promoter (Harfe et al., 
2004). Tamoxifen (TM) administration to these mice induces Cre recombinase activity in all cells 
expressing SHH. A reporter line was generated by inserting a loxP-flanked Stop sequence 
followed by the Enhanced Yellow Fluorescent Protein gene (EYFP) into the Gt(ROSA)26Sor 
ubiquitous locus (Srinivas et al., 2001). By crossing the ShhCreER line with R26YFP, the Stop 
sequence is deleted and EYFP expression is observed in the cells expressing SHH upon TM 
administration at a particular embryonic stage (Figure 6 A). During embryogenesis the dose of 
TM that can be administrated is limited, since TM can interfere with the normal development of 
embryos (Joyner and Zervas, 2006). The limited dose of TM determines that SHH expressing 
cells to be labeled in a mosaic pattern (Figure 6 A). The time of TM administration can be 
chosen and the descendants of the recombined cells can be visualized at any later time point. 
Therefore contribution of the dynamic expression of SHH during embryonic development can be 
determined. 
 
1.2.3.2 SHH expressing progenitors preferentially contribute to different MbDA neuron 
subpopulations over time 
Using GIFM, Joksimovic and colleagues suggested that SHH expression between E7.5 and 
E12.5 sequentially marks three spatially distinct ventral midbrain progenitor domains that give 
rise to different neurons (Joksimovic et al., 2009). However, the distribution of fate mapped cells 
quantified and the potential contribution to other cell types, like astrocytes, was not assessed. 
Further studies, which also used genetic inducible fate mapping technique, quantitatively 
assessed the distribution of fate-mapped cells marked at different points (Blaess et al., 2011; 
Hayes et al., 2011). These studies show that progenitors expressing SHH between E8.5 and 
E12.5 give rise to MbDA neurons. The highest contribution to the MbDA neurons occurs when 
SHH is expressed throughout the LMX1A expressing MbDA precursor domain (Figure 4 B). 
Cells that express SHH between E9.5 and E10.5 also contribute to the red nucleus (RN), 
another midbrain neuronal population. However, the most interesting observation is that SHH 
expressing progenitors contribute differentially to MbDA neuronal subpopulations. Comparison 
of the fate of cells marked between E8.0 and E11.0 by quantitative analysis showed a 
continuous decrease in the relative contribution of cells expressing SHH to the most anterior 
region of the brain over time (see Figure 2 for anterior level). In contrast, there was a slight 
increase in the relative contribution of SHH-derived cells to more posterior regions (see figure 2 
for intermediate level and posterior level). Additionally, cells expressing SHH after E9.5 were 
also found to give rise to astrocytes. SHH expression in the medial floor plate (labeling at E8.5) 
have a bias to contribute to the SN, while MbDA progenitors in the lateral floor plate (labeling at 
E11.5) contribute preferentially to MbDA neurons in the medial VTA (mVTA) (Figure 6 B). GIFM 
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can therefore be used to differentially label cells giving rise to the SN or mVTA and to follow 
their migratory routes and behavior from their early progenitor stage to their final location in the 
ventral midbrain (Figure 6B).  
 
Figure 6. Fate mapping strategy to mark and follow SHH-expressing MbDA progenitors (A) Inducible fate 
mapping strategy. The CreER encoding sequence is inserted into the Shh locus. The R26 reporter allele 
contains a floxed Stop cassette upstream of EYFP. The Stop cassette is removed upon tamoxifen 
mediated recombination and EYFP is expressed in recombined cells. Note that the labeling is mosaic, 
since only a subset of cells is recombined (B) Genetic inducible fate mapping (GIFM) of SHH-expressing 
cells, through labeling at E8.5 results in permanent marking of medial MbDA progenitors that have a 
biased contribution to SN neurons. GIFM Shh-expressing cells, through labeling at E11.5 results in 
permanent marking of lateral MbDA progenitors that preferentially give rise to mVTA neurons.  
 
1.2.4 MbDA neuronal migration 
Once the MbDA neurons are specified, they differentiate and migrate from ventricular zone (VZ) 
of the ventral midbrain toward the pial surface. The differentiation and migration processes 
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occur during a similar developmental time frame (Figure 3). The end result of MbDA migration is 
the correct positioning of MbDA neurons within the ventral midbrain and formation of the three 
MbDA neuron distinct clusters: SN, VTA or RRF.  
MbDA neurons subpopulations have been suggested to follow a combination of two general 
routes of migration: radial migration and tangential migration. These different routes of migration 
are largely classified by direction of migration (e.g. radial movements along the vertical plane or 
tangential movements in the horizontal plane). 
Several studies, based primarily on immunostainings for TH, the rate-limiting enzyme in 
dopamine synthesis and/or birthdating of ventral midbrain cells, have suggested the following 
models for the different MbDA subpopulation migration: 
1) VTA and SN are primarily formed through radial migration from the VZ towards the pial 
surface on a radial path (Hanaway et al., 1971). 
2) MbDA neurons initially (E11.5) migrate radially towards the pial surface and then tangentially 
from the midline to form the VTA and SN (Kawano et al., 1995; Marchand and Poirier, 1983; 
Shults et al., 1990) (Figure 7) 
3) SN is generated at the MHB and migrate first radially ventralwards and then anterior. The 
authors based their conclusions on the assumption that the ventral midline does not give rise to 
differentiated neurons and therefore the authors assume that labeled cells ventral to the floor 
plate are part of an anteroposterior migratory stream (Marchand and Poirier, 1983). 
 
Figure 7. Proposed migratory routes of MbDA neurons. MbDA neurons generated at the VZ of the ventral 
midbrain migrate first toward the ventromedial part of the midbrain along radial processes and laterally in 
the basal part of the midbrain along tangentially arranged fibers. Modified after (Ohyama et al., 1998). 
 
Cell adeshion molecules, proteoglycans and extracellular matrix molecules have been 
implicated in regulating MbDA neuronal migration. The radial migration is thought to occur along 
radial glia processes expressing tenascin (Figure 6) (Kawano et al., 1995). While, tangentially 
migrating MbDA neurons are thought to follow tangentially oriented fibers of other neurons 
originated from the lateral part of midbrain (Kawano et al., 1995; Shults et al., 1990). The neural 
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cell adhesion molecule L1 is expressed on the tangential fibers, whereas MbDA neurons 
express the ligand L1/NgCAM (cell adhesion molecule L1/neuron-glia cell adhesion molecule) 
and the chondroitin sulfate proteoglycan 6B4. It has been proposed that the tangential migration 
of MbDA is controlled by heterophilic interactions between L1 and 6B4 (Ohyama et al., 1998). 
Mice lacking L1 show abnormal position of MbDA neurons (Demyanenko et al., 2001; Vitalis et 
al., 2000).   
Reelin is an extracellular matrix molecule important for neuronal migration and positioning in 
different brain areas, such as cortical and cerebellar cortex. In Reeler mice, which have a 
spontaneous mutation in Reelin gene, MbDA neurons presumably fail to migrate tangentially to 
form SN of and accumulate abnormally in the VTA area (Kang et al., 2010; Nishikawa et al., 
2003). 
Despite of all these studies, the mode of migration including cytoskeleton dynamics and the 
mechanisms that regulate MbDA neuron migration are not well understood. However these 
mechanisms were studied in detail in other brain areas, particularly in the forebrain.  Since 
similar mechanisms might regulate migration of MbDA neurons, migration processes in other 
brain areas will be described in the next chapter.   
1.3 Neuronal migration mechanisms  
In different areas of the brain extracelular cues, guidance receptors and their downstream 
signaling pathways coordinate the migration of newborn neurons through the developing 
nervous system towards their final destination. Defects in migratory processes result in severe 
malformations, such as lissencephaly, which can lead to mental retardation, epilepsy, paralysis 
and blindness (Gleeson and Walsh, 2000; Ross and Walsh, 2001) .  
Neuronal migration is a process that requires changes in the cell shape and the adhesion to an 
extracellular matrix. The morphological changes that occur during migration are largely related 
to actin cytoskeleton dynamics. Therefore, in the following subsection, the dynamic organization 
of cytoskeleton during neuronal migration will be discussed in detail.   
 
1.3.1 Cytoskeleton organization during neuronal migration 
Migrating neurons extend a long leading process that actively explores the environment by 
forming broad lamellae at their leading edges. The movement of the leading edge is closely 
coupled with nucleokinesis and the cell rear forms a contractile tail. The soma and nucleus jump 
forward in a saltatory mode, following the leading process extention (Edmondson and Hatten, 
1987; O'Rourke et al., 1992; Schaar and McConnell, 2005). The saltatory mode of migration 
proposed by Schaar and McConnell, 2005 is caracterized by four repeting steps, as following 
(Figure 8): 1) the leading edge extends and explores the environment. 2) a cytoplasmic 
dilatation forms in the leading process, the soma translocates forward and the centrosome 
moves into the dilatation. 3) the nucleus moves into the dilatation. 4) the rear membrane 
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retracts. Contractions mediated by myosin II break off leftover adhesions and release the soma 
for forward movement. 
These events are cyclic as the neurons migrate forward. During the migration events the 
leading process forms adhesion contacts with the substrate, which can be axons of other 
neurons or radial glia fibres. The temporal and spatial regulation of adhesion is important for the 
proper progression of the migratory steps.  
This saltatory mode of migration was described for many radially or tangentialy migrating 
neurons e.g. cerebellar granule neurons migrating along glial fibers or tangentially migrating 
interneurons (Ang et al., 2003; Gasser and Hatten, 1990; Nadarajah et al., 2001; Solecki et al., 
2009). However, different types of neurons adjust and modify this basic migratory process 
depending of the specific requirements of their migratory pathway, which may also change 
through time e.g. tangentially migrating streams of interneurons from medial ganglionic 
eminence switch to radial migration as they move toward specific locations within the cortical 
plate (Elias et al., 2010). 
 
Figure 8. Coordination of the cytoskeleton during saltatory neuronal migration. The leading process 
extends and forms adhesive contacts with the migration substrate (1). A cytoplasmic dilatation forms at 
the adeshion point on the leading process. The centrosome (red) moves into the dilation (2). Nucleus 
(black) translocates into the dilatation, squeezed by contractions at  the cell rear mediated by myosin II 
(yellow) (3). Adhesion contacts break off and the soma moves forward (4). Modified after (Schaar and 
McConnell, 2005). 
 
1.3.1.1 Migration polarity 
Migrating neurons are highly polarized in the direction of their movement. In the cerebral and 
cerebellar cortex, the leading processes often elongate along the radial dimension of the 
neuroepithelium and radial glial cells (Rakic, 1990; Rakic, 2000a; Rakic, 2000b). In the cerebral 
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cortex neuronal-glial interaction is mediated by integrins, which have been sugested to play a 
role in the interaction between the leading edge and the substrate (Anton et al., 1999).  
The establishment of a leading process has been often studied in the context of axon formation, 
but axonal outgrowth and migration use similar mechanims. The key factors involved in setting 
up polarity of migrating neurons, such as the PAR3/PAR6/PKC complex are also involved in 
establishing polarity for axons (Brose and Tessier-Lavigne, 2000; Chen et al., 2008; Manitt and 
Kennedy, 2002; Tessier-Lavigne and Goodman, 1996). 
Evidence that axon formation and migratory leading process extension are distinct events 
comes from the studies of cortical radial migration and axogenesis, which have studied the 
function of CDK5 (Cyclin-dependent kinase 5), the polarity protein STK11 (Serine/Threonine 
kinase 11) or ENA/VASP (vasodilator-stimulated phosphoprotein) proteins (Barnes et al., 2007; 
Kwiatkowski et al., 2007; Ohshima et al., 2007a)  in mice mutants. While ENA/VASP mutants 
are able to properly form migratory leading and trailing processes, they do not form proper 
axons. 
CSK5 plays critical roles in neuronal migration. CDK5 phosphorylate the microtubule-associated 
protein, DCX (doublecortin), which results in a lower affinity of DCX to bind microtubules and 
reduction of microtubule polymerization (Tanaka et al., 2004). In the Dcx knockdown mutants 
the leading processes are very active and unstable, an excessive branching occurs and radially 
migrating cortical neurons stop their migration. A similar phenotype occurs in mice in which 
Cdk5 or the Cdk5 activator p35 are inactivated (Gupta et al., 2003; Ohshima et al., 2007a). 
 
1.3.1.2 Dilatation formation and nucleokinesis 
In neurons that present a dilatation, the nucleus elongates in the direction of the movement. The 
centrosome moves ahead of the nucleus and microtubules emerging from the centrosome form 
longitudinal bundles linked by cross bridges. It was believed that these bundles of microtubule 
stretch the nucleus, which then translocates along microtubules toward the centrosome. 
However, when using a microtubule disrupting agent, the nucleus was able to move forward. 
Myosin II was found to play a key role in nucleokinesis. When treated with a myosin inhibitor, no 
nucleus or soma translocation occurs, however the leading tip still extends despite the cell 
movement impairment (Bellion et al., 2005; Kato et al., 2008; Schaar and McConnell, 2005). 
Phosphorylation of DCX by CDK5 is also considered important in organizing the link between 
the centrosome and nucleus through its association with the microtubules (Tanaka et al., 2004). 
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1.3.1.3. Rear Retraction and adhesion in neuronal migration 
It has been proposed that myosin constriction at the trailing edge squeezes the nucleus forward 
into the leading process and after nucleokinesis, the cell soma membrane that surrounded the 
nucleus is retracted (Higginbotham and Gleeson, 2007). 
Adhesion is very important in neuronal migration as it is tightly integrated with cytoskeletal 
dynamics. Adhesion molecules, in contact with the migratory substrate, are also connected to 
the actin cytoskeleton. These contacts provide force information from the outside to the 
migrating neuron. Based on this information, changes are generated in the cytoskeletal 
structure. These changes can be used to create pulling forces, using the adhesive contacts as 
traction, or to attract specific intracellular components that will indicate a direction in which the 
neurons polarize and migrate (Schaar and McConnell, 2005). 
 
1.3.2 Mode of migration 
During their migration, neurons can switch between radial and tangential orientated migratory 
routes. These routes require different mechanisms for motility that are modulated by external 
guidance cues and substrates for migration. 
 
1.3.2.1 Radial migration 
Radial migration in brain areas, such as cortex and hindbrain, includes somal translocation (1) 
and glia-guided locomotion (2). 
1) Radial migration through somal translocation 
During somal translocation the cell soma moves along its own leading process. The young 
neuron maintains its primitive ventricular and pial processes, through which the cell body 
moves. Not many studies in the brain have been able to study somal translocation due to the 
lack of neuronal-specific markers that appear in the early, radially shaped cells. However, somal 
translocation has been shown to occur at early stages of cortical development (Nadarajah et al., 
2001) and a similar mechanism has been proposed for serotonergic neurons in hindbrain 
(Hawthorne et al., 2010).  
2) Radial migration through glia-guided locomotion 
In the cortex, during glia guided locomotion neurons use the radial glial fibers as a substrate for 
their migration. Radial glia cells are born early during the development of the ventricular zone 
and extend long processes along the wall of the neural tube, which reach the pial surface 
(Gadisseux et al., 1989). The function of radial glia is to provide support for the migrating 
neuroblasts, but they also have other functions and are not only supportive elements. During 
cortex development, radial glia cells also undergo division to produce new neurons (Heins et al., 
2002; Malatesta et al., 2000; Miyata et al., 2001; Noctor et al., 2001; Noctor et al., 2002). 
Neurons move with their leading process tightly wrapped around the radial glial fibre. Such a 
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mode of migration was observed for radial migration of superficial cortical neurons and 
cerebellar granule cell migration (Edmondson and Hatten, 1987; Gasser and Hatten, 1990; 
Noctor et al., 2001; Takeuchi and O'Leary, 2006). 
1.3.2.2 Tangential migration 
Neurons can migrate tangentially, either along tangentially oriented fibers, axons of other 
neurons or along other cells (Marin and Rubenstein, 2001). 
Studies that showed a mechanism of tangential migration along fibres were performed on the 
interneurons that leave the ganglionic eminence to integrate into the cortex (Borrell and Marin, 
2006; Lopez-Bendito et al., 2006; Martini et al., 2009). The chain migration of SVZ 
(subventricular zone) neurons into the olfactory bulb and Gonadotropin-releasing (GnRH) 
neurons migrate tangentially along vomeronasal axon fibers (Cariboni et al., 2007; Yoshida et 
al., 1995). 
 
1.3.3 Factors regulating neuronal migration  
Based on loss-of-function mouse mutants in which the formation of the SN and/or VTA is 
impaired, only the Netrin receptor DCC (deleted in colorectal carcinoma), the extracellular 
glycoprotein Reelin, and the cell adhesion molecule L1 have been implicated in the regulation of 
MbDA neuronal migration (Ballmaier et al., 2002; Demyanenko et al., 2001; Kang et al., 2010; 
Nishikawa et al., 2003). However many more signaling pathways and molecules have been 
implicated in regulating neuronal migration in other brain areas. In the subsequent sections only 
two factors: Reelin and CXCR4/CXCL12, which impact the thesis results, will be described in 
more detail.  
1.3.3.1 Reelin signaling pathway 
Reelin function in the brain has been extensively studied in the cortex, where loss of Reelin 
function was found to disturb the cortical lamination (Jossin, 2004; Magdaleno et al., 2002). 
Other studies (Goffinet, 1984; Kang et al., 2010; Nishikawa et al., 2003; Terashima et al., 1994) 
showed defects in Reeler mutants in ventral brain areas, such as inferior olivary complex, 
trigeminal motor nucleus, SN, dorsal cochlear nucleus and facial nucleus. Only two studies 
(Nishikawa et al., 2003 and Kang et al., 2010) showed defects in MbDA neurons positioning in 
Reeler mutant. However, the mechanism of Reelin role in MbDA neurons positioning remained 
completely unexplored.  
Though the Reelin gene is highly conserved between mouse and human genomes, little is 
known about the regulation of Reelin mRNA expression (Tissir and Goffinet, 2003). In humans, 
mutations in Reelin gene result in lissencephaly with cerebellar hypoplasia, and reduction of 
Reelin mRNA in postmortem brains was linked to schizophrenia or bipolar illness with psychosis 
(Chen et al., 2002). The Reelin gene encodes an extracellular matrix glycoprotein, Reelin which 
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is secreted by different cell types in the brain, such as Cajal-Retzius cells, hippocampal 
GABAergic neurons, and cerebellar granule cells (Fatemi, 2005).  
Reelin binds to the VLDLR (Very Low Density Lipoprotein Receptor) and ApoER2 (Apolioprotein 
E Receptor 2) (D'Arcangelo et al., 1999). Binding of Reelin to its receptors VLDLR/ApoER2 
triggers the tyrosine phosophorylation of the cytoplasmic adaptor molecule DAB1 (Disabled 1). 
Reelin signaling leads to cytoskeletal changes and a change of gene expression in target 
neurons (Ballif et al., 2004; Bock and Herz, 2003; Bock et al., 2003; Britto et al., 2013; 
Fuchigami et al., 2013; Kruger et al., 2010) (Figure 9). 
                    
Figure 9. Reelin-mediated signaling pathway. Reelin binds to its receptors ApoER2 and VLDLR and 
results in dimerization/oligomerization of DAB1 protein. This  process leads to activation of Src-tyrosine 
kinase family/Fyn-kinase (SFK) and tyrosine phosphorylation of DAB1 protein in a positive -feedback loop. 
Interaction between DAB1 and PI3K (phosphatidylinositol- 3-kinase) and AKT (protein kinase B) impact 
three other important molecules: Cofilin, CRK (v-crk sarcoma virus CT10 oncogene homolog), F-actin 
which indirectly lead to modification in cytoskeleton that play a role in migration. Reelin can also bind to 
coreceptors, such as Ephrins (Bock et al., 2003; Franco et al., 2011; Kruger et al., 2010; Senturk et al., 
2011; Yip et al., 2012). 
 
The Reeler mice, which have a spontaneous mutation in the Reelin gene that results in a Reelin 
null allele, have an abnormal laminar organization of the cerebral and cerebellar cortices and 
the hippocampus (Forster et al., 2006). In 1955, Falconer described for the first time the Reeler 
mouse phenotype: dystonia, tremors and a reeling gate. Yotari mice, which have a spontaneous 
mutation in Dab1, show similar traits as the Reeler mutants, suggesting that Reelin signals 
through DAB1 (Rice et al., 1998). 
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Reelin is secreted by neurons as a full-length protein and can be cleaved into 5 diffusible 
fragments. Whether these fragments have individual functions is unknown (Jossin et al., 2004).  
Reelin receptors, ApoER2 and VLDLR are not completely redundant. Either one or the other 
receptor appears to have a more important function depending on the brain region. Inactivation 
of VLDLR results in only mild defects in the cerebellum, but shows defects in the cortex and 
hippocampus, whereas the inactivation of ApoER leads to strong defects in cerebellum, but not 
in cortex and hippocampus. The Apoer2/Vldlr double knockout shows a phenotype similar to 
reeler mice (Trommsdorff et al., 1999).  
In the Reeler neocortex, the cortical lamination is inverted and the neurons fail to pass through 
earlier-generated neurons, possibly because they are unable to penetrate the subplate, or 
because they maintain extensive contacts with the radial glial fibres. Several hypotheses exist 
regarding the function of Reelin in the cortex: (1) Reelin may act as a permisive factor, (2) 
Reelin may act as an attractant molecule for migrating neurons; (3) it may act as a stop signal 
(Dulabon et al., 2000; Hoffarth et al., 1995; Zhao and Frotscher, 2010). Quattrocchi and 
colleagues showed that Reelin has a protease activity that cleaves Laminin and Fibronectin in 
vitro, thus modifying the basal lamina, and facilitating the branching and anchoring of the 
leading processes important for neuronal migration (Quattrocchi et al., 2002). In Reeler mutant 
mice, the leading processes are less stable, misoriented and not attached to the marginal zone. 
Two studies showed that ectopic expression of Reelin could rescue the major Reeler 
phenotype, providing evidence for Reelin as a permissive factor. However, the inversion of 
cortical layers (late corticogenesis) could not be rescued, which might suggest that Reelin acts 
as a permissive factor for neurons undergoing somal translocation during early corticogenesis, 
but might be critical for glia-guided locomotion (D'Arcangelo, 2005; Jossin, 2004; Magdaleno et 
al., 2002).  
Jossin and colleagues showed that processed fragments of Reelin could diffuse from the pial 
surface to the intermediate zone in the cortex, forming a gradient and acting as an attractant. In 
Dab1 knockouts, neurons do not reach proper position and have a reduced speed (Jossin et al., 
2007). After transfection with Dab1 shRNA, neurons accumulate underneath the preplate (Feng 
et al., 2007; Sanada et al., 2004). In Reeler cerebellum, Purkinje cells fail to migrate out of deep 
locations. Transplantation of granule cells, expressing Reelin into the fourth ventricle resulted in 
malpositioning of Purkinje cells close to the ventricular zone (Miyata et al., 1997). These 
observations led to the proposal that Reelin may attract Purkinje cells (Miyata et al., 2010). 
Reelin also can play a role as a stop signal. By reducing expression of integrin adhesion 
molecules, Reelin promotes detachment from the radial glia (Magdaleno and Curran, 2001). 
Another proposed way, in which Reelin acts as a stop signal, was named the polarization 
model, in which the location of Reelin source plays an important role. Reelin triggers 
polarization when neurons are at marginal zone by activating RAP1 (Ras-proximate-1 or Ras-
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related protein-1) and stabilizing N-Cadherin (N-Cad). At the same time phosphorylation of 
DAB1 and Reelin signaling is downregulated and N-Cad is degraded when neurons migrate 
bipolar. In this model Reelin is suposed to act only on multipolar neurons and this implay the 
existence of 2 signals, one in more immature multipolar neurons and one in more mature 
bipolar neurons (Franco et al., 2011; Jossin and Goffinet, 2001). 
Reelin has been shown to regulate neuronal migration in the cortex by interacting with Notch 
and stimulated DAB1 binds to NICD (Notch internal cytoplasmatic domain) and blocks its 
degradation. In Reeler mice, a low level of Notch NICD is present and loss of Notch in migrating 
neurons results in migration and morphological defects (Hashimoto-Torii et al., 2008). Reelin 
also stabilizes the cytoskeleton by regulating the phosphorylation level of actin and microtubule-
associated proteins, such as Cofilin, which results in the stabilization of the actin cytoskeleton in 
leading process. In reeler mutant mice the level of Cofilin is reduced (Chai et al., 2009a). By 
stabilizing the actin cytoskeleton, Reelin can anchor the leading edge of migrating neurons to 
the cortical surface, a prerequisite for somal translocation (Frotscher, 2010). 
1.3.3.2 CXCL12/CXCR4 signaling pathway  
CXCR4 receptor is a member of the family of G protein coupled receptors (GPCRs). The 
CXCR4 ligand is the CXC motif chemokine stromal derived factor-1 (CXCL12 or SDF1). Data 
from Cxcl12 and Cxcr4 null mice showed that CXCR4/CXCL12 have important function in brain 
development. In the cerebellum of CXCR4 deficient mice, the granule cells are mislocalized 
(Zou et al., 1998). A similar phenotype was observed in Cxcl12 deficient mice, suggesting that 
CXCL12 acts through CXCR4 to regulate cerebellar development (Ma et al., 1998).  
CXCL12/CXCR4 signaling is active when CXCL12, secreted by extracellular matrix, binds to the 
CXCR4 receptor and activates a cascade of events, mediated through the G protein. GTP 
(guanosine triphosphate) replaces GDP (guanosine diphosphate) in the α subunit of the G 
protein. The G protein heterotrimer then dissociates from the ligand/receptor complex and 
signals through a number of downstream pathways, which are not fully understood in the brain, 
but are known to regulate migration, adhesion, and transcriptional activation of target genes 
(Figure 10),(Busillo and Benovic, 2007). 
Proteolytic degradation and CXCR7 scavenger modulate CXCL12 availability. CXCR7 acts as a 
scavenger, binding and removing extracellular CXCL12 (Cubedo et al., 2009). There are 2 
splice variants of CXCL12, presumably having the same function (Jahnichen et al., 2010).  
Meningeal derived CXCL12 has been described to function as a short-range chemoattractant 
for migrating Cajal-Retzius cells, GABAergic interneurons and precerebellar neurons that 
express CXCR4  (Borrell and Marin, 2006; Zhu et al., 2009; Stumm et al., 2003; Tanaka et al., 
2010).  
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Figure 10. CXCL12/CXCR4 signaling pathway. CXCL12 binding to CXCR4 leads to the activation of 
multiple G protein-dependent signaling pathways. Activated G protein is able to liberate Gβγ, activate 
phospholipase C-β (PLC-β) and phosphoinositide-3 kinase (PI3K), ultimately leading to the regulation of 
processes such as cell migration.  Tyrosine phosphorylation of CXCR4 results in the recruitment and 
activation of the JAK/STAT pathway. Modified after (Busillo and Benovic, 2007). 
 
In the cortex, it has been shown that migrating GABAergic interneurons can respond to a 
diffusible gradient of CXCL12 (Stumm et al., 2003; Tanaka et al., 2010). Thus, cortical brain 
slices exposed to a medium containing secreted CXCL12 that perturbs the endogenous level, 
show an increased response of migrating interneurons with the increase in CXCL12 
concentration (Liapi et al., 2008). Furthermore, it was described that CXCL12 plays a role in 
GABAergic interneuron migration by modulating the migration rate and branching frequency in 
primary cell culture (Lysko et al., 2011). Additionally, a more recent cortical study showed that 
CXCR7 can modify CXCR4 responsiveness in interneurons in which both are expressed 
(Sanchez-Alcaniz et al., 2011), suggesting a more complicated CXCL12/CXCR4 signaling 
pathway. 
CXCL12 plays the role of an attractant on a non-diffusable gradient for gonadotropin releasing 
hormone neurons. Gonadotropin releasing hormone neurons migrate along the nasal 
mesenchymal cells that express an increasing level of CXCL12 (Schwarting et al., 2007). 
CXCL12 has also been shown to act as a long-range chemoattractant in the case of 
hippocampal dendate gyrus granule cells migration. CXCR4 expressing granule cells are 
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located far from their migratory target, which expresses CXCL12. Cxcr4 mutant mice show a 
mislocalization of granule cells. Furthermore, ectopic expression of CXCL12 in explant slices 
disrupts granule cells migration, which migrate to the ectopic location of CXCL12 insted of the 
normal location (Bagri et al., 2002).  
Other than chemoatractant function in migration, CXCL12 has been shown to play a role as an 
anchor for granule cell progenitor cells in the cerebellum. CXCL12 expressed in the meninges 
keeps the dividing cerebellar granule cell precursosr from leaving prematurely the extrernal 
granule layer (Klein et al., 2001). 
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1.4 Objectives of the study 
 
During embryogenesis, MbDA neurons are generated from MbDA progenitor cells in the floor 
plate of the ventral midbrain. From their place of origin MbDA neurons have to migrate and 
assemble into the laterally positioned SN and the medially located VTA. However, the precise 
migratory routes of MbDA neurons and the molecular mechanisms regulating MbDA migration 
were not understood.  
The first aim of the present study was to characterize the migratory routes of different 
subpopulation of MbDA neurons giving rise to SN and VTA. Due to the lack of specific markers 
for SN and VTA neurons during their migration phase, a genetic inducible fate mapping method 
was used to fluorescently label the two distinct MbDA populations throughout their 
development. To assess their migration patterns, a detailed analysis of the position of the 
fluorescently labeled SN or VTA MbDA neurons had to be performed at several stages of their 
development. Three-dimensional analysis of the morphology of fate mapped MbDA neurons in 
the ventral midbrain had to be performed to assess the spatial orientation of the leading 
processes of individual migrating MbDA neurons. Considering the fact that migration is a time 
dependent, dynamic process, live imaging monitoring of the migratory behavior of MbDA 
neurons was required. However, the developing mouse brain is a difficult system for 
manipulation and imaging in vivo due to its inaccessibility and opaqueness. To directly monitor 
the MbDA neuron migratory behaviour in vitro, an organotypic slice culture system had to be 
established.  
The second aim of this study was to uncover molecular mechanisms regulating MbDA neuron 
migration. Reelin signaling was thought to play a role in MbDA neuronal migration, since the SN 
does not form properly in mouse mutants, in which Reelin signaling is inactivated. To assess 
whether and how Reelin signaling regulates MbDA neuronal migration it had to be examined 
whether components of the Reelin signaling pathway were expressed in MbDA neurons during 
their migration phase. Secondly, the function of Reelin had to be investigated by monitoring the 
migratory behavior of MbDA neurons in slice cultures upon inhibition of Reelin signaling and by 
assessing the distribution and morphology of MbDA neurons in in mouse mutants, in which 
Reelin signaling is inactivated. CXCR4/CXCR12 signaling plays a role in neuronal migration in 
several brain areas. Therefore, the potential involvement of CXCR4/CXCR12 signaling in MbDA 
neuronal migration was explored. The expression pattern of CXCR4 and its ligand, CXCL12 
was analyzed in the ventral midbrain. Subsequently, the function of CXCR4/CXCR12 signaling 
in MbDA neuronal migration was investigated by blocking CXCR4 function in slice cultures and 
by analyzing the distribution of MbDA neurons in Cxcr4 and Cxcl12 knockout animals. 
This study was performed to gain a better understanding of the development of MbDA neurons 
and to provide new insights into the routes and molecular mechanisms driving MbDA migration.
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2. MATERIALS AND METHODS 
 
2.1 Materials 
2.1.1 Technical Equipment 
Appliance Model/Cat. No. Manufacturer Registered Office 
10x air objective 
(ultramicroscopy) 
CFI Plan Fluor 10x NA 
0.3 wd 16 mm 
Nikon Dusseldorf, DE 
10x objective 
(ApoTome) 
EC PlnN 10x/0.3 DICI 
1.11µm 
Carl Zeiss Jena, DE 
20x air objective 
(ultramicroscopy) 
CFI Plan Fluor 20x NA 
0.5 wd 2.1 mm 
Nikon Dusseldorf, DE 
20x objective 
(ApoTome) 
EC PlnN 20x/0.5 DIC II 
0.67 µm 
Carl Zeiss Jena, DE 
40x long working 
distance water 
immersion objective 
(ultramicroscopy) 
CFI Apo LWD Lambda 
S 40x NA 1.15 wd 0.60 
mm 
Nikon Dusseldorf, DE 
40x objective 
(ApoTome) 
Pln Apo 40x/1.3 Oil 
DIC III 0.26 µm 
Carl Zeiss Jena, DE 
40x objective 
(confocal) 
PLAPO 40x WLSM NA 
0.90 
Olympus Hamburg, DE 
63x objective 
(ApoTome) 
Pln Apo 63x/1.4 Oil 
DIC II 0.24µm 
Carl Zeiss Jena, DE 
Autoclave DX-150 benchtop Systec Wettenberg, DE 
Balance AC211S Sartorius 
Göttingen, 
DE 
Balance ATL-822-1 Sartorius 
Göttingen, 
DE 
Centrifuge Pico 17 
Thermo Fisher 
Scientific 
Schwerte, DE 
Centrifuge 
Labofuge 400R 
75008-162 
Thermo Fisher 
Scientific 
Schwerte, DE 
Confocal microscope Olympus IX81 Olympus Hamburg, DE 
Dry bath FB15103 
Thermo Fisher 
Scientific 
Schwerte, DE 
Fluorescence Lamp Illuminator HXP120C Carl Zeiss Jena, DE 
Gel chambers 
Model 41-1525 
Model 40-1515 
Peqlab Erlangen, DE 
Heating Block Dry bath Typ15103 
Thermo Fisher 
Scientific 
Schwerte, DE 
Heating Plate 
flattening table OTS 
4001 - 4002 - 00 
Medite Burgdorf, DE 
Hot plate Hi1220 Leica Wetzlar, DE 
Hybridization oven InSlide Out 241000 Boekel Scientific  Feasterville, USA 
Incubator (bacteria) AL01-07 Advantage-Lab Schilde, BE 
Incubator (cell culture) 
HERAcell 
150i CO2 50115191 A 
Thermo Fisher 
Scientific 
Langenbold, DE 
Laminar Flow Cabinet 51012197 Heraeus Meckenheim, DE 
Magnetic stirrer AGE 1200 rpm VELP Scientifica Usmate, IT 
Micro-centrifuge 
 
Pico17 
Thermo Fisher 
Scientific 
Schwerte, DE 
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Microscope body, 
inverted 
(ultramicroscopy) 
TI-Eclipse Nikon Instruments Dusseldorf, DE 
Microscope camera 
(ultramicroscopy) 
CMOS Orca Flash 4.0 Hamamatsu 
Herrsching am 
Ammersee, DE 
Microscope Camera 
(stereomicroscope) 
DFC290 
Leica 
Microsystems 
Wetzlar, DE 
Microscope Camera 
(ApoTome) 
AxioCam MRm Carl Zeiss Jena, DE 
Microscope Color 
Camera (ApoTome) 
AxioCam MRc Carl Zeiss Jena, DE 
Microscope,  
with ApoTome 
AxioObserver Z1 
SIP66732 
Carl Zeiss Jena, DE 
Microwave MW7809 Severin Sundern, DE 
Mini-centrifuge 3722L 
Thermo Fisher 
Scientific 
Schwerte, DE 
Motorized sample 
stage 
(ultramicroscopy) 
M-112.12S 
Physik 
Instrumente 
Karlsruhe, DE 
pH Meter FE20 FiveEasy Mettler Toledo Giessen, DE 
Piezo driven mount 
(ultramicroscopy) 
P-721 PIFOC 
Physik 
Instrumente 
Karlsruhe, DE 
Pipette-boy 
Accu-jet pro 
26300 Brand Wertheim, DE 
Pipettes (10, 20, 
200,1000µL) 
FA10002M 
FA10003M 
FA10005M 
FA10006M 
Gilson Middleton, USA 
Power supply 
electrophoresis 
EV231 Peqlab Erlangen, DE 
Power Units Power Supply 231 Carl Zeiss Jena, DE 
Refrigerators 
Freezers 
4°C, -20°C, -80°C 
G 2013 Comfort 
HERAfreeze 
Liebherr 
Kendro 
Lindau Hanau, DE 
Rocking Platform 4440148 VWR Darmstadt, DE 
Spectrophotometer Nanodrop 1000 Peqlab Erlangen, DE 
Stereomicroscope 
with fluorescence 
Model MZ10F 
10446377 
Leica 
Microsystems 
Wetzlar, DE 
Thermoblock 230-1.00AT Peqlab Erlangen, DE 
Thermocycler 
DANN engine PTC-
200 
BioRAD München, DE 
Vacuum pump Vacuubrand Brand Wertheim, DE 
Vibratome HM650V Microm Dresden, DE 
Vortexer 
Vortex mixer Rx3 
 
VELP Scientifica Usmate, IT 
Vortexer Vortex genius IKA Staufen, DE 
Water bath 10679808 GFL Burgwedel, DE 
Water bath (paraffin) WB Typ1012/1013 GFL Burgwedel, DE 
Water bath 
(cell culture) 
Typ 1003 
11212101K 
Labortechnik Burgwedel, DE 
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Computing Software Producer Registered Office 
DNA sequence 
analysis 
DNA strider 1.4f18 CEA Saclay, FR 
Gel documentation Quantity One Bio-Rad München, DE 
Image acquisition Axiovision 4.8 Carl Zeiss Jena, DE 
Image acquisition 
Leica Application Suite 
3.3.0 
Leica Wetzlar, DE 
Image acquisition 
Olympus Fluoview 
ver.3.1 
Olympus Hamburg, DE 
Image editing Illustrator CS3 Adobe Systems München, DE 
Image processing Adobe Photoshop CS3 Adobe Systems München, DE 
Image processing ImageJ 1.46k 
Wayne Rasband, 
National Institutes 
of Health 
Bethesda, USA 
Image processing ImageJ 1.47n (Fiji) 
Wayne Rasband,  
National Institutes 
of Health 
Bethesda, USA 
Image processing Imarisx64 7.6.1 Bitplane Zürich, CH 
Image processing MATLAB The Mathworks Ismaning, DE 
Statistical analysis GraphPad Prism 5.0 
GraphPad 
Software 
San Diego, USA 
Statistical analysis 
IBM SPSS Statistics 
20.0 
International 
Business 
Machines Corp. 
Ehningen, DE 
 
2.1.3. Laboratory consumables 
Consumables Model/Cat. No. Manufacturer Registered Office 
12-well culture plate 353043 
BD Biosciences 
 
Heidelberg, DE 
24-well culture plate 353047 
BD Biosciences 
 
Heidelberg, DE 
6-well culture plate 353046 BD Biosciences Heidelberg, DE 
Autoclave tape 
 
SteriClin sticky tape 
 
VP group Feuchtwangen, DE 
Blades Apollo 
Apollo Herkenrath 
GmbH & Co KG 
Solingen, DE 
Cover glasses LAME110071 Labomedic Bonn, DE 
Culture dishes 
100x20mm 
831802003 Sarstedt Sarstedt, USA 
DermaClean gloves PFC 4303971 Ansell München, DE 
Embedding cassettes Histosette VWR Darmstadt, DE 
Embedding molds Peel-A-Way  Polysciences Inc. Eppelheim, DE 
Eppendorf tubes 
1.5mL 
72690 Sarstedt Nümbrecht, DE 
Filter tips  
ART 100/200/1000 
barrier tips 
Thermo Fisher 
Scientific 
Schwerte, DE 
Forceps Dumont  (#5) 11252 – 30 
Fine Science 
Tools 
Heidelberg, DE 
Graefe Forceps 
(0.8mm) 
11050-10 
Fine Science 
Tools 
Heidelberg, DE 
Iris scissors (11 cm) 14060-11 
Fine Science 
Tools 
Heidelberg, DE 
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Iris Scissors (9 cm) 14060-09 
Fine Science 
Tools 
Heidelberg, DE 
Lens Cleaning Tissue 
105 2105841 Whatman Dassel, DE 
Liquid scintillation vials Z190527 Sigma-Aldrich  Steinheim, DE 
Microcentrifuge tubes 
1.5mL 
780400 BIO-CERT Wertheim, DE 
Microtome/Cryostat 
blades 
819 Leica Wetzlar, DE 
Millicell membrane 
insert 
PIGMORG 50 Merck Millipore  Darmstadt, DE 
Perforated spoon 
Moria MC17BIS 10370 
-18 
Fine Science 
Tools 
Heidelberg, DE 
Noyes Spring Scissors 
(14 mm) 
15012-12 
Fine Science 
Tools 
Heidelberg, DE 
Parafilm PM-996 Bemis Köln, DE 
Pasteur plastic 
pipettes 1mL 
2655181 VWR Darmstadt, DE 
Pasteur-Plastic Pipette 2655181 VWR Darmstadt, DE 
PCR strip tubes 732-0551 VWR Darmstadt, DE 
PCR strip tubes 
individual cap 
732-0545 VWR Darmstadt, DE 
PCR tubes  0.2mL 81-38440 PEQLAB Erlangen, DE 
Petri dishes 
100x15mm 
351029 BD Biosciences Heidelberg, DE 
Petri dishes 35x10mm 351008 BD Biosciences Heidelberg, DE 
Polypropylene conical 
tubes 1.5mL 
352096 BD Biosciences Heidelberg, DE 
Polypropylene conical 
tubes 50mL 
352070 BD Biosciences Heidelberg, DE 
Razor Blade 121-6 Plano GmbH Wetzlar, DE 
Rein Rotmarder Brush 
770 
149-2120 VWR Darmstadt, DE 
Round bottom tubes – 
17x100mm 
352059 BD Biosciences Heidelberg, DE 
Serological pipettes 
4487 (5mL) 
4488 (10mL) 
4489 (25mL) 
Corning Life 
Sciences 
Kaiserslautern, DE 
Single use feeding 
needle 
18061-20 
Fine Science 
Tools 
Heidelberg, DE 
Slides boxes HS15994E Carl Roth Karlsruhe, DE 
Sterifilp Sterile 
Disposable Vacuum 
 
9479650 Merck Millipore  Darmstadt, DE 
Student Surgical 
Scissors 
91401-12 
Fine Science 
Tools 
Heidelberg, DE 
Surgical Blade no.10 0201000010 
Feather Safety 
Razor co.LTD 
Köln, DE 
Syringes – 1mL 300013 BD Biosciences Heidelberg, DE 
Tissue Wipers 05511 Kimtech Surrey, UK 
Winged Needle  P295A05 Venisystems Hospira, USA 
µ-Dishes, 35 mm low 80136 Ibidi Martinsried, DE 
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2.1.4 Chemicals 
Chemicals Catalog no. Manufacturer Registered Office 
Acetic anhydride 1.00639.1000 VWR  Darmstadt, DE 
Ampicillin  A5354 Sigma-Aldrich Steinheim, DE 
Agarose 16500-500 Life Technologies Darmstadt, DE 
AMD3100 
octahydrochloride 
A5602 Sigma-Aldrich Steinheim, DE 
Ampuwa water 40676.00.00 
Ampuwa, 
Fresenius 
Bad Homburg, DE 
Aqua-PolyMount  18606 Polysciences Inc. Eppelheim, DE 
Ascorbic acid A4403 Sigma-Aldrich Steinheim, DE 
Benzyl alcohol 402834 Sigma-Aldrich Steinheim, DE 
Benzyl benzoate B6630 Sigma-Aldrich Steinheim, DE 
Bisbenzimide H33258 
(Hoechst 33258) 
10mg/mL B2883 Sigma-Aldrich Steinheim, DE 
BM purple AP 
substrate 
11442074 Roche  Penzberg, DE 
Bromphenol blue A1120.005 AppliChem Darmstadt, DE 
CaCl 22322.295 VWR Darmstadt, DE 
Chlorophorm  22711.260 VWR Darmstadt, DE 
Corn Oil C8267 Sigma-Aldrich Steinheim, DE 
Denhardt’s Solution 
50x concentrate 
D2532 Sigma-Aldrich Steinheim, DE 
Dextran sulfate A4970.0250 AppliChem Darmstadt, DE 
Digoxigenin-labeled 
NTPs 
11277073910 Roche Penzberg, DE 
DMEM 41966-029 Life Technologies Darmstadt, DE 
DMSO D8418 Sigma-Aldrich  Steinheim, DE 
DNA ladder (1kb) 10787-018 Life Technologies Darmstadt, DE 
DNAse I LS002138 Cell Systems Kirkland, USA 
dNTPs (100mM) 28-4065-52 GE Healthcare Dornstadt, DE 
EDTA E6511 Sigma-Aldrich Steinheim, DE 
Ethanol 20821.321 VWR  Darmstadt, DE 
Ethidium bromide 2218.2 Carl Roth Karlsruhe, DE 
Formamide 155-15026 Life Technologies Darmstadt, DE 
Gel red  41003 Biotium Hayward, USA 
Glucose G7528-250g Sigma-Aldrich Deisenhofen, DE 
Glue  
Roti coll 1 
0258.1 
Carl Roth  Karlsruhe, DE 
Glycerol BP 229-1 
Thermo Fisher 
Scientific 
Schwerte, DE 
Goat serum G9023519 Sigma-Aldrich Steinheim, DE 
Hanks’Balanced Salts 
solution 
H9394-100mL Sigma-Aldrich Steinheim, DE 
Hexane 21390.293 VWR Darmstadt, DE 
Histoacryl glue BRAU9381104 Braun Aesculap Tuttlingen, DE 
Horse Serum 26050-088 Life Technologies Darmstadt, DE 
Immersol TM518F Carl Zeiss Jena, DE 
Isoflurane 
Forane 
2594.00.00 
Abbott Wiesbaden, DE 
Isopropanol P/7500/15 
Thermo Fisher 
Scientific 
Schwerte, DE 
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Propidium Iodide P4864 Sigma-Aldrich Steinheim, DE 
KCl 26764.260 VWR Darmstadt, DE 
Luria-Bertani-Medium A0954 AppliChem Darmstadt, DE 
MgCl 25108.260 VWR Darmstadt, DE 
Na2HPO4 28028.298 VWR Darmstadt, DE 
NaCl 27808.297 VWR Darmstadt, DE 
NaH2PO4 28013.264 VWR Darmstadt, DE 
NaHCO3  27775.293 VWR Darmstadt, DE 
NaOH 31627.290 VWR Darmstadt, DE 
Normal donkey serum 017-000-121 
Jackson 
ImmunoResearch 
Suffolk, UK 
Paraffin Remover 41-5600-00 Medite Burgdorf, DE 
Paraformaldehyde 0335.2 Carl Roth Karlsruhe, DE 
PBS tablets 18912-014 Life Technologies Darmstadt, DE 
PCR purification kit 28104 Qiagen  Hilden, DE 
Penicillin-Streptomicin 
100x 
P4333 Sigma-Aldrich Steinheim, DE 
Phenol A0889.0100 AppliChem Darmstadt, DE 
Polyethyleneglycol  P5413 Sigma-Aldrich Steinheim, DE 
Plasmidial DNA 
isolation 
Maxiprep Pure Link 
K210017 
Life Technologies Darmstadt, DE 
Progesterone P-3972 Sigma-Aldrich Steinheim, DE 
Ribonucleic acid, 
transfer, from Bakers 
Yeast 
R5636 Sigma-Aldrich Steinheim, DE 
Rnase  inhibitor 13398800 Roche Penzberg, DE 
Sarcosyl L9150 Sigma-Aldrich Steinheim, DE 
SDF1alpha/CXCL12 250-20A PeproTech Hamburg, DE 
Sodium azide S2002 Sigma-Aldrich Deisenhofen, DE 
Sucrose 27480.360 Sigma-Aldrich Deisenhofen, DE 
Tamoxifen T5648 Sigma-Aldrich Deisenhofen, DE 
Taq DNA polymerase 
recombinant 
10342-020 Life Technologies Darmstadt, DE 
Tetramisole 
hydrochloride 
L9756 Sigma-Aldrich  Steinheim, DE 
ThermoClean 25220100 Bioanalytic Freiburg, DE 
Tissue Tek O.C.T. 4583 Sakura 
Alphen aan den 
Rijn, NL 
Triethanolamine 28746290 VWR Darmstadt, DE 
Tris-HCl 108219.1000 Merck Millipore Darmstadt, DE 
TritonX100 1.08603.1000 Merck Millipore Darmstadt, DE 
Tween20 28829.183 VWR Darmstadt, DE 
UltraPure LMP 
Agarose 
15517-022 Life Technologies Darmstadt, DE 
Xylene CN80.2 Carl Roth Karlsruhe, DE 
 
2.1.5 Antibodies 
2.1.5.1 Primary antibodies 
Primary Antibodies Cat. No. Manufacturer Registered Office 
Anti-DIG-AP Fab 
fragments 
11093274910 Roche  Penzberg, DE 
Mouse anti-BrdU 555627 BD Biosciences Heidelberg, DE 
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Mouse anti-Brn3a Sc-8429 
Santa Cruz 
Biotechnology 
Heidelberg, DE 
Mouse anti-Reelin 
(CR-50) 
D223-3 MBL Eching, DE 
Mouse anti-TH MAB318 Merck Millipore  Darmstadt, DE 
Mouse Biotynilated 
anti-Cxcr4 
AB097 BD Biosciences Heidelberg, DE 
Rabbit anti-Calbindin CB38 Swant Bellinzona, CH 
Rabbit anti-cleaved 
Caspase-3 
9664S Cell Signaling Leiden, NL 
Rabbit anti-CXCR4 
(UMB-2) 
Kindly provided by R.Stumm laboratory (Fischer et al., 2008)  
Rabbit anti-GFP A11122 Life Technologies Darmstadt, DE 
Rabbit anti-GIRK2 APC-006 Alomone labs Jerusalem, IL 
Rabbit anti-Lmx1a AB10533 Merck Millipore  Darmstadt, DE 
Rabbit anti-Nurr1 Sc-990 
Santa Cruz 
Biotechnology  
Heidelberg, DE 
Rabbit anti-TH AB152 Merck Millipore  Darmstadt, DE 
Rat anti-GFP 04404-26 Nacalai Tesque Kyoto, JP 
 
2.1.5.2 Secondary antibodies 
Secondary 
Antibodies/ 
Conjugates  Cat. No. Manufacturer Registered Office 
Alexa Flour 488-
conjugated donkey 
anti-rabbit IgG 
A21206 Life Technologies Darmstadt, DE 
Alexa Flour 488-
conjugated donkey 
anti-rat IgG 
AB150149 Life Technologies Darmstadt, DE 
Biotynilated anti-
guinea pig 
706-065-148 
Jackson 
ImmunoResearch 
Suffolk, UK 
Biotynilated anti-rabbit 711-065-152 
Jackson 
ImmunoResearch 
Suffolk, UK 
Biotynilated anti-rat 712-065-150 
Jackson 
ImmunoResearch Suffolk, UK 
Biotynilated donkey 
anti-mouse 715-065-150 
Jackson 
ImmunoResearch Suffolk, UK 
Cy3- conjugated 
Streptavidin  016-160-084 
Jackson 
ImmunoResearch Suffolk, UK 
Cy3-conjugated 
donkey anti-goat IgG 05-165-147 
Jackson 
ImmunoResearch Suffolk, UK 
Cy3-conjugated 
donkey anti-ms IgG 715-165-150 
Jackson 
ImmunoResearch Suffolk, UK 
Cy3-conjugated 
donkey anti-rabbit IgG 11-165-152 
Jackson 
ImmunoResearch Suffolk, UK 
DyLight 488-
conjugated donkey 
anti-Guinea Pig IgG 706-485-148 
Jackson 
ImmunoResearch Suffolk, UK 
DyLight 488-
conjugated donkey 
anti-rat IgG 712-485-150 
Jackson 
ImmunoResearch Suffolk, UK 
DyLight 647- 712-606-150 Jackson Suffolk, UK 
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conjugated donkey 
anti-rat IgG 
 ImmunoResearch 
 
2.1.6 Enzymes 
General enzymes Cat. No. Manufacturer Registered Office 
Proteinase K 03115879001 Roche Penzberg, DE 
Deoxyribonuclease 
(DNAse) 
M610A Promega Corp Mannheim, DE 
Ribonuclease (RNAse 
A) 
PureLink 12091-021 Life Technologies  Darmstadt, DE 
Restriction enzymes Cat. No. Manufacturer Registered Office 
BamHI RO189S 
New England 
Biolabs 
Frankfurt am 
Main, DE 
EcoRV RO195S 
New England 
Biolabs 
Frankfurt am 
Main, DE 
NotI RO189S 
New England 
Biolabs 
Frankfurt am 
Main, DE 
SphI RO182S 
New England 
Biolabs 
Frankfurt am 
Main, DE 
 
2.1.7 RNA and DNA Polymerases 
Polymerase Cat. No. Manufacturer Registered Office 
Taq DNA Polymerase 
Recombinant (500U) 
10342-020 Roche  Penzberg, DE 
Taq RNA SP6 
Polymerase (1000U) 
10810274001 Roche  Penzberg, DE 
Taq RNA T3 
Polymerase (1000U) 
11031163001 Roche  Penzberg, DE 
Taq RNA T7 
Polymerase (1000U) 
10881767001 Roche  Penzberg, DE 
 
2.1.8 RNA in situ probes 
RNA 
Probe 
Gene name Description 
Restriction 
Enzyme 
RNA 
Polymerase 
Provided 
by 
RELN Reelin 
pCRII-Topo 
vector, 0.64 kb 
(cDNA)RELN 
inserted fragment 
NotI Sp6 
Mengqing 
Xiang lab, 
Rutgers 
University 
ApoER2 
Low-density 
lipoprotein 
receptor-
related 
protein 8 
pCRII-Topo 
vector, 
(cDNA)ApoER2 
BamHI T7 
Mengqing 
Xiang lab, 
Rutgers 
University 
DAB1 Disabled-1 
pYX-Asc vector 
with 0.66 kb 
(cDNA)DAB1 
inserted fragment 
NotI T7 
Source 
Bioscience 
ID 6410411 
VLDLR 
very-low-
density-
lipoprotein 
receptor 
pCRII-Topo 
vector, 0.56kb 
(cDNA)VLDLR 
inserted fragment  
BamHI T7 
Mengqing 
Xiang lab, 
Rutgers 
University 
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CXCR4 
C-X-C 
chemokine 
receptor 
type 4 
pCRII-Topo 
vector,1kb 
(cDNA)CXCR4 
inserted fragment 
EcoRV SP6 
Fadel Tissir,  
Université 
catholique 
de Louvain 
CXCL12 
C-X-C motif 
chemokine 
12 
pCRII-Topo 
vector, 1kb 
(cDNA)CXCL12 
inserted fragment 
EcoRV SP6 
Fadel Tissir,  
Université 
catholique 
de Louvain 
CXCR7 
C-X-C 
chemokine 
receptor 
type 7 
pGEM T easy 
vector, 1.3 kb 
(cDNA)CXCR7 
inserted fragment 
SphI SP6 
Ralf Stumm, 
University of 
Jena  
 
2.1.9. PCR primers used for genotyping mice 
Primer  Sequence 5’- 3’ 
ApoER2  
MT R: GCTTGTTGGAATTCAGCCAGTTACC 
WT R: CCACAGTGTCACACAGGTAATGTG 
WT F: ACGARGACCCCAATGACAGCAGCG 
MT F: GATTGGGAAGACAATAGCAGGCATGC 
Cre 
F: TAAAFATATCTCACGTACTGACGGTG 
R: TCTCTGACCAGAGTCATCCTTAGC  
Cxcl12 
F: ACGCCAAGGTCGTCGCCGZGCTGG 
R: GTTAGGGTAATACAATTCCTTAGA 
Cxcr4 
WT F: CTGTCATCCCCCTGACTGAT 
WT R: TTCTCATCCTGGCCTTCATC 
MT: CACGAGACTAGTGAGACGTG 
Dab1  
WT F: CGGCAGGGAGTAGTAGATCG 
WT R: AGGAGCGAAATCACTCAAGC  
MT R: AGACTGCCTTGGCAAAAGCG 
Reeler 
WT F: CTGCTACACACTTGACATACCTTAATCTAC  
WT R: AGAGCCTAGAGGTTAGGGACACAACTCTTC 
MT F: TAAGGGAGTCCTGGTCTCTTTCTGTCTTTA 
R26 
RR1: AAAGTCGCTCTGAGTTGTTAT 
RR2: GCGAAGAGTTTGTCCTCAACC 
RR3: GGAGCGGGAGAAATGGATATG 
Vldlr 
WT F: TGGTGATGAGAGGCTTGTATGTTGTG 
WT R: TTGACCTCATCGCTGCCGTCCTTG 
MT F: CGGCGAGGATCTCGTCGTGACCCA 
MT R: GCGATACCGTAAAGCACGAGGAAG 
 
2.1.10 Buffers and solutions  
Buffers /Solutions Content 
Solutions for genotyping 
Lysis Buffer (for genotyping) 
333 µL 1.5 M Tris, pH 8.8 (50 mM), 20 µL 0.5 M EDTA (1 
mM), 500 µL 10% Tween, 9.1 mL dH2O  
Solutions for RNA in situ hybridization  
Triethanolamine (TEA)-HCl  
0.1M 
650 µL TAE in 50 mL Ampuwa H2O, 130 µL 12M HCl 
RNAse A 
100 mg RNAse A, 100 µl Tris-HCL (pH 7.5), 30 µl 5 M 
NaCl (15 mM), 9.8 mL  
SSC 20X 
88.2 g NaCitrate (C6 H5 Na3 O7), 174 g NaCL in 1 L 
Ampuwa H2O (pH 7.0) 
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RNase Buffer 
100 mL 5 M NaCl (0.5 M), 10 mL 1 M Tris-HCl (pH 7.5, 10 
mM), 10 mL 0.5 M EDTA (pH 8, 5 mM), 880 mL dH2O 
NTMT 
2 mL 5 M NaCl (100 mM) 10 mL 1 M Tris-HCl, pH 9.5 
(100 mM) 5 mL 1 M MgCl2 (50 mM) 0.1 mL Tween 20 
(0.1%) 82.9 mL dH2O 
Hybridization Solution 
50 mL Formamide (deionized), 20 mL 50% Dextran 
sulfate, 2 mL 50x Denhardt’s, 2.5 mL yeast tRNA (10 mg/ 
mL), 6 mL 5 M NaCl, 2 mL 1 M Tris-HCl (pH 8.0), 1 mL 0.5 
M EDTA, 1 mL 1 M NaPO4 (pH 8.0), 5 mL 20% Sarcosyl, 
11.5 mL Ampuwa H2O  
TE buffer pH8.0 
1mL 1M Tris-HCl pH8, 200µL 0.5M EDTA; up to 100mL 
with dH2O 
Washing solution Tween 0.1% in PBS (1x) 
Solutions for bacteria transformation  
LB medium 
25 g of powder of LB medium according to Miller in 1 L 
dH2O, autoclaved and cooled to RT, added 1mg/mL 
Ampicillin, stored at 4°C  
TSB buffer, pH 6.5 
5g Polyethyleneglycol (10%), 2.5 mL 1M MgCl2 (50mM), 
2.5 mL DMSO (5%), up to 50 mL in dH2O, pH 6.7; filtered 
sterile and stored at 4°C. 
Agar-LB medium 
40 g of powder of LB agar according to Miller in 1 L dH2O, 
pH 7.5, autoclaved and cooled to 50°C, added 1mg/mL 
Ampicillin, stored at 4°C  
Solutions for organotypic slice culture preparation 
Culture medium 
 
48.73% DMEM high glucose, 25% Horse serum, heat 
inactivated, 25% HBSS 1X, 1.27%Glucose, 
Penicillin/Streptomycin1x, filtered sterile and stored at 4°C  
Krebs (10x) 
252 mL NaCl 5M, 25mL  KCl 1M, 12mL  NaH2PO4 1M, 
12mL MgCl2 1M and 3,68 g CaCl2 up to 1L with dH2O, 
stored at 4°C up to 3 months 
Krebs (1x) 
100mL Krebs buffer (10x), 50mL NaHCO3 0.5M, 1,98 g 
Glucose, up to 1L with dH2O, used fresh 
LMP-agarose (4%) 
4 g LMP agarose in 100 mL dH2O, melted in a microwave 
and kept at 45°C in a water bath. 
Solutions for immunofluorescence 
PBS (5x) 
40 g NaCl (137 mM) 1 g KCl (2,7 mM) 7.1 g Na2HPO4 (10 
mM) 1.36 g KH2P4 (2 mM) in 1 L dH2O  
PBS-azide (0.1%) 0.1% sodium-azide in PBS 
PFA (20%, 
Paraformaldehyde) 
500 g PFA 2.0 L ddH2O 8.0 mL NaOH, filtered through 0.4 
μm filter and stored at -20°C 
Fixation solution (4% PFA) 10 mL 20% PFA in 50mL PBS  
PBT (0.1%) 10 mL 10% Triton-X (0.1 %), 990 mL PBS (1x) 
PBT (0.2%) 20 mL 10% Triton-X (0.2 %), 980 mL PBS (1x) 
Washing solution 0.1% Triton-100x in PBT 
Blocking solution 10% NDS  in PBT  
Citrate Buffer, 10 mM, pH 6.0 
(for paraffin sections) 
1.92 g Citric acid (anhydrous), 0.05%Tween 20 in 1 L 
dH2O 
Borate Buffer, 0.1 M, pH 8.5 
(for BrdU staining) 
3.10 g Boric acid, 4.8 g Sodium tetraborate⋅ 10 H2O in 1 L 
dH2O 
Solutions for gel electrophoresis 
50 x Tris-acetate-buffer (TAE) 
242g Tris-base, 100mL 0.5M EDTA (pH 8.0), 57.1mL 
glacial acetic acid in 1L H2O, stored at room temperature 
1 x TAE 
50 x TAE was diluted 1:50 with H2O, stored at room 
temperature 
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10x Loading buffer 
50%Glycerol, 0.4%; Bromphenol blue 0.4%; Xylene 
Cyanol, Mixed and stored at 4°C 
 
2.2 Mice 
2.2.1 List of mouse lines  
Common 
symbol  
Allele symbol and 
name  
Allele type 
Provided by/ 
Purchased from 
Reference 
Apoer2 KO 
LRP8
tm1Her 
Targeted mutation 1, 
Joachim Herz 
Targeted 
(Knockout) 
Amparo Acker-Palmer 
lab, Goethe University 
Frankfurt 
(Trommsdorff 
et al., 1999) 
CD1 Wild-type Wild-type 
Charles River 
Laboratories   
Cxcl12 KO 
Cxcl12tm1Tng 
Targeted mutation 1, 
Takashi Nagasawa 
Targeted 
(Knockout) 
Ralf Stumm lab, Jena 
University 
(Nagasawa et 
al., 1996)  
Cxcr4 KO 
Cxcr4tm1Qma 
Targeted mutation 1, 
Qing Ma 
Targeted 
(Knockout) 
Ralf Stumm lab, Jena 
University 
(Ma et al., 
1998)  
Dab1 KO 
Dab1tm1Cpr 
Targeted mutation 1, 
Jonathan A Cooper 
Targeted 
(Knockout) 
Amparo Acker-Palmer 
lab, Goethe University 
Frankfurt 
(Howell et al., 
1997)  
R26EYFP 
Gt(ROSA)26Sortm1Sor 
Targeted mutation 1, 
Philippe Soriano 
Targeted 
(Reporter) 
Frank Costantini lab, 
Columbia University 
(Srinivas et 
al., 2001)  
Reeler  
Relnrl 
Reeler 
Spontaneous 
Amparo Acker-Palmer 
lab, Goethe University 
Frankfurt 
 (Bar et al., 
1995)  
ShhCreER 
Shhtm2(cre/ERT2) 
Targeted mutation 2, 
Clifford J Tabin 
Targeted 
(Knock-in) 
Clifford Tabin lab, 
Harvard University 
 (Harfe et al., 
2004)  
Vldlr KO 
Vldlrtm1Her 
Targeted mutation 1, 
Joachim Herz 
Targeted 
(Knockout) 
Amparo Acker-Palmer 
lab, Goethe University 
Frankfurt 
(Frykman et 
al., 1995)  
 
2.2.2 Mice breeding and maintenance 
All transgenic mouse lines were bred into a CD1 background strain. To reduce genetic drift, 
transgenic mice were intercrossed every second generation with outbred CD1 mice. The mice 
were housed and bred in a controlled environment, with 12 hours light/night cycles. Food and 
water supply was available ad libidum. All animal experiments were performed in accordance 
with the regulations approved by the University of Bonn Animal Care and Use Committee. 
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2.2.3 Mouse genetics  
2.2.3.1 Genetic inducible fate mapping system 
ShhCreER/+ allele was generated by knocking in a CreER cassette into the Shh locus (Harfe et al., 
2004). Tamoxifen administration to these mice induces Cre recombinase expression in all cells 
expressing Shh. R26EYFP/EYFP reporter mice were generated by inserting a loxP-flanked STOP 
sequence followed by the Enhanced Yellow Fluorescent Protein gene (EYFP) into the 
Gt(ROSA)26Sor locus (Srinivas et al., 2001). When bred to mice expressing Cre recombinase, 
the Stop sequence is deleted and EYFP expression is observed in the Cre-expressing tissue(s) 
of the double mutant offspring. The ShhCreER/+ mice were crossed to R26EYFP/EYFP reporter mice 
to generate ShhCreER/+; R26EYFP/+ descendants. The ShhCreER/+; R26EYFP/EYFP males were mated 
with CD1 wild-type females to generate ShhCreER/ +; R26EYFP/+ progeny.  
Embryonic day 0.5 (E 0.5) was considered the noon of the day when a vaginal plug was 
detected. Tamoxifen (TM) was dissolved in corn oil at 20 mg/mL. To reduce miscarriages, 5 
mg/mL Progesterone was added into the TM solution. Pregnant females were given 3-4 mg TM 
through oral gavage with animal feeding needles at 12 pm of E8.5 or E11.5. The ShhCreER/+  and 
R26
EYFP allele was identified by PCR-based genotyping using specific oligonucleotides, as 
previously described (Kimmel et al., 2000; Soriano, 1999). For primer sequences and 
genotyping procedure see sections 2.1.9 and 2.2.7. 
2.2.3.2 Inactivation of the Reelin signaling pathway 
The Vldlr, Apoer2 and Dab1 knockout (KO) mice were developed in the laboratory of Dr. 
Joachim Herz. Brains of adult and embryo Reeler mice, adult brains of Vldlr, Apoer2, Dab1 
knockouts and Apoer2/Vldlr double knockout, together with control littermates were kindly 
provided by the laboratory of Prof. Amparo Acker-Palmer, Goethe University Frankfurt. 
Genotyping, perfusion and dissection of the brains were performed in the laboratory of Prof. 
Amparo Acker-Palmer.  
Reeler mice have a spontaneous mutation in the Reeler gene (Relnrl), which encodes for the 
Reelin protein (Bar et al.1995). Therefore no Reelin protein is produced. The Vldlr, Apoer2 and 
Dab1 KO mice were produced by disrupting the gene’s reading frame via inserting a neomycin-
resistance cassette through gene targeting. The Vldlr KO mice were generated by inserting the 
neomycin-resistance cassette into exon 5, which encodes a part of the ligand binding region of 
Vldlr (Frykman et al., 1995). The Apoer2 KO mice were generated by inserting the neomycin-
resistance cassette into exons 17 and 18, encoding for the transmembrane segment and part of 
the cytoplasmic tail of the Apoer2 (Trommsdorff et al., 1999). The Dab1 KO mice were 
generated by inserting the neomycin-resistance cassette into exon 2, encoding for the first 
aminoacids of the phosphotyrosine-binding domain of Dab1 (Howell et al., 1997).  
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2.2.3.3 Inactivation of CXCL12/CXCR4 signaling pathway  
Generation of Cxcr4 KO and Cxcl12 KO mice was performed by inserting a neomycin-
resistance cassette in exon 2 of the Cxcr4 or Cxcl12 genes, which encodes for the fourth 
transmembrane domain of Cxcr4 (Ma et al., 1998) or for the Cxcl12 binding region, respectively 
(Nagasawa et al., 1996). The insertion of the neomycin-resistance cassette disrupts the reading 
frame and no protein product is detectable by western blot analysis. Brains of Cxcr4 and Cxcl12 
KO embryos, together with control littermates were kindly provided by the laboratory of Prof. R. 
Stumm, Jena University. Dissection, genotyping and PFA fixation of the brains was performed 
in the laboratory of Prof. R. Stumm. 
 
2.3 Molecular biology  
 
2.3.1 Genotyping of the mice  
 
2.3.1.1 Tissue lysis 
For identification of genetically modified animals in a litter, a small piece of tissue from the ear 
(ear punch), the tail tip (for E11.5-18.5 and postnatal mice) was collected for genotyping. 
The tissue was digested in 100 μL lysis buffer with 1 μL proteinase K at 60°C overnight, 
followed by heat inactivation of proteinase K at 95°C for 10 min. 1 μl of the clear superficial 
layer of the digest-solution, which contained the genomic DNA, was analyzed by PCR.  
2.3.1.2 PCR protocols  
The following PCR protocols were performed: 
Rosa26  
Amount of reaction component 
 Thermal cycler Program 
  1.00 µL sample 
  2.00 µL  PCR rxn buffer (1x)  
Steps 
Temp. 
°C       
Time 
min.   0.16 µL  dNTPs (25 nM) 
  1.00 µL   R26-RR1 (5 µM) primer 1) 1st Denaturing 94 2:00 
  1.00 µL   R26-RR2 (5 µM) primer 2) Denaturing 94 1:00 
  1.00 µL   R26-RR3 (5 µM) primer 3) Annealing 61 1:00 
  0.60 µL MgCl2 (1.5 mM) 4) Extension 72 10:00 
13.04 µL dH2O  5) Last Extension 72 10:00 
    0.2 µL Taq Polymerase (1 U) 6) Incubation 8 hold 
20.00 µL volume (total) Repeat steps 2 – 4 for 30 cycles 
Gel electrophoresis – 1.5% agarose,  wild-type: 500 bp, mutant: 220 bp 
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Cre  
Amount of reaction component 
 Thermal cycler Program 
  1.00 µL sample 
  2.00 µL  PCR rxn buffer (1x)  
Steps 
Temp. 
°C       
Time 
min.   0.16 µL  dNTPs (25 nM) 
  1.00 µL   F (5 µM) primer 1) 1st Denaturing 95 2:00 
  1.00 µL   R (5 µM) primer 2) Denaturing 95 0:40 
  0.60 µL MgCl2 (1.5 mM) 3) Annealing 59 1:00 
14.04 µL dH2O  4) Extension 72 0:50 
    0.2 µL Taq Polymerase (1 U) 5) Incubation 8 hold 
20.00 µL volume (total) Repeat steps 2 – 4 for 30 cycles 
Gel electrophoresis – 1.5% agarose,  mutant: 300bp 
Reeler  
Amount solution / sample 
 Thermal cycler Program 
  1.00 µL sample 
  2.00 µL  PCR rxn buffer (1x)  
Steps 
Temp. 
°C       
Time 
min.   0.16 µL  dNTPs (25 nM) 
  1.00 µL WT-F (5 µM) primer 1) 1st Denaturing 95 2:00 
  1.00 µL WT-R (5 µM) primer 2) Denaturing 95 0:30 
  1.00 µL MT-F (5 µM) primer 3) Annealing 63 0:30 
  0.60 µL MgCl2 (1.5 mM) 4) Extension 72 1:00 
14.04 µL dH2O  5) Last extension 72 10:00 
    0.2 µL Taq Polymerase (1 U) 6) Incubation 8 hold 
20.00 µL volume (total) Repeat steps 2 – 4 for 30 cycles 
Gel electrophoresis – 1.5% agarose:  MT band 300bp 
 
Dab1 protocol 1 
Amount of reaction component  Thermal cycler Program 
  2.00 µL sample  
Steps 
Temp. 
°C       
Time 
min.   2.40 µL  PCR rxn buffer (5x) 
  0.24 µL  dNTPs (10 mM) 1) 1st Denaturing 94 2:00 
  0.30 µL WT (20 µM) primer 2) Denaturing I 94 0:20 
  0.30 µL MT-R (20 µM) primer 3) Annealing WT-F 65 0:15 
  0.96 µL MgCl2 (25 mM) 4) Annealing MT-R 68 0:10 
  5.75 µL dH2O  5) Denaturing II 94 0:15 
  0.05 µL Taq Polymerase (5U/µL)  6) Annealing 60 0:15 
12.00 µL volume (total) 7) Extension 72 0:10 
 Gel electrophoresis – 1.5% agarose 
 MT Wild-type: 344 bp; Mutant band: 150 bp 
8) Last extension 72 2:00 
9) Incubation 10 hold 
Repeat steps 2 – 4 for 10 cycles 
Repeat steps 5 – 7 for 28 cycles 
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Dab1 protocol 2 
Amount of reaction component  Thermal cycler Program 
  2.00 µL sample  
Steps 
Temp. 
°C       
Time 
min.   2.40 µL  PCR rxn buffer (5x) 
  0.24 µL  dNTPs (10 mM) 1) 1st Denaturing 94 2:00 
  0.30 µL WT (20 µM) primer 2) Denaturing I 94 0:20 
  0.30 µL WT-R (20 µM) primer 3) Annealing WT-F 65 0:15 
  0.96 µL MgCl2 (25 mM) 4) Annealing MT-R 68 0:10 
  5.75 µL dH2O  5) Denaturing II 94 0:15 
  0.05 µL Taq Polymerase (5U/µL)  6) Annealing 60 0:15 
12.00 µL volume (total) 7) Extension 72 0:10 
 Gel electrophoresis – 1.5% agarose 
 Wild-type: 344 bp 
8) Last extension 72 1:00 
9) Incubation 10 hold 
Repeat steps 2 – 4 for 10 cycles 
Repeat steps 5 – 7 for 28 cycles 
 
Apoer2  
Amount of reaction component 
 Thermal cycler Program 
  2.00 µL sample 
  1.20 µL  PCR rxn buffer (10x)  
Steps 
Temp. 
°C       
Time 
min.   0.96 µL  dNTPs (2.5 mM) 
  0.60 µL WT-F (20 µM) primer 1) 1st Denaturing 94 1:50 
  0.60 µL WT-R (20 µM) primer 2) Denaturing 94 0:30 
  0.30 µL MT-F (20 µM) primer 3) Annealing 56 0:45 
  0.30 µL MT-R (20 µM) primer 4) Extension 72 0:45 
  0.72 µL MgCl2 (25 mM) 5) Last extension 72 2:00 
  4.78 µL dH2O  6) Incubation 10 hold 
  0.06 µL Taq Polymerase (5U/µL)  
Repeat steps 2 – 4 for 35 cycles 
 12.00 µL volume (total) 
Gel electrophoresis – 1.5% agarose, wild-type: 602 bp, mutant: 420 bp 
 
Vldlr  
Amount of reaction component  Thermal cycler Program 
  2.00 µL sample  
Steps 
Temp. 
°C       
Time 
min.   1.20 µL  PCR rxn buffer (10x) 
  0.96 µL  dNTPs (2.5 mM) 1) 1st Denaturing 94 3:00 
  0.30 µL WT-F (20 µM) primer 2) Denaturing 94 0:20 
  0.30 µL WT-R (20 µM) primer 3) Annealing 65 
0:15* 
(*0.5°C/cycle) 
  0.30 µL MT-F (20 µM) primer 4) Extension 68 0:10 
  0.30 µL MT-R (20 µM) primer 5) Denaturing 94 0:15 
  0.96 µL MgCl2 (25 mM) 6) Annealing 60 0:15 
  5.64 µL dH2O  7) Extension 72 0:10 
  0.04 µL Taq Polymerase (5U/µL)  8) Last extension 72 2:00 
12.00 µL volume (total) 9) Incubation 10 hold 
  2.00 µL sample Repeat steps 2 – 4 for 10 cycles 
Repeat steps 5 – 7 for 25 cycles   1.20 µL  PCR rxn buffer (10x) 
Gel electrophoresis – 1.5% agarose, wild-type: 400 bp, mutant: 200 bp 
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Cxcr4   
Amount of reaction component 
 Thermal cycler Program 
  2.00 µL sample 
  1.20 µL  PCR rxn buffer (10x)  
Steps 
Temp. 
°C       
Time 
min.   0.96 µL  dNTPs (2.5 mM) 
  0.40 µL WT-F (20 µM) primer 1) 1st Denaturing 94 3:00 
  0.40 µL WT-R (20 µM) primer 2) Denaturing 94 0:30 
  0.80 µL MT (20 µM) primer 3) Annealing 62 1:00 
 4) Extension 72 1:00 
  0.96 µL MgCl2 (25 mM) 5) Last extension 72 2:00 
  5.22 µL dH2O  6) Incubation 10 hold 
  0.06 µL Taq Polymerase (5U/µL)  
Repeat steps 2 – 4 for 35 cycles 
 12.00 µL volume (total) 
Gel electrophoresis – 1.5% agarose, wild-type: 193 bp, mutant: 305 bp 
 
Cxcl12   
Amount of reaction component 
 Thermal cycler Program 
  2.00 µL sample 
  1.20 µL  PCR rxn buffer (10x)  
Steps 
Temp. 
°C       
Time 
min.   0.96 µL  dNTPs (2.5 mM) 
  0.40 µL Cxcr4 F (20 µM) primer 1) 1st Denaturing 94 3:00 
  0.40 µL Cxcr4 R (20 µM) primer 2) Denaturing 94 0:30 
  0.96 µL MgCl2 (25 mM) 3) Annealing 62 1:00 
  6.02 µL dH2O  4) Extension 72 1:00 
  0.06 µL Taq Polymerase (5U/µL)  5) Last extension 72 2:00 
 12.00 µL volume (total) 6) Incubation 10 hold 
Gel electrophoresis – 1.5% agarose,  
mutant: 539 bp 
Repeat steps 2 – 4 for 40 cycles 
For primer sequences see section 2.1.9 
 
2.3.1.3 DNA electrophoresis  
The agarose gel was prepared by heating 1.5% standard agarose in TAE buffer until dissolved 
and then allowed to cool down (aprox. 40°C). Ethidium bromide (10 µg/mL) or gel red (1:10000) 
was added and the solution poured into a gel chamber. The PCR mix and 6x loading buffer 
were loaded onto the gel and run for 40 min at 120 V. After electrophoresis, the gel was 
illuminated with a UV lamp of a Gel Doc transilluminator and a picture was captured. 
 
2.3.2 Molecular cloning 
 
2.3.2.1 Generation of competent bacteria  
The plasmids were transformed into competent Escherichia coli (E.coli) DH5α bacteria. 
Competent E.coli were generated following a protocol adapted from Chung and Miller, 1988. 
Bacteria were cultivated on a LB-agar plate without antibiotic at 37°C overnight. Several 
emerging colonies were picked from the plate and grown at 37 °C in 20 mL LB without antibiotic 
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overnight. The following day, 2 µL of overnight culture was used to inoculate 200 mL LB 
medium. Cells were grown at 37°C overnight, until they reached an OD of 0.4-0.45 at 600 nm. 
Next, bacterial culture was centrifuged at 4°C and 4000 rpm for 8 min. The pellet was 
resuspended in 1/10th volume of TSB buffer, then incubated on ice for 10 min. The competent 
cells were aliquoted in a volume of 100 µL and stored at -80°C. To verify the transformation 
efficiency, a 100 µL aliquot of bacteria was mixed with 100 pg plasmid DNA having an antibiotic 
resistance gene. The cells were incubated on ice for 30 min. Next, cells were grown in 900 µL 
TSB buffer with 200 mM glucose at 37°C and 225 rpm for 1 h, to permit expression of the 
antibiotic resistance gene. The cells were plated agar plates, containing the appropriate 
antibiotic for selection of transformants. A transformation efficiency of 2 x 105 transformants per 
µg DNA was obtained. 
2.3.2.2 Bacteria transformation   
100 µL of competent bacteria were thawed on ice for 5 min. 1 µL of desired plasmid was added 
to the competent bacteria. Bacterial cells were then incubated on ice for 30 min. Subsequently, 
bacterial cells were incubated at 42°C for 45 sec using a water bath and then on ice for 2 min. 
900 µL of LB medium without antibiotic was added and the cells were grown at 37°C and 225 
rpm for 1 h using a thermo-block. The cells were centrifuged for 2 min at 2000 rpm and 900 µL 
supernatant were removed. The cells were resuspended in the remaining 100 µL supernatant 
and plated on a LB-agar plate supplemented with the appropriate antibiotic. Bacteria cells were 
cultivated at 37°C overnight.  
2.3.2.3 Preparation of DNA 
Colonies cultivated on LB-agar plate were used to inoculate 3 mL of LB medium supplemented 
with the appropriate antibiotic. The 3 mL cultures were grown at 37°C and 225 rpm for 6 h. 
Next, 200 µL of the 3 mL cultures were used to inoculate 200 mL of LB medium with antibiotic. 
Cells were grown at 37°C and 225 rpm overnight. The following day, bacterial cells were 
centrifuged at 4000 rpm. Pelted cells were resuspended and lysed, and DNA was extracted and 
purified using the PureLink HiPure Plasmid Maxiprep kit according to the manufacturer’s 
protocol. 
 
2.3.3 Measurement of DNA concentration 
For the measurement of DNA content, the NanoDrop system from Peqlab was used. DNA 
concentration was determined measuring at a wavelength of 260nm (nucleic acids peak of 
absorption). Additionally a measurement at a wavelength of 280 nm was done to determine 
eventual protein contamination. A ratio of OD 260/280 > 1.80 was regarded as pure.  
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2.4 Organotypic slice cultures  
 
2.4.1. Organotypic slice preparation 
To directly monitor the migratory behavior of neurons, an organotypic slice culture protocol was 
established. Generation of organotypic brain slices, which allow the normal development of 
ventral MbDA neurons at early developmental stages (E12.5-E14.5) involves a number of 
critical steps, as follows: dissection of the embryonic brain, vibratome sectioning and culturing 
(Figure 11). 
 
2.4.1.1 Dissection and embedding of the embryonic brain 
Pregnant female mice (gestation day 12.5) were anesthetized using isoflurane and sacrificed by 
cervical dislocation. Embryos were dissected out of the uterus and placed on ice in Krebs buffer 
(1x).  To dissect the brains, heads of the embryo were removed and fixed by piercing with 
forceps through the eye level. Another pair of forceps was used to carefully remove the skin and 
skull. Next, brains were lifted out and transferred into fresh ice-cold Krebs buffer (1x).  
Subsequently, the tissue was briefly washed in 4% LMP-agarose at RT and then embedded in 
fresh 4% LMP-agarose. Brains were oriented in a position horizontal to the bottom of the 
agarose block, using a Pasteur pipette with a fire-polished round tip. The 4% LMP-agarose with 
tissue was then placed on ice for 3 min to solidify. Next, the agarose surrounding the tissue was 
trimmed and the brain-agarose blocks were glued onto the specimen stage of a vibratome.  The 
ventral side of the brain (for horizontal sectioning) or the lateral side of the brain (for sagittal 
sectioning) was positioned parallel to the stage. The stage with the glued brain blocks was 
submerged into cold Krebs buffer (1x). 
 
2.4.1.2 Vibratome sectioning  
Brains were sectioned on a vibratome at 300 µm. The Krebs buffer (1x) was maintained at 4°C 
during the sectioning. A frequency of 50 Hz, blade amplitude 1.1 mm and a speed of 25 mm/sec 
were used. Brain slices were collected using a fine paintbrush by moving the slices into a mini 
perforated spoon. 
 
2.4.2 Organotypic slice culture 
Slices were placed on a semi-porous membrane and cultured in serum-supplemented medium 
at 37°C, 5% CO2. Brain slices received medium from below and air from above. The slices were 
maintained in vitro for up to 3 days. 50% of the culture medium was changed on the second day 
of culturing.  
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2.4.3. Organotypic slice culture treatments 
To inhibit Reelin function in slice cultures, 4 µg/mL CR-50 antibody was added to the culture 
medium prior to imaging (Utsunomiya-Tate et al., 2000). The antibody was kept in the medium 
during the entire imaging time, without medium renewing. 
To block CXCL12 signaling, slices were treated with the CXCR4 – antagonist, AMD3100 
(120µM, Sigma) (Borrell and Marin, 2006). The inhibitor was prepared in the culture medium 
and was added to the slices prior to imaging and kept in the medium during the entire imaging 
time.  
 
                            
Figure 11. Schematic illustrating the preparation of organotypic slice cultures. 300 μm 
horizontal and sagittal brain slices was prepared by sectioning an E12.5 brain using a 
vibratome. (A) Schematic sagittal and top views of an E12.5 mouse brain. Levels of sections are 
indicated. (B) Schematics of the slices that can be obtained by horizontal and sagittal sectioning 
and that contain both forebrain (Fb) and midbrain (Mb). The area containing MbDA neurons is 
indicated in green, the area containing MbDA precursors is depicted in yellow, black arrows 
indicate routes of migration. (C) The slices containing dopaminergic neurons are cultured on 
membrane inserts. Abbreviations: vMb, ventral midbrain; dMb, dorsal midbrain; Hyp, 
hypothalamus; Hb, hindbrain. 
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2.5 Histology 
 
2.5.1 Tissue fixation and perfusion 
Pregnant animals were first anesthetized with isoflurane and then sacrificed by cervical 
dislocation. Embryos were removed and placed in ice cold PBS. Embryo heads or brains were 
dissected and washed with ice cold PBS. The heads (E11.5-E16.5) or the brains (E17.5-E18.5) 
were fixed in 4% PFA for 30 - 120 min and washed with PBS. 
Postnatal and adult animals were perfused. The animals were first anesthetized with isoflurane 
and then perfused transcardially under anesthesia, first with PBS and then with 4% PFA. After 
perfusion the brains were dissected, post-fixed in 4% PFA overnight at 4°C and then washed 
with PBS.  
 
2.5.2 Tissue embedding  
For cryo-embedding the fixed tissue was incubated in 15% sucrose, until submerged (6 h to 
overnight) at 4°C. Subsequently, the tissue was incubated in 30% sucrose overnight at 4°C. 
After the tissue was submerged in 30% sucrose, it was embedded in OCT TissueTek, then 
frozen on dry-ice and stored at –80°C.  
For paraffin embedding, the specimen was dehydrated in graded ethanol series (from 70% 
ethanol to 100% ethanol) at room temperature (RT), for 20-30 min for each incubation step. To 
clear the tissue, the specimen was transferred to 100% Xylene at RT. Subsequently, the 
specimen was incubated in three changes of paraffin at 60°C. The tissue was embedded in 
molds filled with fresh paraffin, placed on a hot plate at 64°C. The paraffin blocks were left at RT 
to solidify and then stored at RT. 
 
2.5.3 Tissue sectioning 
Cryosectioning 
The cryo-blocks were sectioned on a cryostat at a knife temperature of -22 to -24°C and an 
object temperature of -20 to -22°C. 12 µm embryonic brain sections were collected on 
superfrost ultra plus adhesion slides in series of ten slides, dried at RT for 2 hours and then 
stored at -20°C. For adult brains, 40 µm sections were collected in a 96 well plate and stored at 
4°C in PBS with 0.01% sodium azide. 
Paraffin-sectioning 
The paraffin blocks were sectioned at a thickness of 7 µm on a microtome. The sections were 
mounted on superfrost ultra plus adhesion slides, dried overnight on a heating plate at 37°C and 
then stored at RT. 
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2.5.4 Immunostaining 
Immunostaining is commonly used to detect antigens in cells and tissue. Antibodies conjugated 
with fluorescent dyes bind to specific antigens.  
2.5.4.1 Immunostaining of frozen and paraffin embryonic brain sections 
Frozen sections were thawed in PBS, briefly fixed in 4% PFA, and then rinsed in PBS and PBT 
(0.1%) at RT for 10 min. 
Paraffin sections were incubated 3 times in Xylene for 3 min each at RT to deparaffinize. Then 
the sections were rehydrated in graded ethanol series (from 100% ethanol to 70% ethanol) at 
RT, 2 min for each incubation step. Subsequently, the paraffin sections were submerged in 10 
mM citrate buffer (pH 6.0) and boiled for 5 min in a pressure cooker.  
Both frozen and paraffin sections were transferred into a humidified chamber and incubated in 
blocking solution (10% NDS/PBT) at RT for 1 h. Sections were incubated in primary antibody 
solution at 4°C overnight or at RT for 2 h. The following primary antibodies and dilutions were 
used: rabbit anti-TH (1:500), rat anti-GFP (1:1500), rabbit anti-LMX1A (1:3000), rabbit anti-
NURR1 (1:200), mouse anti-BRN3A (1:50), rabbit anti-CXCR4 (UMB-2, undiluted), biotinylated 
rat anti-mouse CXCR4 (1:500). Subsequently, the primary antibody solution was removed. The 
sections were washed three times with PBT and then incubated with secondary antibody 
solution at RT for 2 h. The following secondary antibodies and dilutions were used: donkey anti-
rabbit IgG-Alexa 488 (1:500), donkey anti-rabbit Cy3 (1:200), donkey anti-rat IgG-DyLight 488 
(1:100) or donkey anti-rat Alexa 488 (1:500), donkey-anti mouse Cy3 (1:200). For the detection 
of CXCR4, Cy3-labeled streptavidin was used (1:1000). For Hoechst fluorescent 
counterstaining of nuclei, Hoechst solution (1:10000) was added to the secondary antibody 
solution. Sections were washed three times with PBT, air dried for 2 min and then mounted with 
Aqua Polymount. Subsequently, the sections were dried at RT for several hours in the dark and 
then stored at 4°C. All washing steps were carried out in Coplin jars. To prepare the primary 
and secondary antibody solutions, the antibodies were diluted in PBT with 3% NDS. 
2.5.4.2 Immunostaining of adult frozen brain sections 
40 µm floating adult brain sections were washed in PBS and then PBT (0.2%) at RT for 10 min. 
each. Next, sections were stained using the protocol descried in 2.3.4.1. The following primary 
antibodies and dilutions were used: mouse anti-TH (1:500), rabbit anti-Girk2 (1:500) and rabbit 
anti-Calbindin (1:5000). Donkey anti-rabbit IgG-Alexa 488 (1:500) and donkey-anti mouse Cy3 
(1:200) secondary antibodies were used. All washing steps and antibody solutions preparation 
were performed using PBT (0.2%). All steps were carried out in a 12 well plate. 
2.5.4.3 Immunofluorescence staining of embryonic organotypic slice cultures 
Organotypic slice cultures were fixed in 4% PFA at RT for 30 min, then rinsed in PBS and PBT 
(0.2%) for 10 min. Slices were incubated in blocking solution (NDS/PBT (0.2%)) at RT for 2 h. 
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Subsequently, slices were incubated with primary antibody solution at 4°C overnight. The 
following primary antibodies and dilutions were used: rabbit anti-TH (1:500), rat anti-GFP 
(1:1000), mouse anti-BrdU (1:200), rabbit anti-cleaved caspase 3 (1:200). The primary antibody 
solution was removed; slices were washed and then incubated in secondary antibody solution, 
at RT for 3 h. The following secondary antibodies were used: donkey anti-rabbit Cy3 (1:200), 
donkey anti-rat Alexa 488 (1:500). For the detection of BrdU, biotinylated anti-mouse antibody 
(1:200) and Cy3-labeled streptavidin (1:1000) were used. All washing and incubation steps 
were performed using PBT (0.2%). All steps were carried out in a 6 well plate. 
For BrdU staining, the same protocol as above was used, with the following modifications: 
between fixation an blocking steps, slices were incubated with 4M HCl at RT for 10 min, 
neutralized with 0.1M borate buffer at RT for 5 min and washed three times with PBS. 
Throughout the procedure NDS was replaced by goat serum.  
2.5.4.4 Whole mount immunostaining for ultramicroscopy 
Brains from E12.5 embryos were fixed in 4% PFA for 1 h, washed with PBS, incubated with 
blocking solution 10%NDS/ PBT at 4°C overnight. The brains were incubated with primary 
antibodies: rabbit anti-TH (1:500) and rat anti-GFP (1:1000) at 4°C for 2 days. Next, the primary 
antibody solution was removed and the brains were washed three times with PBT at RT for 15 
min. The tissue was incubated with secondary antibodies: donkey anti-rat IgG-DyLight 647 
(1:100) and donkey anti-rabbit Cy3 (1:200) at RT for 1 day. Subsequently, the tissue was 
washed three times with PBT and three times with PBS for 20 min. All washing steps and 
antibody solutions preparation were performed using PBT with 0.2% Triton X-100. All steps 
were carried out in 12 well plates. 
 
2.5.5 RNA in situ hybridization  
RNA in situ hybridization (ISH) is a commonly used method to detect mRNA localization in 
tissue sections and cells. A labeled anti-sense riboprobe (RNA probe) is generated and 
hybridized with the complementary mRNA, upon proteinase K permeabilization of the cellular 
membranes. The stable and labeled RNA/mRNA complex is visualized by 
immunohistochemistry.  
2.5.5.1 RNA probe preparation 
Single-stranded labeled RNA probes were used for ISH. Plasmids containing the complete or 
partial cDNA of the gene of interest were used for generating an antisense RNA probe. 
2.5.5.1.1 DNA linearization and purification 
The plasmids were linearized with restriction enzymes (see section 2.1.8). A concentration of 2 
to 5 unites of enzyme was used for 1 µg DNA. All reactions were performed in the appropriate 
buffers supplemented with 1% BSA when recommended, at 37°C for 2 h.   
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For purifying the liniarized DNA, the PCR purification kit from Qiagen was used, according to 
the manufactures protocol. The DNA sample solution was run through a column, where DNA is 
able to bind to a silica membrane in the presence of chaotropic salts. All contaminants, which 
are not able to bind remain in the solution and are washed out. The DNA was eluted using 10 
mM Tris-HCl, pH 8.5 and was used for in vitro transcription. 
2.5.5.1.2 RNA in vitro transcription 
RNA probes were transcribed from the linearized DNA templates described in section 2.4.5.1.1, 
using DNA-dependent RNA polymerases from the bacteriophage SP6, T3 or T7. DIG-labeled 
NTP mix was used as a substrate. DIG was included in the mix for detection of the RNA probe 
with anti-DIG-AP Fab fragments antibody upon hybridization.  
 
In vitro transcription mix protocol 
1.5 µL  Purified DNA (1-2 µg) - incubate 3 hours at 37°C  
- add 1 µL DNase I 
- incubate 15 min., 37°C  
- add 2 µL EDTA (4mM), 2.5 µL LiCl (100mM) and 
75 µL 100% EtOH to precipitate RNA 
- incubate 15 min, -80°C 
- centrifuge max. speed, 15 min 
- air-dry 3-5 min at RT 
- add 50 µL ddH2O with 1% RNase inhibitor 
- measure concentration and store at -20°C 
 2 µL  Transcription buffer (10x) 
2 µL  
DIG-NTP labeling mix 
(10x) 
0.5 µL  RNase inhibitor (10U) 
0.5 µL  RNA polymerase (30U) 
12.5 µL ddH2O  
20 µL volume final 
 
DNA purification was performed by phenol extraction and ethanol precipitation according to the 
previously described protocol (Sambrook and Russell, 2001) 
Dr. M. Xiang kindly provided Reelin, Dab1, Vldlr and Apoer2 cDNA for generating anti-sense 
RNA probes (Haas et al., 2000; Trommsdorff et al., 1999). Prof. Dr. R. Stumm kindly provided 
cDNA for generating Cxcr7 RNA probes (Stumm et al., 2003). Prof. Dr. F. Tissir kindly provided 
cDNA for generating Cxcl12 and Cxcr4 anti-sense RNA probes (Tissir et al., 2004). 
2.5.5.2 ISH procedure 
Paraffin embryonic sections were deparafinized and rehydrated in graded ethanol series (see 
section 2.4.4.1) prior to the ISH protocol. The sections were post-fixed in 4% PFA, rinsed in 
PBS and incubated with 5 µL proteinase K (20 µg/µL)/50 mL PBS. Next, the sections were 
washed with PBS and acetylated in 50 mL 0.1 M TEA-HCl with 125 µL acetic anhydride. 
Washing in PBS and dehydration in 70% and 95% EtOH followed this step. The RNA probe 
(aprox. 1 µg) of interest was added to 1 mL hybridization buffer and incubated 2 min at 80°C. 
After air drying, the sections were transferred to a humidified hybridization cassette 
(formamide:H2O-1:1, v/v). 300 µL hybridization solution containing RNA probe was added to 
each slide with sections, covered with RNase-free coverslips and incubated at 55°C overnight. 
On the following day, coverslips were removed in prewarmed SSC 5X. To reduce unspecific 
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hybridization the slides were incubated in a high stringency wash (formamide - 2xSSc (1:1 v/v)) 
at 65°C for 30 min. Next, the slides were washed with RNAse buffer, containing 0.1% RNase A 
at 37°C for 10 min to remove the non-hybridized RNA. Subsequently, the slides were washed 
twice with high stringency solution at 65°C for 20 min, then one time in SSC (2x) and SSC 
(0.1x) at 37°C for 15 min. The slides were placed in a humidified chamber and incubated with 
blocking solution (washing solution with 10% goat serum) at RT for 1 h. Sections were 
incubated with primary antibody: anti-DIG-AP Fab fragments (diluted 1:5000 in 1% goat serum/ 
washing solution) for 3 hours or overnight. When the antibody was removed, the slides were 
washed several times in washing solution, followed by two washes in NTMT (containing 1 
mg/mL levamisole to reduce background of endogenous alkaline phosphatase activity) at RT for 
10 min. In the last step the slides were incubated in BM purple, a substrate for alkaline 
phosphatase (with 0.5 mg/mL levamisole) at RT. After staining became visible (24 – 72 h), the 
slides were washed, briefly post-fixed in 4%PFA and mounted with Aqua Polymount. Stained 
sections were stored at RT. 
 
2.5.6 Combined ISH and immunostaining  
For combined ISH and immunostaining, the ISH protocol was modified as following: after 4% 
PFA fixation and PBS wash, frozen or paraffin sections were acetylated (without proteinase K 
incubation). Next, sections were dehydrated in graded ethanol series (from 70% to 100% 
ethanol) and incubated in chloroform for 5 min. The hybridization buffer containing the RNA 
probe was incubated for 5 min at 80°C and then cooled on ice for 2 min. After hybridization with 
DIG labeled RNA probes and detection of DIG with anti-DIG-AP Fab fragments antibody, 
sections were incubated with BM purple. The color reaction was stopped in TE buffer and post-
fixed in 4% PFA at RT for 20 min. Subsequently, the sections were processed for 
immunostaining (protocol described in section 2.3.4.1). Blocking steps and incubation with 
primary and secondary antibodies were carried out in PBS containing 0.2% Triton X100.  
 
2.6 Imaging 
 
2.6.1 Imaging of paraffin and frozen sections 
 
2.6.1.1 Immunostaining 
Images of sections labeled with immunostaining were taken on a Zeiss AxioObserver Z1 
inverted microscope with an ApoTome set-up, using a 20x air objective. The ApoTome system 
allows the acquisition of optical sections of thin specimens (10-50 µm) by computationally 
removing out-of-focus light in each image plane. Images were acquired using Zeiss AxioVision 
software. To image larger tissue areas the AxioVision Mosaix module was used. Several 
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individual images were automatically stitched together, creating a single picture from a large 
area. 
 
2.6.1.2 Combined ISH and immunostaining 
Pictures were taken for brightfield (ISH) and fluorescence channels using the Zeiss 
AxioObserver Z1 with a 20x air objective. The ApoTome was active only for the fluorescence 
channel.  To present the RNA in situ hybridization and the immunofluorescence signal in one 
image, brightfield images of the RNA in situ hybridization signal were assigned to a RGB 
channel in Axiovision software; the channel was then inverted in Adobe Photoshop.  
 
2.6.2 Time-lapse imaging of organotypic slice cultures 
Slices were let to recover overnight before starting the time-lapse. In the following day after 
preparation, slices were transferred to an Ibidi µ-dish with 1 mL culture medium and 1.5 µL 
ascorbic acid (200 nM). Ascorbic acid was used to protect the slices against phototoxicity. For 
time-lapse imaging the slices were transferred to an environmental chamber at 37°C, 5%CO2. 
Images of EYFP-labeled fate mapped neurons were acquired at 100X magnification with 10 min 
intervals for 8–12h on a Zeiss Axio-Observer inverted microscope with a live-cell imaging 
system. 
 
2.6.3 Ultramicroscopy 
Ultramicroscopy is a relatively new technique (Dodt et al., 2007), that allows high-resolution 
imaging of large tissues such as a whole mouse brain with fast data acquisition and little photo-
bleaching. It utilizes a thin, horizontal, light sheet that penetrates the tissue. In this study 
ultramicroscopy was used to create a 3D reconstruction of the ventral midbrain.  
Since mouse brain is not transparent, the tissue cannot be imaged without prior clearing. 
2.6.3.1 Tissue clearing 
Brains from E12.5 Shh
CreER/+
; R26
EYFP/+ 
mice were immunostained as described in section 
2.3.4.4. For tissue-clearing, brains were dehydrated in graded ethanol series (from 30% to 
100% ethanol) at RT for 15 min. Next, the tissue was incubated in fresh 100% ethanol at 4°C 
overnight. The following day, brains were placed in hexane for 1 hour at RT and then 
transferred into a clearing solution of 1 part benzyl alcohol with 2 parts benzyl benzoate. The 
clearing solution has a similar refractive index as the fixed tissue, so that the light passing 
through the medium is not scattered by the different refractive index of the tissue (Spalteholz, 
1914; Steinke and Wolff, 2001). 
The samples were kept in the clearing solution at RT for 2 days preceding imaging (protocol 
modified after (Dodt et al., 2007). 
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2.6.3.2 Imaging set-up1  
Optically sectioned volumetric imaging was performed using a previously described light sheet 
microscope (Spille et al., 2012) based on an inverted microscope body 8 (Figure 12). Cleared 
specimen was placed in a custom-made sample cuvette with coverslip bottom (Hellma, 
Müllheim). The cuvette with inner dimensions of 20 mm x 4 mm x 2 mm was filled with clearing 
solution and sealed with a coverslip. For fluorescence excitation, laser light was focused into the 
specimen orthogonal to the detection path through the optical grade sidewall of the cuvette. The 
excitation beam was tailored to form a thin sheet of light with a thickness of 2 - 6 µm (Ritter et 
al., 2010) and a width of 700 µm (FWHM) within the sample. Fluorescence was collected from 
below by either a 10x air objective or a 40x long working distance water immersion objective 
and imaged onto a scientific grade CMOS camera. 3D image data were acquired by moving the 
sample through the light sheet in steps of 1 µm using a motorized sample stage) controlled by 
ImSpector software (LaVision BioTec). Focal shift occurred during acquisition of image stacks 
due to the refractive index mismatch between clearing solution (n = 1.56) and immersion 
medium (air, n = 1.00 or water, n = 1.33). Instead of moving the light sheet with the detection 
focus (Mertz and Kim, 2010) to compensate for this effect, we employed a piezo driven 
objective mount. Its displacement was coupled linearly to the motion of the sample stage z-axis. 
Empirically we found a displacement ratio between objective mount and sample stage z-axis of 
180/500 for air objectives and 75/500 for water immersion objectives. 
                          
Figure 12. Ultramicroscopy set-up. The sample is illuminated from one side by a green laser forming a 
thin sheet of light. The cleared specimen is placed in a sample cuvette, submerged in clearing solution.  
 
According to the laws of Gaussian optics, a thin light sheet has a high divergence angle 
resulting in a loss of optical sectioning towards the image borders along the optical axis of 
                                                 
 
1 Kindly provided by J.-H.Spille, Prof. U. Kubitschek laboratory, University of Bonn 
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illumination. This is characterized by the Rayleigh length xR = πw0²n/λ. For a 3 µm thin light 
sheet, xR = 70 µm at λ = 640 nm in clearing solution. To avoid this effect and acquire optically 
sectioned full frame images, typically 8 image stacks of the same sample volume were acquired 
consecutively with the light sheet focus displaced along the optical axis by approximately 140 
µm between them. Using the 10x objective, a sample volume of 1.33 mm x 1.33 mm x 1.00 mm 
could thus be acquired in 8 x 100 seconds at a typical exposure time of 100 ms per frame and a 
voxel size of 0.65 µm x 0.65 µm x 1.00 µm. Using higher laser powers, this value could be 
reduced by a factor of 10 using the maximum camera frame rate. Light sheet microscopy was 
especially useful for volumetric imaging not only because of the high image rate, but especially 
because of its efficient use of the photon budget. Each slice within the sample was exposed to 
illumination light once per light sheet focus position, i.e. typically 8 times per data set. In 
contrast, using e.g. confocal microscopy each part of the sample would be exposed to 
illumination light once per z slice, i.e. 100 times more often than with light sheet microscopy if 
800 z slices were acquired.  
 
2.6.3.3 Image processing2  
Instead of stitching the optically sectioned parts of the images the following post-processing 
steps were applied: To eliminate out of focus information contained in the images and 
numerically increase the sectioning effect, for each frame within a stack a floating minimum z -
projection running over ± 4 frames was applied. This resulted in stacks containing in focus 
information in an image area with a width of approximately 2xR = 140 µm around the light sheet 
focus position and only little information outside of this area. Full image frames were 
reconstructed from a maximum intensity projection of all frames from the same sample plane 
illuminated with different light sheet focus positions. This approach bears some similarity to 
TSLIM (Schacht et al., 2011) and the image processing in early implementations of structured 
illumination microscopy (Neil et al., 1997). However, in contrast to TSLIM, the illumination focus 
and not the sample is displaced along the optical axis. Further, instead of taking two images – 
one in and one out of focus – of a sample plane as in (Neil et al., 1997), only in focus images 
were acquired here. The out of focus information to be subtracted was obtained from 
neighboring slices in a z-stack which were acquired anyways, thus reducing the number of 
exposures by a factor of two. Image processing was performed using MATLAB functions written 
for this purpose. 
 
2.7 Quantifications 
 
                                                 
2 Kindly provided by J.-H.Spille, Prof. U. Kubitschek laboratory, University of Bonn 
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2.7.1 Fate mapped MbDA neurons 
 The distribution of MbDA neurons was quantified on sections at three anteroposterior midbrain 
levels of at least three embryos for each time point. For each level, the medial-lateral 
distribution of fate-mapped MbDA neurons (double-positive for TH and EYFP, THpos/EYFPpos) 
was determined by dividing the ventral midbrain into bins of 100 µm thickness along the 
mediolateral axis (N=3). Statistical significance was analyzed using two-ways ANOVA, with 
Bonferroni post-hoc multiple comparison test (GraphPad). 
 
2.7.2 Organotypic slice culture migration assay 
The velocity (total distance traveled per time) of the moving cells in organotypic slice cultures 
was assessed using Fiji, MTrack2 (Schindelin et al., 2012). Based on their velocity the migrating 
cells were divided in three categories: low speed (2-10 µm/h), medium speed (10-25 µm/h) and 
high speed (>25 µm/h). The percentage of cells out of the total number of cells for each 
category was determined (N=9 slices). Statistical significance was analyzed with Student’s t-
test. Migration trajectories of EYFPpos cells were manually tracked with Fiji MtrackJ plugin. The 
midline of a horizontal slice was assigned as x-axis. The best-fit tangential path was considered 
as being perpendicular to the x-axis and was assigned as y-axis. The trajectory in reference to 
the x- and y-axes was obtained by tracking somal coordinates through the imaging sequence. 
Deviations from the best-fit trajectory (0°) were represented in degrees (0°– 90°).  
 
2.7.3 Cxcl12 and Cxcr4 KO analysis  
The area containing THpos MbDA neurons was divided into 2 bins along the dorsoventral axis 
(from the ventricle to the ventral pial surface) and into 8 (E14.5) or 10 (E16.5) bins along the 
mediolateral axis (from the midline to the lateral pial surface, on either side of the midline). For 
each side, the number of THpos cells was determined in each bin and normalized for the total 
number of TH
pos
 cells (expressed in percentage) (Table 1). To take into account TH
pos
 neurons 
on both sides of the midline, an average was formed between the left and the right side. 
Statistical significance was analyzed with one-way ANOVA and LSD post-hoc multiple 
comparison test (SPSS, IBM).  
 
2.7.4 Ultramicroscopy 
3D-volume renderings of the MbDA neuron-containing area (THpos/EYFPpos) were generated 
from image stacks at 10x magnification (Fiji-3D viewer plugin). Cell bodies and processes were 
traced in image stacks acquired at 30x magnification with Surpass Scene FilamentTracer 
(Imaris, Bitplane). Statistical significance was analyzed with Student’s t-test. 
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3. RESULTS 
 
3.1 Fate mapping strategy to follow the migration of MbDA neurons contributing to the 
SN or medial VTA 
In this study, genetic inducible fate mapping method (GIFM), was used to differentially label 
distinct SHH-expressing progenitor cells and follow their fate and migratory routes from their 
early progenitor stage to their final location in the ventral murine midbrain. A knock-in mouse 
line that expresses CreER from the Shh locus (Harfe et al., 2004) was used in conjunction with 
a reporter line in which enhanced fluorescent protein (EYFP) reporter gene was under the 
control of the Gt(ROSA)26Sor (R26) ubiquitous promoter (Joyner and Zervas, 2006). The R26 
allele contains a floxed Stop sequence upstream of EYFP (R26EYFP) (Srinivas et al, 1999). 
EYFP can only be expressed after excision of the Stop sequence by Cre-mediated 
recombination (Figure 13A). Temporal control was achieved by administrating tamoxifen at 
chosen time points (Figure 13B). Since the CreER nuclear translocation occurs within 6 h after 
TM administration and is maintained for approximately 24 h, cells expressing SHH from 6 to 36 
h after TM administration can be genetically marked (active labeling)  (Hayashi and McMahon, 
2002; Zervas et al., 2004). Once marked, the cell labeling is retained (retained labeling) (Figure 
13B). 
 
Figure 13. Recombination scheme in Shh
CreER/+
; R26
EYFP/+
 mice. A) Fate mapping strategy to mark and 
follow SHH-expressing cells and their descendants. The CreER encoding sequence is inserted into the 
Shh locus. The R26 reporter allele contains a floxed Stop cassette upstream of EYFP. This Stop cassette 
is removed upon tamoxifen induced Cre mediated recombination and EYFP is permanently expressed in 
recombined cells. TM: tamoxifen, orange triangle: loxP site. B) Recombination results in active labeling 
within 24 h. After this, the labeling is retained and transmitted to the descendant cells. 
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SHH is expressed in MbDA progenitors in the medial floor plate between E8.5 and E9.0, but at 
E11.5, it is excluded from the medial domain and restricted to lateral MbDA progenitors (Blaess 
et al., 2011; Hayes et al., 2011; Joksimovic et al., 2009; Legue and Joyner, 2010). When GIFM 
of SHH-expressing cells is induced at E8.5, medial MbDA progenitors and their descendants 
are marked; these cells show a biased contribution to the SN (marking scheme 1) (Figure 14). 
Induction at E11.5 marks lateral MbDA progenitors and their descendants; this population 
contributes preferentially to the medial VTA consisting of the paranigral and intrafasicular 
nucleus (marking scheme 2) (Figure 14) (Blaess et al., 2011; Hayes et al., 2011; Joksimovic et 
al., 2009). Progenitor populations labeled with the marking scheme 1 or 2 give also rise to 
neurons of the lateral VTA (parabrachial nucleus) and contribute a few cells to the mVTA or SN, 
respectively. Nevertheless the two populations are sufficiently distinct to separately examine the 
migratory routes and behavior of MbDA neurons contributing to the SN or the mVTA (Figure 
14).  
        
Figure 14. Genetic inducible fate mapping (GIFM) of MbDA neurons. GIFM of SHH-expressing cells 
through TM administration at E8.5 (TM at E8.5) results in labeling of medial MbDA progenitors that have 
a biased contribution to SN neurons (SN marking scheme). TM administration at E11.5 results in labeling 
of lateral MbDA progenitors that preferentially give rise to mVTA neurons (mVTA marking scheme). 
Arrows indicate possible models for the migration of differentiating MbDA neurons: radial migration of 
neurons destined for the SN and VTA; radial migration followed by tangential migration of neurons 
destined for the SN.  
Fate mapped differentiated MbDA neurons were identified by immunostainings for TH and 
EYFP. This double-labeling approach was necessary, since, in addition to MbDA progenitors 
and MbDA neurons, some non-MbDA neurons are labeled with the SN and mVTA marking 
scheme in the ventral midbrain (Blaess et al., 2011). Quantification of EYFP positive (EYFPpos) 
and EYFPpos/THpos cells at E13.5 and E14.5 showed that within the areas that contain 
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differentiated MbDA neurons, more than 70% of EYFPpos cells were also THpos (Figure 15 C). 
                  
Figure 15. More than two-thirds of differentiated cells labeled with the SN marking scheme express 
Tyrosine Hydroxylase (TH). (A, B) Immunostaining for EYFP and TH on horizontal sections. Outlined 
areas contain differentiated MbDA neurons (TH
pos
). (C) Quantification of TH
pos
/EYFP
pos
 in the areas 
outlined in A and B. Significance was determined by Student’s t -test, p<0.001.  
 
3.2 Distribution of MbDA neurons destined for the SN shifts from medial to lateral during 
embryonic development 
To investigate the migratory routes of MbDA neurons, the distribution of fate mapped MbDA 
neurons labeled with the SN or mVTA marking scheme was determined between E11.5 and 
E16.5. The detailed analysis at E11.5 for MbDA neurons labeled with the SN marking scheme 
and the analysis at E13.5 and E15.5 for MbDA neurons labeled with both the SN and the mVTA 
marking scheme, are shown as examples (Figure 16, 17). The distribution of the fate-mapped 
MbDA neurons (EYFPpos/THpos ) was analyzed at three levels along the anteroposterior axis of 
the developing ventral midbrain (referred to as anterior, intermediate and posterior) (Figure 17 
O). From anterior to posterior these areas correspond to the following MbDA nuclei in the adult 
brain: the anterior SN; the intermediate SN and the anterior VTA; the posterior SN, posterior 
VTA, SN and RRF (Figure 17 P).  
At anterior levels, MbDA neurons labeled with the SN marking scheme were distributed lateral 
relative to the midline at E11.5, E13.5 and E15.5 (Figure 16 A; Figure 17 C,C’, I, I’). At 
intermediate levels, MbDA neurons labeled with the SN marking scheme were medial at E11.5 
and E13.5, but located in a lateral position at E15.5 (Figure 16B, 17 E, E’, K, K’). At posterior 
levels, the MbDA destined for the SN were located medially at all the stages analyzed. In 
contrast, MbDA neurons labeled with the mVTA marking scheme were located medially at both 
intermediate and posterior levels (Figure 17 F-H’, 17 L-N’). Very few neurons labeled with the 
mVTA marking scheme were located at anterior levels, corresponding with the localization of 
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MbDA labeled with the VTA marking scheme in the adult brain (Figure 17 D, D’, J, J’, P). 
  
Figure 16. Cells labeled with the SN marking scheme at E11.5 show lateral positions at anterior levels 
and medial positions at intermediate and posterior levels. (A, B, C) Coronal sections at three 
anteroposterior levels were immunostained for EYFP (green) and TH (red). Arrowheads show MbDA 
neurons at anterior levels located at some distance from the midline. The ventricle and the pial surface 
are outlined. Scale bars: 100 µm 
 
To quantify the mediolateral position of the fate-mapped MbDA neurons, the ventral midline in 
each section was determined. The ventral midbrain was divided into bins of 100 µm along the 
mediolateral axis (Figure 18 A-D). The number of fate-mapped MbDA neurons per bin was 
counted and expressed as percentage of the total number of fate-mapped MbDA neurons per 
section (Figure 18 E,F, 19 A-C).  
At anterior levels, MbDA neurons labeled with the SN marking were located in increasingly 
lateral positions at subsequent stages (Figure 16 A, 19 A). Analysis at intermediate and 
posterior levels showed that MbDA neurons labeled with both marking schemes are located 
close to the midline (0-300µm) between E11.5 and E13.5 (Figure 18 E, F; 19, B, C). At later 
stages (E15.5-E16.5), intermediate and posterior levels analysis showed the MbDA neurons 
labeled with the SN marking scheme in increasingly more lateral positions, while MbDA neurons 
labeled with the mVTA marking scheme maintained a relative medial position (0-400 µm) 
(Figure 18 E, F; 19 B, C). Statistical significance was determined by ANOVA and post-hoc 
Bonferroni analysis.  
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Figure 17.  Distinct distribution of MbDA neurons destined for the SN or mVTA (Figure legend continues 
on the following page) 
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Figure 17. (A, B) Drawing showing the SN or mVTA marking scheme. (C-H) E13.5 and (I-N) E15.5 
coronal sections at three anteroposterior levels were immunostained for EYFP (green) and TH (red) to 
visualize fate-mapped MbDA neurons. Only a subset of cells is labeled at any given SHH-expressing 
domain due to the mosaic recombination pattern. Upper right corner: higher magnification of the boxed 
area. (C´-N´). Schematics show the distribution of fate-mapped cells (blue or green dots). Note that E13.5 
and E15.5 images and schematics are not to scale. MbDA neurons labeled with the SN marking scheme 
are located in or close to the midline at E13.5, and are found in more lateral positions at  anterior and 
intermediate levels at E15.5 (C, E, I, K). In contrast, MbDA neurons labeled with the mVTA marking 
scheme remain in a medial position (F, L). Hardly any neurons labeled with the mVTA marking scheme 
are located at anterior levels (D, J) (O) Schematic indicating the plane of section shown in C -N. Green: 
MbDA neuron-containing area. (P) Schematic indicating the corresponding levels in the adult brain. Scale 
bar: 100 µm, Insets scale bar: 25 µm 
 
Statistical analysis for MbDA neurons labeled with the SN marking scheme at intermediate 
levels, showed that the change in distribution of neurons from medial (0-100 µm) to lateral 
(>600 µm) ventral midbrain was highly significant (p < 0.001) when comparing E12.5 with E15.5 
or E12.5 with E16.5 (p < 0.001). Further, there was a significant change (p < 0.01) in distribution 
of neurons from medial (100-200 µm) to lateral (>600 µm) when comparing E12.5 with E16.5. 
These differences are probably due to MbDA movement from medial to lateral positions in the 
ventral midbrain between E12.5 and E15.5-E16.5. Statistical analysis for MbDA labeled with the 
mVTA marking scheme, at intermediate levels, showed highly significant differences (p < 0.001) 
in distribution of neurons from medial (0-100 µm) to slightly more lateral (100-200 µm) ventral 
midbrain when comparing E12.5 with E13.5, E14.5, E15.5 and E16.5, which probably accounts 
for tissue expansion over time. 
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Figure 18. MbDA neurons destined for the SN take increasingly lateral positions over time on 
intermediate sections. (A-D) To-scale-analysis of the distribution of MbDA neurons labeled with the SN or 
mVTA marking scheme at E13.5 and E16.5. Blue or green dots indicate fate-mapped MbDA neurons 
(TH
pos
/EYFP
pos
). The solid line indicates the midline; dashed lines indicate the maximum lateral position 
of MbDA neurons at E13.5 or E16.5. (E, F) Medial-lateral distribution of fate-mapped MbDA neurons was 
quantified between E12.5 and E16.5 at intermediate section levels. (E) There was highly significant shift 
from medial (0-100µm) to lateral (≥ 600 µm from the midline) in the distribution of MbDA neurons labeled 
with the SN marking scheme between E12.5 and E15.5/E16.5, indicating a lateral movement of these 
cells. (F) In contrast MbDA neurons labeled with the mVTA marking scheme remain in a relative medial 
area. Data presented as ± SEM, N=3.  
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Figure 19. Distribution of fate-mapped MbDA neurons at anterior and posterior section levels (A, B) 
Medial-lateral distribution of MbDA neurons labeled with the SN marking scheme between E12.5 and 
E16.5 at anterior and posterior section levels. The ventral midbrain was divided in 100 µm wide bins from 
medial to lateral; fate-mapped MbDA neurons were counted in each bin. There is a shift from medial to 
lateral (≥ 600 µm from the midline) in the distribution of MbDA neurons between E12.5 and E16.5 in 
anterior sections. In posterior sections, only few MbDA neurons were found in lateral positions. (C) 
Medial-lateral distribution of MbDA neurons labeled with the mVTA marking scheme between E12.5 and 
E16.5 at posterior section levels. There is no significant lateral shift over time. Data are presented as ± 
SEM, N=3.  
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3.3 MbDA neurons giving rise to the SN or VTA have different orientation of their leading 
process  
The leading process selects the orientation of migrating neurons in response to chemotactic 
cues in the environment and its orientation can serve as an indicator for the direction of 
migration (Rakic, 1990; Yee et al., 1999). Cells labeled with the SN marking scheme in brain 
sections correlating with the lateral displacement of MbDA neurons appear to have tangentially-
oriented leading processes (Figure 20 A-D). The MbDA neurons labeled with the mVTA marking 
scheme showed predominantly radially-oriented leading processes. This suggests that MbDA 
destined to VTA migrate mainly radially, from the VZ towards the pial surface (Figure 20 E-G).  
    
Figure 20. MbDA neurons labeled with the SN marking scheme show laterally oriented processes, 
whereas MbDA neurons labeled with the mVTA marking scheme show mainly radially oriented 
processes. (A-G) Coronal sections at an intermediate level were stained with antibodies against TH and 
EYFP, but only EYFP immunostaining is shown to visualize processes. (A-D) SN marking scheme at 
intermediate level, immunostaining for EYFP on coronal sections of E10.5 -E13.5 embryos. (E-G) mVTA 
marking scheme at  intermediate level, immunostaining for EYFP on coronal sections of E12.5 -E14.5 
embryos. The ventricle and the pial surface are outlined. (A-G) Orange arrowheads indicate radially 
oriented TH
pos
 neurons, green arrowheads indicate tangentially oriented TH
pos
 neurons. Scale bar:100 µm 
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To investigate the morphology of fate-mapped MbDA neurons (EYFPpos/THpos) more precisely, 
the entire midbrain was imaged using ultramicroscopy3 (Figure 21). Unlike widefield and 
confocal fluorescence microscopy, ultramicoscopy allows fast multidimensional data acquisition 
of entire tissues with minimal photo-bleaching and with good optical resolution. Before 
subjecting the whole brains to ultramicroscopy, the entire E12.5 brain was immunostained for 
TH and EYFP and then the tissue was cleared as described in section 2.5. 
 
Figure 21. Ultramicroscopy and 3D renderings of the ventral Mb labeled with the SN or mVTA marking 
scheme
1
. (A) 3D rendering of the ventral midbrain (vMb) for the SN marking scheme. Cells 
immunostained for EYFP (green) and TH (red). Top, anterior and lateral views of the vMb show the 
medial precursor domain and EYFP, fate mapped cells positioned laterally, outside the progenitor 
domain, within the TH
pos
 area. (B) 3D rendering of the vMb for the mVTA marking scheme. Top, anterior 
and lateral 3D views of the vMb show t he two lateral precursor domains and EYFP, fate mapped cells 
spread medially within the TH
pos
 domain.  
 
Analysis of 3-D reconstructions of the acquired image stacks showed that most MbDA neurons 
had a bipolar morphology (Figure 22 B, D). MbDA neurons labeled with the SN marking scheme 
displayed radially-oriented processes when located close to the VZ, but tangentially-oriented 
processes after reaching the mantle layer (Figure 22 A, B, E). In contrast, MbDA neurons 
labeled with the mVTA marking scheme had predominantly radially-oriented processes and only 
few tangentially-oriented processes (6 out of 72 cells) (Figure 22 C, D, E). Classification of the 
                                                 
3 Ultramicroscopy performed by J-H.Spille, Prof. U. Kubitscheck laboratory, University of Bonn  
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processes into trailing processes (radially-oriented towards the ventricular zone or tangentially-
oriented toward the midline) and leading processes (radially-oriented towards the pial surface or 
tangentially-oriented, away from midline) showed that neurons labeled with both marking 
schemes had leading and trailing processes (Figure 22 F). In summary, MbDA neurons 
destined for the SN have first radial and then tangential leading/trailing processes supporting a 
model in which they initially undergo radial migration to reach the mantle layer and 
subsequently switch to tangential migration to form the SN. In contrast, neurons giving rise to 
the mVTA have almost exclusively radial leading/trailing processes, consistent with a simple 
radial mode of migration.  
 
Figure 22.  MbDA neurons destined for the SN have tangentially oriented processes.  Ultramicroscopy to 
monitor the morphology of fate -mapped MbDA neurons. (A, C) Single plane from a 3D-reconstruction of 
the ventral midbrain at E12.5, immunostained for EYFP (green) and TH (red). The medial progenitor 
domain (EYFP
pos
) is visible. Fate-mapped MbDA neurons (EYFP
pos
/TH
pos
) indicated by arrows. (B, D) 
Fate-mapped MbDA neurons traced in 3-D reconstructions to assess their morphology. Arrows indicate 
tangentially trailing or leading processes (B) and radially leading processes (D). (E) Quantification of 
radial vs. tangential orientation of the leading process. MbDA neurons labeled with the SN marking 
scheme have leading processes with both tangential and radial orientation. Leading processes of MbDA 
neurons labeled with the mVTA marking scheme have a predominantly radial orientation. (F) 
Classification of neuronal process orientation into trailing processes (radially oriented toward VZ or 
tangentially oriented toward midline) and leading processes (radially oriented towards pial surface or 
tangentially oriented away from midline). Scale bar (A, C): 100 µm; (B, D): 20 µm 
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3.4 Organotypic slice cultures of embryonic ventral midbrain: a system to study MbDA 
neuron migration live in vitro 
Live-cell imaging allows the analysis of spatial dynamics of cells over time. This approach is 
particular suitable for studying cell migration, which is mediated by dynamic change in the 
cytoskeleton. However, the developing mouse brain is not suitable for easy manipulation and 
live cell imaging, in vivo since the mouse embryo is inaccessible and opaque. Organotypic slice 
cultures of embryonic brains are therefore widely used to study murine neuronal migration, in 
vitro. Time-lapse imaging in slice cultures has been particularly successful for studying cortical 
neuronal migration (Noctor et al., 2004; Martini et al., 2009, Marin et al., 2010; Ayala et al., 
2007). Embryonic organotypic slice culture systems in brain regions outside of the cortex are 
less well established. Therefore an organotypic slice culture system of the ventral midbrain was 
established to study the MbDA neurons migration.The onset of migration of MbDA neurons is at 
embryonic day (E) 12.5. Therefore E12.5 mouse ventral midbrain was used for slice 
preparation.  
A major challenge of live cell imaging in vitro is keeping cells alive and functioning as naturally 
as possible for the duration of the experiment. A number of steps were required in order to 
obtain slices that allow the normal development of MbDA neurons. The most critical step was 
the dissection of the embryonic brain, which had to be both fast and precise. In contrast to the 
generation of adult brain slices, it is crucial to section the brains on a vibratome equipped with a 
cooling system and to use a low frequency combined with a high speed sectionning to obtain 
intact slices of E12.5 brains. Details of the organotypic slice culture protocol are provided in 
section 2.4. 
 
3.4.1 MbDA neurons require the presence of the projection target area for proper 
development in organotypic slice cultures 
To visualize the radial and tangential migration of MbDA, coronal vibratome slices of ventral 
midbrain were prepared. Immunostainings for TH indicate the development of MbDA neurons in 
organotypic slice cultures. In coronal slices, the forebrain target areas of MbDA neurons are 
absent and subsequently the neurons formed aberrant projections to the dorsal midbrain 
(Figure 23). These aberrant projections were considered an abnormal development of MbDA 
neurons in the slice cultures, and coronal slice cultures were not used for further analysis of 
migration. Horizontal and sagittal brain slices were generated instead. This sectioning approach 
allows the forebrain target areas of MbDA projections to be included in the slice.  
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Figure 23. Midbrain coronal slice cultures stained for TH to label MbDA neurons. (A-C) Slices after 1, 2 
or 3 DIV (days in vitro). MbDA neurons develop aberrant projections towards the dorsal midbrain (red 
arrows). Arrowheads show the location of the MbDA cell bodies.  
 
 
3.4.2 Projections of MbDA neurons in organotypic slice cultures are dependent on the 
integrity of the forebrain 
Horizontal organotypic slices (acute and after several days in culture) obtained from E12.5 
mouse brain are shown as an example (Figure 24). The horizontal slices were compared with 
frozen brain sections at the equivalent developmental stages (Figure 24). MbDA neurons were 
visualized with immunohistochemistry for TH in horizontal slices. Fixed horizontal sections show 
that MbDA project to targets in the forebrain (Figure 24 B). These projections start to form at 
E12.5 and extend towards the forebrain during the subsequent days both in fixed horizontal 
sections and live horizontal slices (Figure 24 A, B). After 3 DIV or when the forebrain target area 
was damaged, aberrant projections extended towards the dorsal midbrain in the horizontal 
slices.  
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Figure 24.  Projections of MbDA neurons in organotypic slice cultures are dependent on the integrity of 
the forebrain. (A) An acute slice (0 DIV) shows the normal location of MbDA neurons in the ventral 
midbrain. The white arrowhead indicates the area that  is shown in higher magnification in the inset. 
Projections to the forebrain have not yet developed. After 1 DIV, projections to the forebrain start to form. 
Projections extend into the forebrain at 2-3 DIV. White arrowheads indicate the location of the cell bodies 
shown in higher magnification in the insets (white frame).  Yellow squares highlight the normal projections 
in intact slices shown in higher magnification in the insets (yellow frame). Aberrant projections develop in 
slices with damaged forebrain. Red squares indicate the aberrant projections to the dorsal midbrain 
shown in higher magnification in the insets (red frame).  Damage is indicated with red asterisks. After 3 
DIV, most slices (n=5/7) had aberrant projections towards the dorsal midbrain. (B) TH imm unostaining on 
horizontal frozen brain sections at different developmental stages show the development of dopaminergic 
projections in vivo.  White arrowheads indicate the location of the cell bodies shown in higher 
magnification in the insets (white frame). Yellow squares highlight the position of the projections shown in 
higher magnification in the insets (yellow frame).The level of the frozen sections was chosen to closely 
match the level of the organotypic slice cultures. Note that a single frozen sections (12 µm) does not 
represent the entire organotypic slice (300 µm). Therefore, projections shown at E13.5 and E14.5 were 
observed on sections 120 µm more ventral than the section containing the cell bodies (yellow asterisks).  
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3.4.3 Organotypic slice cultures of the ventral midbrain can be maintained in culture for a 
limited period of time 
 
Fluorescence illumination, especially in the UV range, is harmful for cells and causes 
photobleaching and phototoxicity. In the ventral midbrain organotypic slice cultures presented 
here, the slices could be maintained in vitro for maximum three days.   Analysis of proliferating, 
necrotic and apoptotic cells in the organotypic slice cultures was performed to verify the viability 
of cells in the slice culture system. BrdU immunostaining to visualize proliferating cells 
demonstrated that cells proliferated under culture conditions after 1 DIV. Proliferation was 
reduced after 4 DIV (Figure 25A).  After 3 DIV, many cells in the ventral midbrain undergo 
necrosis (propidium iodide staining) and apotosis (immunostaining for cleaved caspase-3) 
(Figure 25B,C). In conclusion, the slices can be maintained in vitro for maximum 3 days. During 
this time the proliferative capacity of the VZ progenitors is maintained throughout the slice and 
MbDA neurons maintain their normal projections and positions.  
3. RESULTS 
 
71 
 
                    
Figure 25. Cell proli feration and cell viability in midbrain organotypic slice cultures. (A) Proli ferating cells 
were labeled by the addition of BrdU (50 ng/mL) to the culture medium for 18 h and subsequently 
immunostained for BrdU. After 1 DIV, BrdU labeled cells a re located in the VZ (red arrows). After 4 DIV, 
proli ferating cells are more scattered and a distinct VZ is no longer maintained. (B) Necrotic cells were 
labeled by addition of propidium iodide (1µg/µL) to the culture medium for 2 h and visualized by 
fluorescence microscopy. After 1DIV, the ventral midbrain is not necrotic, but many propidium iodide 
labeled cells can be seen in the dorsal midbrain and forebrain. After 3 DIV the cell viability decreases in 
the ventral midbrain. Scale bar: 500 µm (C) Immunostaining for cleaved caspase-3 to visualize apoptotic 
cells. At 1 or 2 DIV, only few MbDA neurons are apoptotic, but after 3 DIV, MbDA neurons start to 
undergo apoptosis. Panels in the middle and on the right are higher magnifications of the boxed area in 
the left panels.  
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3.5 Time-lapse imaging demonstrates distinct migratory routes for MbDA neurons 
destined for the SN or medial VTA  
To examine the migratory behavior of neurons labeled with the SN or mVTA marking scheme 
directly, the migration of fluorescently marked cells in organotypic slice cultures was monitored 
using time-lapse imaging. GIFM of SHH-expressing cells results in mosaic labeling, therefore 
only some of the MbDA neurons originating in either the medial or lateral MbDA progenitor 
domain are marked. This is advantageous for live imaging, since single migrating neurons can 
be observed and traced (Blaess et al., 2011; Bodea and Blaess, 2012). The E12.5 horizontal or 
sagittal brain slices were cultured for 1 day to allow the tissue to adapt to the culture conditions. 
Subsequently, the slices were imaged for at least 8 hours. Imaging of cells labeled with the 
mVTA marking scheme in sagittal slices showed that they are undergoing radial migration (5 
slices) (Figure 14F). Cells labeled with the SN marking scheme, but not the mVTA marking 
scheme, underwent tangential migration in horizontal slices (SN marking scheme: 4 slices, 
mVTA marking scheme: 3 slices) (Figure 26 C). During tangential migration, soma translocation 
followed the extension of a leading process (Figure 26 C). The observed cells showed transient 
trailing processes (5/10 cells) and short backward movements (3/10 cells). In addition, some 
tangentially migrating neurons underwent a phase of active forward movement followed by a 
resting period (4/10 cells). The average migration speed of migrating cells was 25 µm/h, but 
ranged between 2 µm/h and 40 µm/h (Figure 26 B, C). These data demonstrate that neurons 
that contribute to the SN undergo tangential migration, while neurons destined for the mVTA 
only follow a radial migration route.  
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Figure 26. MbDA neurons destined for the SN undergo tangential migration. Time-lapse imaging of fate-
mapped MbDA neurons in organotypic slice cultures. (A) The plane of section for horizontal slice 
preparations. (B) Schematic showing the tangential migratory route of MbDA neurons (white arrow) 
labeled with the SN marking scheme (yellow) in a horizontal sl ice. Blue dot indicates the initial position of 
the neuron. Green area: differentiated MbDA neurons. Ctx: cortex, vMb: ventral midbrain. (C) Example for 
time-lapse imaging of EYFP
pos
 neurons labeled with the SN marking scheme in an E12.5 horizontal slice 
after 1DIV. Images were taken every  20 min. The neuron migrates laterally (arrowhead) from its initial 
position in the ventral midline. See schematic in B for the imaged area. (D) Plane of section for sagittal 
slice preparations. (E) Schematic showing the migratory route of MbDA neurons (white arrow) labeled 
with the mVTA marking scheme (yellow) in a sagittal slice. Blue dot indicates the initial position of the 
neuron. Green area: differentiated MbDA neurons. (F) Example for time-lapse imaging of EYFP
pos
 
neurons labeled with the mVTA marking scheme in an E12.5 sagittal slice after 1 DIV. Images taken 
every 10 min. The neuron migrates radially (arrowhead) from its initial position. See schematic in E for the 
imaged area. Scale bar: 12.5 µm 
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3.6 Reelin signaling regulates tangential migration of MbDA neurons destined for the SN 
It has been reported previously that the Reelin pathway could play a role in regulating tangential 
migration of MbDA neurons, since the SN does not form and MbDA neurons accumulate in the 
VTA of Reeler mutants. (Kang et al., 2010; Matsuzaki et al., 2007; Nishikawa et al., 2003). 
Reelin regulates migration in several brain areas via the transmembrane receptors ApoER2 and 
VLDLR. Upon binding of Reelin to its receptors the cytoplasmic adaptor protein, DAB1 is 
phosphorylated and mediates downstream Reelin signaling (Ballif et al., 2004; D'Arcangelo et 
al., 1999).  
To determine a possible role of Reelin in MbDA neuronal migration, the expression of 
components of the Reelin signaling pathway was analyzed. RNA in situ hybridization at E13.5 
showed that Vldlr and Apoer2 were expressed at low levels throughout the region containing 
MbDA neurons at intermediate levels (Figure 27 C, D, G, and H). In contrast, Dab1 expression 
was largely restricted to the area where tangentially migrating MbDA neurons destined for the 
SN are located (Figure 27 B, F, I-N; 28 B, E). Reelin was expressed immediately dorsally to the 
Dab1-expressing cells, in an area positive for the red nucleus marker BRN3a (Brain-specific 
homebox/POU domain protein 3A) (Figure 27 E, E’). 
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Figure 27. Reelin and its components are expressed in MbDA neurons. (A-H) RNA in situ hybridization 
for components of the Reelin signaling pathway and immunostaining for TH. Dab1, Vldlr and Apoer2 are 
expressed in the anterior SN (A-D). Reelin is expressed dorsal to the Dab1
pos
 cells. (E) RNA in situ 
hybridization for Reelin and immunohistochemistry for BRN3A, a marker for red nucleus. Neurons shows 
overlap staining, indicating that the red nucleus is the source of Reelin in the region adjacent to the MbDA 
neurons. (E-J) RNA in situ hybridization for components of the Reelin pathway on intermediate sections. 
(F) Dab1 is specifically present in the lateral population of MbDA neurons. Apoer2 and Vldlr receptors are 
broadly expressed in MbDA neurons (G-J). Bright field in situ hybridization images are presented in the 
insets.  
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Figure 28. Dab1 is primarily expressed specifically in MbDA neurons destined for SN. (A -D) RNA in situ 
hybridization for Dab1 at E13.5 and E15.5. (B -F) Overlay of the Dab1-expressing area onto 
representative schematics showing the distribution of MbDA neurons fate -mapped with the SN marking 
scheme (J, M) or the mVTA marking scheme (K, N) at intermediate section levels.   
 
To investigate whether Reelin signaling is indeed required for the tangential migration of SN 
neurons, Reelin function was inhibited in slice cultures, using the function-blocking antibody 
CR50 (Utsunomiya-Tate et al., 2000). Function-blocking antibody, CR-50, inhibits the Reelin 
molecules assemble. The migratory behavior of cells fluorescently labeled with the SN marking 
scheme was monitored using time-lapse imaging (CR50-treated slices: N= 6; control slices: 
N=4) (Figure 29A-C). Inhibition of Reelin signaling led to a significant reduction in the speed of 
tangentially migrating cells (Figure 29B). This effect was specific, since treatment with Reelin 
function-blocking antibody did not alter the speed of radially migrating cells labeled with the 
mVTA marking scheme (CR50-treated slices: N= 6; control slices: N=4) (Figure 29C). Analysis 
of the trajectories of migrating EYFPpos cells (Figure 29D,E) showed that Reelin inhibition 
resulted in a significant deviation of migrating neurons (N=46) from the tangential trajectory 
compared with neurons in control slices (N=33) (Figure 29E). 
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Figure 29. Tangential migration of SN MbDA neurons is mediated by Reelin signaling. (A) Experimental 
set-up for the inhibition of Reelin function in organotypic slice cultures. (B, C) Quantification of the 
accumulated migratory speed of particles in a horizontal slice labeled with the SN marking scheme (B) or 
in a sagittal slice labeled with the mVTA marking scheme (C) with or without the addition of Reelin 
function-blocking antibody. Inhibition of Reelin signaling interferes with the speed of tangentially, but not 
radially migrating particles. Data is presented as ±SEM, n ≥ 3 (D, E) Quantification of migrating cells 
trajectories in slices treated (N=46) or untreated with Reelin function-blocking antibody (N=33). (D) 
Schematic representation of the migratory route of a MbDA neuron on a best -fit linear trajectory and its 
possible deviations. In a best-fit linear trajectory the neuron migrates laterally (arrowhead) from its initial 
position in the ventral midline (white dot) along the y-axis (yellow dashed line). The grades of deviation 
(blue lines) from the y-axis to x-axis (yellow MbDAshed line) were quantified.  (E) Inhibition of Reelin in a 
horizontal slice interferes with trajectories of tangentially migrating neurons.  
 
Since Reelin plays a role in cell polarization in hippocampal and neocortical pyramidal neurons 
(Franco et al., 2011; Jossin, 2011; Matsuki et al., 2010; Matsuki et al., 2008), the morphology of 
THpos MbDA neurons in wildtype and Reeler mutant brains was analyzed at E13.5. Laterally 
positioned MbDA neurons in the Reeler mutants lacked tangentially-oriented processes, but 
formed processes that were perpendicular to the tangential plane (Figure 30 A, B).  
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Figure 30. Reelin interferes with polarization of MbDA neurons (A, B) Immunohistochemistry for TH on 
E14.5 wildtype and Reeler mutants. Scale bar 100 µm. (A’, B’). Higher magnification of the outline area in 
A, B. MbDA neuronal processes are indicated with orange arrowheads. Note the chang e in MbDA 
neuronal process orientation from predominantly laterally -oriented processes in wildtype to radially 
oriented-processes in the Reeler mutant. Scale bar: 10 µm 
 
To assess whether Reelin signaling in MbDA neurons is indeed mediated by VLDLR/ApoER2 
and DAB1, the midbrain phenotypes of Reeler mutant, Dab1 knockout or Vldlr/Apoer2 double 
KO mice at postnatal day 25 (P25) were analysed. In both, Dab1 and Vldlr/Apoer2 KO mice, the 
SN did not extend laterally and MbDA neurons appeared to accumulate within the VTA region at 
intermediate levels, a phenotype comparable to Reeler mutant mice (Figure 31 E-H). At anterior 
levels the SN formed, but appear disorganized (Figure 31 A-D).  
These data show that Reelin regulates the speed, trajectories and polarization of tangentially 
migrating MbDA neurons through the VLDLR/ApoER2 and DAB1 pathway and suggest that 
Reelin signaling has distinct functions at anterior and intermediate levels.  
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Figure 31. Reelin regulates the organization of the SN at anterior levels and the formation of SN at 
intermediate levels. Immunohistochemistry for TH on P25 Reeler mutants, Dab1 knockout and 
Vldlr/Apoer2 double knockout mutants. The lateral SN does not form in the mutants. (E-H) The anterior 
SN forms in mutants in which Reelin signaling is inactivated, but the neurons are disorganized.  Scale bar 
100 µm.  
  
The accumulation of MbDA neurons within the VTA region and the lack of SN formation at 
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intermediate levels of Reeler mutant mice can be eventually correlated with abnormally 
positioned SN neurons in the VTA area. To test this hypotesis imunostainings for Calbindin 
(used as marker for VTA) and GIRK2 (used as marker for SN) were performed on adult sections 
of Reeler, Dab1 knockout and Vldlr/Apoer2 double KO mutants. The GIRK2pos neurons are 
abnormally located, but still located laterally to the Calbindin
pos
, VTA neurons (Figure 32 A-L). 
This suggests that the initial tangential migration occurs in absence of Reelin signaling and that 
Reelin signaling might only be required for the final stage of tangential migration. This is 
consistent with Dab1 expression in cells that are already positioned laterally (Figure 28 B, E).  
       
Figure 32. GIRK2
pos
 neurons are abnormally located, but still largely separated from Calbindin
pos
 VTA 
neurons.(A-L) Immunohistochemistry for TH on P25 Reeler mutants, Dab1 knockout and Vldlr/Apoer2 
double knockout mutants. Yellow arrows highlight the areas with an apparent  increase of neurons; white 
arrows indicate an apparent reduction of neurons. Scale bar: 100 µm  
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3.7 CXCR4 and its ligand CXCL12 modulate the initial migration of MbDA neurons 
The mechanisms that control the initial radial migration of MbDA neurons from the VZ into the 
mantle layer are unknown. Given that MbDA neurons migrate towards the ventral pial surface 
during their radially oriented movement, it can be hypothesized that an attractant expressed by 
the meningeal cell layer surrounding the pial surface could be important for this process. A 
potential candidate is the chemokine CXCL12. CXCL12 is a potent chemoattractant during 
neuronal migration in the forebrain and the hindbrain, where it is secreted from meningeal cells 
(fore- and hindbrain) or Cajal Retzius cells (forebrain). CXCL12 signals through the CXCR4 and 
CXCR7 receptors (Balabanian et al., 2005; Burns et al., 2006; Sanchez-Alcaniz et al., 2011; 
Stumm and Hollt, 2007; Wang et al., 2010). 
 
Figure 33. CXCR4 is specifically expressed in the medial MbDA neuronal population. (A -D) 
Immunohistochemistry for CXCR4 (red) and TH (green). CXCR4 is expressed in MbDA neurons while 
they migrate from the ventricular zone towards the pial surface (E11.5 -E15.5). (A-C). By E18.5, CXCR4 
protein is no longer detected in the vMb. Insets: High magnifications of the boxed areas (D) 
Immunohistochemistry for CXCR4 (red) and LMX1A (green) (E), CXCR4 (red) and Nurr1 (green) on 
E13.5 sections (F). High magnifications confocal z-stacks show LMX1A (E’) and NURR1 (F’) positive 
neurons surrounded by the CXCR4 protein. (G) RNA in situ hybridization for Cxcr7 show no expression in 
the MbDA neurons. (H, I) RNA in situ hybridization for CXCL12 and immunohistochemistry for TH on 
E13.5 and E15.5 sections shows that CXCL12 is expressed in the meninges underlying the pial surface 
where MbDA neurons accumulate. (A-I) Scale bar: 100µm. (E’, F’) Scale bar: 10µm 
 
To investigate if CXCL12/CXCR4 signaling plays a role in MbDA neuron migration, first the 
expression of Cxcl12, CXCR4 and Cxcr7 was analyzed in the embryonic ventral midbrain. 
Cxcl12 mRNA was expressed in the meningeal cell layer at the time of MbDA neuronal 
migration (Figure 33 H, I). CXCR4 was expressed in THpos MbDA neurons starting at E11.5 
(Figure 33 A). At E13.5 and E15.5, CXCR4 was expressed in medially located THpos MbDA 
neurons, but also in THneg cells located below the VZ. (Figure 33 B, C). These THneg CXCR4pos 
82 
 
cells were positive for NURR1 (nuclear receptor related 1 protein), which is expressed in 
differentiating MbDA neurons before the onset of TH expression, and for LMX1A, a marker for 
MbDA progenitors and differentiated MbDA neurons (Figure 33 E, F). CXCR4 expression levels 
are slightly downregulated in cells located close to the pial surface (Figure 33 G). By E18.5, 
CXCR4 could no longer be detected in the ventral midbrain (Figure 33 D). In contrast, Cxcr7 
was only expressed in the ventricular zone (Figure 33 J).  
The restricted spatial and temporal expression of CXCR4 in medially located MbDA neurons 
suggested that CXCL12/CXCR4 signaling might play a specific role in regulating the initial radial 
migration of MbDA neurons. To investigate this, the distribution of MbDA neurons was analyzed 
in mice in which Cxcr4 (Cxcr4 KO) or Cxcl12 (Cxcl12 KO) were inactivated (Ma et al., 1998; 
Nagasawa et al., 1996). At intermediate and posterior section levels, TH
pos
 MbDA neurons in 
mutant embryos accumulated in a position outside of the midline than MbDA neurons in 
wildtype embryos (Figure 34 A-E, 35 A-E). To quantify the change in cell distribution, ventral 
midbrain sections of Cxcl12 KO and wildtype embryos were divided into several bins along the 
dorsoventral and mediolateral axis. The number of MbDA neurons was counted in each bin and 
normalized for the total number of counted MbDA neurons. This analysis confirmed the ventral 
to dorsal and medial to more lateral shift in the distribution of MbDA neurons in Cxcl12 and 
Cxcr4 KO embryos (Figure 34 E, F). A similar trend was observed in E16.5 Cxcr4 KO embryos, 
while no obvious defect in cell distribution was observed in Cxcl12 KO embryos at this stage 
(Figure 35 E, F). Interestingly, the abnormal accumulation of MbDA neurons was more severe 
at E14.5 than at E16.5, suggesting a partial rescue of the phenotype at later stages. These data 
demonstrate that CXCR4/CXCL12 modulates the initial MbDA neuronal migration.  
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Figure 34. CXCR4 and its ligand CXCL12 modulate the migration of MbDA neurons. (A-F) 
Immunohistochemistry for TH shows the abnormal distribution of MbDA neurons in CXCL12 and CXCR4 
knockout brains at E14.5 at intermediate levels (A -C). Yellow arrowheads indicate ectopically localized 
MbDA neurons. (A’-C’) High magnifications of the boxed areas. (D -F) The ventral midbrain was divided 
into 2 bins along the dorsoventral axis and into 8 bins along the mediolateral axis in wildtype, Cxcl12 and 
Cxcr4 KO brains at E14.5. TH
pos
 cells were counted in each bin and presented as a % of TH
pos
 cells from 
the total number of TH
pos
 cells counted. (E, F) MbDA neurons show an altered dorsoventral and 
mediolateral distribution. Data are presented as ±SEM, N=4. Statistical significance determined by 
ANOVA and post-hoc LSD analysis, *p<0.05, **p<0.01. Scale bar: 20 µm (A’-C’), 100 µm (A -C). PS: pial 
surface. 
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Figure 35. CXCR4 and its ligand CXCL12 have a transient effect on migration of MbDA neurons. (A -F) 
Immunohistochemistry for TH shows the abnormal distribution of MbDA neurons in CXCL12 and CXCR4 
knockout brains at E16.5 at posterior levels (A-C). Yellow arrowheads indicate ectopically localized MbDA 
neurons. (A’-C’) High magnifications of the boxed areas. (D -F) The ventral midbrain was divided into 2 
bins along the dorsoventral axis and into 10 bins along the mediolateral axis in wildtype, Cxcl12 and 
Cxcr4 KO brains at E16.5. TH
pos
 cells were counted in each bin and presented as a % of TH
pos
 cells from 
the total number of TH
pos
 cells counted. (E, F) At E16.5 MbDA neurons show a milder alteration in 
dorsoventral distribution than at E14.5 in Cxcl12 and Cxcr4 KO brain. Data are presented as ±SEM, N=4. 
Statistical significance determined by ANOVA and post-hoc LSD analysis, *p<0.05, **p< 0.01. Scale bar: 
20 µm (A’-C’), 100 µm (A-C).  
 
To examine whether perturbation of CXCR4/CXCL12 signaling influences MbDA migration by 
regulating the speed or trajectories of migrating MbDA neurons, CXCR4 signaling was inhibited 
in slice cultures with the CXCR4 antagonist AMD3100. The migration of cells labeled with the 
SN or mVTA marking scheme was monitored (treated slices: N= 4; untreated slices: N=5) 
(Figure 36 A). However, neither the speed nor the trajectories of migrating cells was changed in 
cultures treated with the CXCR4 antagonist (Figure 36 B, C). 
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Figure 36. (A) Experimental set -up for the inhibition of CXCR4 function in organotypic slice cultures. 
AMD3100 inhibitor was added to organotypic slice cultures. (B, C) Quantification of the accumulated 
migratory speed of particles in a sagittal slice labeled with the mVTA marking scheme (A) or a horizontal 
slice labeled with the SN marking scheme (B) with or without the addition of AMD3100. Inhibition of 
CXCR4 interferes with the speed of tangentially, but not radially migrating particles. Data is presented as 
±SEM, n ≥ 3. Scale bar: 100 µm. 
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4. DISCUSSION 
 
Understanding how migrating neurons navigate within the increasing complexity of the 
developing brain is a fundamental question in developmental neuroscience. Neurons navigate 
from ventricular zones along either radial or tangential paths and often settle in regions distinct 
from their origin. Neuronal migration mechanisms have been studied in great detail in dorsal 
brain areas, such as the cortex or the cerebellum, where neurons arrange themselves into 
distinct cell layers. However, much less is known about neuronal migratory behavior in ventral 
brain areas, such as the midbrain, where neurons assemble into cell clusters. 
This study provides a detailed molecular and functional characterization of the migratory paths 
that are taken by MbDA neurons in the ventral midbrain. The results presented in this thesis 
demonstrate that MbDA neurons destined for the SN have to undergo an active tangential 
migration process to reach their final position in the ventral midbrain, whereas MbDA neurons 
destined for the VTA primarily undergo radial migration. The tangential migratory process is 
mediated by Reelin signaling, which controls the rate of migration, migration trajectories and 
leading process polarization of MbDA neurons destined for the SN. The initial radial migration of 
MbDA neurons from their progenitor zone toward the mantle layer is modulated by 
CXCR4/CXCL12 signaling.  
4.1 Migratory paths of MbDA neurons 
TH positive MbDA neurons are generated in the VZ of the ventral midbrain (Mb) starting at 
E10.5 (Bayer et al., 1995; Kawano et al., 1995). Subsequently, MbDA neurons migrate towards 
the mantle layer to form the SN and the VTA. Despite their distinct location in the ventral 
midbrain, the SN and VTA form a continuous structure, making it difficult to define the exact 
boundaries between the two cell clusters (Bjorklund and Dunnett, 2007). Nevertheless, MbDA 
neurons that populate the lateral ventral midbrain and form the SN have to take a different 
migratory route than MbDA neurons that cluster in the medial ventral midbrain and form the 
VTA. 
The results of the present study propose the following model for MbDA neuronal migration. 
Neurons destined to form the SN undergo a three-step migration: 1) they migrate radially from 
the VZ towards the pial surface, 2) they switch to tangential migration in order to move away 
from the midline and segregate from VTA neurons, 3) they undergo a long distance tangential 
migration to reach their final position in the ventral-lateral Mb. In contrast, neurons that form the 
VTA primarily undergo a one step migration, i.e. radial migration from the VZ towards the pial 
surface. This model is supported by results obtained from analysis of the distribution of MbDA
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 neurons destined for the SN and mVTA at different stages during development, 3D 
morphological analysis of the entire MbDA area and time-lapse imaging in organotypic slice 
cultures. Two pieces of evidence demonstrate that the lateral movement of future SN neurons is 
an active migration process and not just a lateral displacement caused by newly generated 
medial cells or by the overall growth of the tissue: 1) MbDA neurons destined for the SN and 
VTA are initially located in the medial ventral Mb (E12.5-E13.5), but only neurons destined for 
the SN are found at significantly more lateral positions at later developmental stages (>E14.5). 
2) Time-lapse imaging shows that neurons destined for the SN migrate tangentially away from 
the midline (E12.5-E14.5). These observations suggest that there is an initial lateral migration of 
SN neurons from the medial-ventral towards the lateral ventral Mb (E12.5-E14.5) resulting in the 
segregation of SN destined neurons from the VTA destined neurons by E14.5. Analysis of the 
distribution of SN destined MbDA neurons after E14.5 demonstrate that these neurons continue 
to move laterally at subsequent stages.  
Previous attempts to characterize the migratory routes of MbDA neurons using birthdating of 
ventral midbrain progenitors, sometimes in combination with TH immunostaining, have led to 
contradictory conclusions (Hanaway et al., 1971; Marchand and Poirier, 1983; Kawano et al., 
1995, Shults et al., 1990). Thus, several potential migratory paths have been proposed for 
neurons that form the SN. The first study (Hanaway et al., 1971) analyzed the location and 
birthdates of radioactively labeled midbrain neurons at different stages between E12.5 and 
E16.5 and proposed a different model than the one indicated in this thesis. The authors 
suggested that SN destined neurons migrate radially from the VZ towards the lateral ventral Mb. 
Further, the authors indicate that VTA destined neurons migrate radially towards the medial 
ventral Mb and that subsequently, a subset of these cells migrate tangentially towards more 
lateral positions. Other birthdating studies, using BrdU labeling combined with TH 
immunostaining, suggested a model similar to the one proposed in this thesis (Kawano et al., 
1995; Shults et al. 1990). These studies suggest that the cells contributing to the SN and VTA 
initially follow a radial route (E11.5-E13.5) along radial glia processes that extend from the 
ventricular zone to the mantle layer. Then, the cells move laterally, presumably on a tangential 
migratory route (>E12.5), from the ventral midline towards the lateral Mb along tangentially 
arranged nerve fibers. However, MbDA neurons destined for the SN and the VTA could only be 
distinguished from each other upon reaching their final positions rather than during their actual 
migratory phase. It must also be taken into consideration, that in all these studies, the migratory 
behavior of the neurons could not be monitored directly and was only inferred from the analysis 
of the distribution of labeled cells in sections.  
The current study overcomes this problem by using novel systems of labeling and observing SN 
and VTA destined neurons. The MbDA precursor cells that give rise to SN and VTA clusters 
have been specifically labeled using the genetic inducible fate mapping method. This genetic 
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labeling method makes use of the differential expression of SHH in MbDA progenitors at 
different developmental stages (E8.5 versus E11.5). Thus, only the MbDA precursor cells that 
give rise predominantly to the SN or the mVTA could be labeled. Since the labeling is heritable, 
the descendents of MbDA precursor cells that give rise to one or the other MbDA neuron 
subpopulation could be tracked at any time point during development. Moreover, this 
fluorescent labeling also allowed monitoring of the behavior of the cells in organotypic slice 
cultures. Thus by specifically monitoring the migratory behavior of MbDA neurons that form SN 
or mVTA, this analysis could dissect for the first time the paths of MbDA contributing to either 
SN or mVTA. 
As discussed previously, MbDA neurons most likely migrate radially along radial fibers, however 
the molecular profile of these fibers is unclear. Kawano and colleagues (1995) suggested that 
MbDA neurons migrate along radial fibers expressing tenascin, an extracellular matrix protein 
between E10.5 and E13.5. However, in the present study it was found that tenascin is not 
expressed in the radial fibers in the medial ventral Mb, where MbDA migrate radially, but only in 
the lateral Mb at E13.5. Radial fibers in the medial ventral Mb were found to express the 
intermediate filament protein and radial fiber marker Nestin between E11.5 and E14.5 (Allen 
Developing Mouse Brain Atlas, 2012 and this study). Additionally, another intermediate filament, 
vimentin, is expressd at E12.5 in the medial ventral midbrain as shown by (Shults et al., 1990). 
The tangential migration of MbDA neurons is presumably supported by tangential axonal fibers 
that function as a scaffold (Kawano et al., 1995). These fibers originate from cell bodies in the 
lateral mesencephalon, but they could not be assigned to any of the known mesencephalic fiber 
tracts. These tangentially oriented fibers transiently express NCAM-H (highly polysialylated 
neuronal cell adeshion molecule) and L1 (immunoglobulin superfamily molecules) between 
E11.5 and E15.5 coinciding with the time period of MbDA migration (Ohyama et al., 1998). 
At anterior levels, only the SN, but not the VTA is present in the adult brain. Hence the three-
step migration paradigm for SN neurons proposed in the current study is most obvious at 
intermediate anteroposterior levels of the developing MbDA neuronal field, where both SN and 
VTA are formed. MbDA neurons destined for the anterior SN assume relatively lateral positions 
immediately after their radial migration. However, the present analysis of the mediolateral 
distribution of anterior SN neurons suggests that tangential migration also contributes to their 
final lateral position. At posterior levels, only a few labeled MbDA neurons are observed in 
lateral positions with the SN marking scheme. The lack of a specific labeling for MbDA neurons 
that give rise to RRF MbDA neurons made it impossible to assess the migratory behavior of this 
MbDA neuronal subpopulation.  
The potential difference in the migratory behavior of anterior and posterior SN neurons 
correlates with a proposed difference in their origin: anterior SN neurons are thought to be of 
posterior diencephalic origin, while more posterior MbDA neurons are mesencephalic. These di- 
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and mesencephalic populations are different in their molecular profile during their progenitor 
and early differentiation phase. It remains unclear whether these differences persist at later 
stages of development, but if they do, they could possibly explain the distinct migratory behavior 
of the two populations (Lahti et al., 2012; Smits et al., 2006) 
4.2 Reelin-mediated signaling pathway plays a role in SN formation by regulating the 
tangential migration of MbDA neurons destined to the SN  
Reelin, a large extracellular glycoprotein, regulates migration in several other areas of the brain 
and signals via the transmembrane receptors ApoER2 and VLDLR. Upon binding of Reelin to 
its receptors, the cytoplasmic adaptor protein DAB1 is phosphorylated and mediates 
downstream Reelin signaling (Ballif et al., 2004; D'Arcangelo et al., 1999). 
It has been previously shown that the SN does not form in the Reeler mutants, which have a 
spontaneous mutation in the Reelin gene that results in Reelin loss-of-function (Kang et al., 
2010, Nishikawa et al., 2003). Though these studies analyzed the intermediate levels of the 
developing MbDA neuronal field in Reeler mutants, where both SN and VTA are formed, they 
did not assess the underlying cellular mechanisms by which Reelin regulates SN formation. In 
the current study, the Reeler mice and the mutant mice in which other components of the Reelin 
signaling pathway were inactivated, were analyzed at different anteroposterior levels. Moreover, 
the present results show that Reelin and its downstream pathway components are expressed in 
ventral midbrain during the time period that corresponds to MbDA migration and seem to 
regulate multiple aspects of the tangential migration of MbDA neurons destined to SN. 
 
4.2.1 Expression of Reelin and its downstream signaling components in the embryonic 
ventral midbrain  
It was unclear from which source Reelin is secreted during MbDA migration. One study 
(Nishikawa et al., 2003) that used the anti-Reelin antibody CR-50 showed that Reelin protein is 
present in the MbDA area of the ventral Mb, as well as in the striatum at E15.5. The authors 
proposed that Reelin is supplied to the ventral Mb, by incoming projections from the striatal 
patch neurons, via axonal transport. A number of studies have shown that Reelin is present in 
axons, suggesting that it may be transported along axons over long distances (Derer et al., 
2001; Martinez-Cerdeno et al., 2002; Pappas et al., 2001; Roberts et al., 2005). As 
demonstrated in the current study, by E15.5, many MbDA neurons have already migrated and 
the MbDA that give rise to SN are already segregated laterally. This means that Reelin should 
be present in ventral Mb before E15.5 if it plays indeed a role in regulating MbDA neuronal 
migration. 
This study shows that the Reelin mRNA is present in Mb already at E13.5, a time point when 
MbDA neuronal migration occurs. Furthermore, the Reelin mRNA colocalizes with BRN3A, a 
marker for red nucleus neurons. These findings indicate that the red nucleus might be the 
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source of Reelin in the ventral Mb at the time of MbDA migration. It is interesting that red 
nucleus neurons, which are derived from a ventral progenitor domain that is laterally adjacent to 
the MbDA neuron progenitor domain, appear to be an early source of Reelin. MbDA and red 
nucleus progenitors share several molecular markers such as SHH and the transcription factor 
FOXA2 (Blaess et al., 2011; Prakash et al., 2009; Prakash and Wurst, 2006). Red nucleus 
neurons are born between E10.25 and E10.75 and subsequently migrate radially to their final 
position in the ventral midbrain (Prakash et al., 2009). The first SN neurons are born around 
E10.5, suggesting that SN and red nucleus neurons could undergo radial migration during the 
same time period. It is intriguing that there appears to be a coordinated migration between two 
ventral neuronal populations with similar birth dates and adjacent progenitor domains. It 
remains to be investigated whether mutants that lack the red nucleus also have defects in the 
formation of the SN. Mutants in which the number of red nucleus neurons is merely reduced do 
not show an obvious phenotype in SN formation (Prakash et al., 2009). In addition, Vasudevan 
and colleagues show that MbDA neurons location plays a role in modulating the migration of 
GABAergic neurons (Vasudevan et al., 2012). Altogether these results suggest a migratory 
regulation network of different neuronal subpopulations in the ventral midbrain.  
Apoer2 and Vldlr mRNA are present throughout the ventral midbrain starting at E13.5. However, 
Dab1, the key regulator of Reelin signaling is specifically expressed in the most laterally located 
MbDA neurons. These lateral MbDA neurons are positioned ventral to cells in the red nucleus 
that express Reelin mRNA and they overlap with cells marked with the SN marking scheme. In 
light of this data, it seems that only the MbDA neuronal population destined for the SN is able to 
respond to Reelin signaling. 
 
4.2.2 Defects in MbDA positioning when the Reelin signaling pathway is inactivated 
Kang and colleagues (2010) showed an abnormal positioning of MbDA neurons in Reeler mice 
at the intermediate level, where SN and VTA are located. They demonstrated that the number 
of MbDA neurons in P0 Reeler mutants is significantly reduced in the SN area, whereas the 
total number of MbDA neurons is not reduced. The reduction in MbDA neuron number in SN 
seems to correlate with an accumulation of MbDA located more medially, at the lateral border of 
the VTA.  
The data presented here complete the analysis of MbDA in the Reeler mutant at all 
anteroposterior levels and shows that the SN forms at anterior levels, but appears disorganized. 
At posterior levels, MbDA neurons in the RRF also appear to be disorganized in the mutant 
mice. These findings suggest that the lack of SN formation and the ectopic cluster present at 
the lateral border of VTA at the intermediate level is not due to a change in fate of the SN 
neurons towards VTA neurons. This hypothesis is further sustained by data showing that the 
cluster of cells at the lateral border of VTA expresses GIRK2, a marker of SN neurons (this 
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study). GIRK2 is normally expressed laterally in the SN MbDA population and its presence at 
the lateral border of VTA indicates that these cells fail to migrate laterally and form the SN. 
Interestingly, despite the migratory defect in Reeler mutant mice, the projections towards their 
striatal targets are normal (Nishikawa et al., 2003). 
The effect of Reelin on SN neurons is mediated through the canonical VLDLR/ApoER2 and 
DAB1 signaling pathway. Data presented here show that Dab1 KO mice phenocopy the 
phenotype observed in the Reeler mutants. This is consistent with previous studies (Kang et al, 
2010), which showed that Yotari mice, that have a spontaneous loss-of-function mutation in 
Dab1, have the same phenotype as Reeler mice. The thesis data also show that Vldlr KO and 
Apoer2 KO mice have no obvious defect in MbDA positioning. However, the Vldlr/Apoer2 
double KO mice show a phenotype that is slightly milder than that of the Reeler and Dab1 KO 
mice. In contrast, the recent study of Sharaf and colleagues (2013), which quantified MbDA 
neurons in Vldlr and Apoer2 single KO mice shows that MbDA neurons are mispositioned in 
these mice, even though the phenotype is milder than that of Reeler and Dab1 KO mice. 
Moreover, the authors show that the phenotype is more pronounced in Vldlr KO mice than in 
ApoER2 KO mice and they also suggest that Vldlr/Apoer2 double KO mice have the same 
phenotype as the Reeler muntant and Dab1 KO mice. However, a quantified comparison of the 
Vldlr KO and Apoer2 KO mice was not provided. To clarify these discrepancies between the two 
studies the MbDA phenotype of the Vldlr/Apoer2 double KO should be further quantified. The 
milder Vldlr/Apoer2 phenotype observed in this study suggests that there might be other 
coreceptors for Reelin involved in MbDA migration. In the cortex, inactivation of EphBs (Ephrin 
receptor tyrosine kinases) results in defects in migration that recapitulate the Reeler phenotype 
(Bouche et al., 2013; Senturk et al., 2011). However, in the present study EphBs were not found 
to be expressed in the ventral midbrain. In addition to EphB, Protocadherin and integrins have 
also been proposed to function as co-receptors for Reelin in the cortex (Anton et al., 1999; 
Senturk et al., 2011; Senzaki et al., 1999). It remains unexplored whether they might play a role 
in MbDA neuronal migration. 
 
4.2.3 Mechanisms of Reelin function in MbDA neuronal migration 
The mechanism of Reelin function has been studied in great detail in the radial migration of 
cortical projection neurons and several models have been proposed to explain how Reelin 
controls cortical migration. Reelin has been shown to act on fiber scaffold differentiation (Forster 
et al., 2002) or on polarization of migrating neurons (Jossin and Cooper, 2011). Moreover, it has 
been suggested that Reelin functions as a chemoattractant, a chemorepellent, a stop signal, a 
signal for neurons to detach from radial glia, or a signal stabilizing the leading process (Dulabon 
et al., 2000; Franco et al., 2011; Gilmore and Herrup, 2000; Jossin, 2011; Ogawa et al., 1995; 
Sanada et al., 2004; Schiffmann et al., 1997; Sheppard and Pearlman, 1997). The Reelin signal 
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is believed to function either as a permissive or as an instructive factor (Jossin, 2004; 
Magdaleno and Curran, 2001)  
This thesis is the first study to investigate the detailed mechanism of Reelin function in the Mb. 
Data presented here shows that Reelin regulates the tangential migration of MbDA neurons 
destined for the SN by modulating their trajectory and speed. Furthermore, Reelin plays a role 
in the polarization of MbDA neurons. However, it still remains unclear how Reelin regulates the 
polarization of MbDA neurons and whether Reelin is an instructive or a permissive factor for 
MbDA migration. The mechanisms of Reelin function in MbDA neuronal migrat ion are discussed 
in detail in the following sections. 
4.2.3.1 Reelin signaling regulates tangential migration of SN destined MbDA neurons  
The time-lapse imaging in organotypic slice cultures presented here demonstrates that inhibition 
of Reelin signaling interferes specifically with the speed and trajectories of tangentially migrating 
neurons destined for the SN. Similar results, but in radially migrating cortical neurons in the 
ventricular and subventricular zone, where the first transition of bipolar to multipolar migration 
occurs, have been shown by Britto and colleagues (Britto et al., 2011; Britto et al., 2013). The 
authors show that cortical neurons displayed defective radial trajectories and migratory speeds 
in Reeler mutants. However, in contrast to the studies performed on cortical and cerebellar 
neurons (Sanada et al., 2004; Kuo et al. 2005; Myiata et al., 2010), radial migration of MbDA 
neurons is not affected by the inhibition of Reelin signaling.  
The specific effect of Reelin on tangentially migrating neurons is consistent with data  showing 
that Dab1 is only expressed in laterally positioned MbDA neurons at E13.5. Since GIRK2 
expressing SN neurons are clustered at the lateral border of the VTA and not intermingled with 
Calbindin expressing VTA neurons, Reelin signaling does not seem to play a role in the 
tangential migration that results in segregation of the SN and VTA neurons. These observations 
indicate that Reelin is involved only in the last step of tangential migration, which results in the 
formation of the laterally positioned SN cluster. The mechanisms that regulate the switch from 
radial to tangential migration and the segregation of SN and VTA neurons in the medial zone 
remain to be identified.  
 
4.2.3.2 Reelin signaling plays a role in MbDA neuronal polarization 
Analysis of Reeler mice at E13.5 shows a misorientation of the cellular processes (radial 
orientation instead of tangential) of the laterally positioned MbDA neurons. Moreover, in slice 
cultures, the tangential migrating MbDA neurons destined for the SN change their trajectory 
when Reelin is inhibited. The change in trajectory could be caused by the missorientation of the 
leading process, which gives the migrating cell its directionality. These data suggest that Reelin 
plays a role in the polarization of the SN destined MbDA neurons that migrate tangentially. 
However, a role of Reelin in establishing the polarization of MbDA neurons is unlikely, since 
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already at E11.5 and E12.5 the MbDA neurons destined for the SN have tangentially oriented 
processes before they start to express Dab1. This indicates that at the time when MbDA 
neurons start to respond to Reelin, they already present a bipolar, tangential morphology. 
Moreover, Reeler mice do not show a misorientation of the cellular processes at E12.5. These 
findings suggest that Reelin might play a role in the maintenance of tangential orientation of 
cellular processes of SN destined MbDA neurons. 
One mechanism by which Reelin can play a role in the maintenance of neuronal polarity is by 
stabilizing the cytoskeleton (Witte and Bradke, 2008). Reelin is involved in regulation of the 
cytoskeleton as it interacts with intracellular signals that modulate Actin dynamics, such as Rho 
GTPases and Cofilin (Leemhuis and Boch, 2011; Krüger et al., 2010, Chai et al., 2009). In 
bipolar, radially migrating cortical neurons, Reelin stabilizes the actin cytoskeleton in the leading 
processes by inducing phosphorilation of cofilin. Cofilin depolymerizes F-actin, thereby 
supplying actin monomers for the formation of new actin filaments. The phosphorylation of 
cofilin renders cofilin unable to depolymerize F-actin in the leading processes of migrating 
neurons. This reduces actin dynamics and stabilizes the cytoskeleton (Chai et al., 2009b; 
Leemhuis et al., 2010). Furthermore, in multipolar, radially migrating cortical neurons, Reelin is 
involved in the formation of the proper polarization via Rap1 (Ras related protein, GTPase) and 
NCad (N-cadherin) (Jossin and Cooper, 2011; Franco et al., 2011). In Reeler mutants, NCad is 
reduced and the multipolar neurons migrate in a disorganized manner, which leads to a 
defective cortical lamination. Reelin triggers polarization when neurons start to migrate by 
activating Rap1 and stabilizing NCad. This model, called ‘polarity model’ is however only valid 
for multipolar, immature neurons, and it is unclear whether it could be applied for MbDA 
migration. 
4.2.3.3 Reelin is not likely to regulate the formation of guidance fibers for MbDA neuronal 
migration   
It has been previously proposed that MbDA neurons giving rise to SN and VTA migrate radiall y 
along glia fibers and subsequently, tangentially arranged fibers serve as a support for the 
tangential migration of SN destined neurons. Studies that unraveled Reelin function in the 
neuronal migration in other brain areas have proposed that Reelin can also play a role in 
establishing of radial fibers. For example, Förster and colleagues (2002) showed that Reelin 
signaling through Dab1 is important for the formation of the radial glia scaffold in the dentate 
gyrus of the hippocampus. In Reeler mutants and mice lacking Dab1, radial glia fibers 
expressing Nestin do not form and consequently the granule cells fail to migrate and 
accumulate in the hilar region. 
In the ventral Mb, radial glia fibers extend from the VZ, where the cell bodies are, towards the 
pial surface. However, Dab1 mRNA is neither expressed in the VZ nor in the medial ventral 
midbrain, and function blocking experiments in slice cultures show no effect on MbDA radial 
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migration. Furthermore, it has been previously shown that the ventral midbrain radial fibers 
expressing BLBP (brain lipid binding protein), RC2 (radial glia) and vimentin (intermediate 
filaments) are not affected at E14.5 - E15.5 in Reeler mutants (Kang et al., 2010; Nishikawa et 
al, 2003). These observations suggest that Reelin is not involved in radial glia formation and 
hence, does not seem to affect MbDA radial migration indirectly.  
Another possibility is that Reelin plays a role in the formation of tangential fibers. However, 
tangential fibers expressing the polysialylated neural cell adhesion molecule (N-CAM), at 
intermediate levels of the MbDA neuron field between E11.5 and E15.5 (Ohyama et al., 1998) 
were not affected in Reeler or Yotari mutant mice (Kang et al., 2010; Nishikawa et al., 2003). 
This evidence suggests that Reelin does not play a role in the tangential fiber formation.  
 
4.2.3.4 Does Reelin act as an instructive or a permissive signal for MbDA neuronal 
migration? 
In the cortex, it has been previously shown that Reelin can be cleaved into smaller fragments 
that could potentially diffuse and build a chemoattractive gradient (Jossin et al., 2004; Lambert 
de Rouvroit et al., 1999). Moreover, Reelin can function as attractant in the cortex. Sanada and 
colleagues (2004) showed that if Dab1 is inactivated in a mosaic manner in migrating cortical 
neurons, wild-type cells migrate towards the Reelin-expressing layer, while Dab1 null neurons 
stay beneath the wild-type cells. This data indicate that wild-type neurons are attracted by the 
Reelin source and that this attraction is mediated through Dab1. Whether Reelin is similarly 
processed and has an attractive effect on MbDA neurons in the ventral Mb remains to be 
examined. 
Since Reelin regulates the tangentially migration of MbDA neurons, it could play a role in 
attracting the SN neurons laterally. To attract MbDA neurons, Reelin should be expressed in a 
region lateral to these neurons, in the direction of their migration. However, the thesis results 
show that the Reelin mRNA expression domain, which overlaps with the red nucleus, is located 
dorsally rather than laterally to tangentially migrating, Dab1-expressing MbDA neurons at E13.5. 
In addition and as discussed previously, Reelin protein could also be detected throughout the 
SN, supposedly secreted by incoming projections from striatal neurons at E15.5 (Nishikawa et 
al., 2003). Whether Reelin protein is expressed in a similar position at an earlier stage has not 
been yet investigated due to the lack of an efficient antibody staining. The expression data 
would suggest that Reelin is unlikely to be an attractant for MbDA neurons due to its location. 
4.3 CXCL12/CXCR4 signaling modulates the initial migration step of MbDA neurons 
CXCL12 has been previously described as a potent chemoattractant during neuronal migration 
in the forebrain and the hindbrain, where it is secreted from meningeal cells (fore- and hindbrain 
or Cajal Retzius cells (forebrain). CXCL12 signals through the CXCR4 and CXCR7 receptors 
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(Balabanian et al., 2005; Burns et al., 2006; Sanchez-Alcaniz et al., 2011; Stumm and Hollt, 
2007; Wang et al., 2010). 
This study demonstrates that CXCL12 and its receptor CXCR4 are expressed in ventral 
midbrain during the time period of MbDA migration, and this CXCL12/CXCR4 signaling 
modulates the radial migration of MbDA neurons, from the ventricular zone to the mantle layer.  
 
4.3.1 CXCR4 is expressed in MbDA neurons during their migration phase 
CXCR4 is expressed in the medial ventral Mb, in the area between the VZ and the pial surface, 
between E11.5 to E17.5, during a time when MbDA neurons undergo radial migration. CXCR4 
expression overlaps with the MbDA neuronal markers, TH and LMX1A. The chemokine 
CXCL12, a CXCR4 specific ligand, is expressed in the meninges of the underlying pial surface.  
CXCL12 can attach to extracellular matrix molecules such as proteoglycans or heparin, and a 
potential candidate for CXCL12 attachment in the ventral midbrain is 6B4 PG (6B4 
proteoglycan-phosphacan), a chondroitin sulfate proteoglycan previously shown to be 
expressed in MbDA neurons (Ohyama et al., 1998).  
The concentration of CXCL12 can be not only modulated by proteolytic cleavage through 
metalloproteinase (Bussilo and Benovic, 2007), but also by CXCR7 receptor, which can act as a 
scavenger by binding and removing the extracellular CXCL12 in the cortex (Cubedo et al., 
2009; Wang et al., 2011). However, it is shown here that Cxcr7 is not expressed in the MbDA 
neurons area. Therefore, in the midbrain CXCL12 activity is likely mediated by proteolytic  
degradation. However, whether metalloproteinase that mediate proteolytic degradation of 
CXCR4 are expressed in the ventral Mb remains to be explored.  
 
4.3.2 CXCR4 and CXCL12 mutants might regulate the radial migration of MbDA neurons  
CXCL12/CXCR4 signaling has been previously shown to play a role in regulating the tangential 
migration of neurons in different brain areas such as GABAergic interneurons and Cajal-Retzius 
cells in the cortex and precerebellar neurons (Borrell and Marin, 2006; Lysco et al., 2011; Zhu et 
al., 2009, Stumm et al., 2003; Tanaka et al., 2010; Liapi et al., 2008). CXCL12/CXCR4 signaling 
also regulates radial migration of cortical projection neurons, hippocampal granule neurons and 
sympathetic neural precursor cells (Bagri et al., 2002; Dziembowska et al., 2005; Kasemeier-
Kulesa et al., 2010; Liapi et al., 2008). The current study shows a significant accumulation of 
MbDA neurons in a dorsal position just lateral of the midline area in E14.5 Cxcr4 and Cxcl12 KO 
mice. This change in the dorsal ventral midbrain area is accompanyed by a reduction in 
ventrally positioned MbDA neurons in Cxcl12 mutants. These findings as well as the lack of 
expression of CXCR4 in laterally positioned DA neurons suggest a role for CXCR4/CXCL12 
signaling in radial migration. 
However, the distribution of cells in the Cxcr4 KO mice indicates a potential more complicated 
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effect of CXCR4 signaling on DA neuronal migration, since less DA neurons are observed along 
the ventral midline of Cxcr4 mutants. Moreover, the phenotype in both KO mice appears to be 
transient, since the MbDA mispositioning was more severe at E14.5 than at E16.5.This 
observation suggest that CXCL12/CXCR4 signaling is not essential for radial migration, but 
rather regulates the efficiency of early MbDA neuronal migration. Since CXCL12 is the only 
known ligand for CXCR4, it is unexpected that the Cxcr4 KO phenotype is partially different 
from the Cxcl12 KO phenotype. CXCL12-independent functions of CXCR4 have not been 
demonstrated, but it was recently shown that the neurotransmitter GABA can directly bind 
CXCR4 and act as an allosteric modulator (Guyon et al., 2013). Whether GABA or other 
potential modulators could influence CXCR4 function in absence of CXCL12 in the ventral 
midbrain remains to be explored. 
Upon the inhibition of CXCL12/CXCR4 signaling in organotypic slice cultures, neither the speed 
nor the trajectory of radially migrating cells was significantly changed. MbDA neurons in which 
CXCR4 is inactivated might therefore simply stop their radial-oriented migration too early and 
consequently, accumulate closer to their progenitor domain, as compared to the wildtype MbDA 
neurons.  Premature cessation of migration, upon CXCR4 inactivation, has been reported for 
migrating sympathetic precursor cells in the chick (Kasemeier-Kulesa et al., 2010). Alternatively, 
loss of CXCL12/CXCR4 signaling might lead to a delay in the onset of radial migration, a 
mechanism that would be consistent with the amelioration of the observed phenotype between 
E14.5 and E16.5. 
A delay in migration has been previously reported for other molecules thought to be essential 
for migration. Lissencephaly-1 (LIS1, also known as Pafah1b1) is a central component of a 
protein complex that regulates nuclear migration. Reducing LIS1 activity in mice leads to severe 
defects in multiple types of radially migrating neurons, including cortical projection neurons 
(Wynshaw-Boris et al., 2010).  However, a relatively recent study has shown that LIS1 deficient 
neurons do not show a complete migratory arrest, and eventually reach the proper cortical 
layers, albeit with a significant delay (Hippenmeyer et al., 2010).  
 
4.3.3 CXCL12 can act as a chemoattractant signal   
Previous findings from other brain areas such as the hippocampus, cortex and cerebellum have 
shown that CXCL12 can act as a paracrine or long-range attractant signal for migrating 
neurons. 
 
4.3.3.1 CXCL12 can act as a paracrine chemoattractant signal 
Many studies have proposed that CXCL12 is expressed along the migratory pathways of 
migrating neurons expressing CXCR4, where it acts as a paracrine signal (Stumm and Hollt, 
2007; Stumm et al., 2003). For example, Cajal-Retzius cells expressing CXCR4 migrate 
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tangentially from the cortical hem towards the cortical surface, along the marginal zone, which is 
covered by meninges secreting CXCL12. The CXCL12 secreted by the meningeal membranes 
is necessary and sufficient to guide the tangential migration of Cajal-Retzius cells, by 
stimulating cell movement and ensuring that the Cajal-Retzius cells localize and disperse at the 
marginal zone. The treatment of cortical slices, or in utero electroporation with the antagonist of 
CXCR4, AMD3100, results in the dispersion of some Cajal-Retzius cells from the marginal zone 
into deep layers of the developing cortex, while other Cajal-Retzius cells fail to migrate (Borrell 
and Marin, 2006).  
Another example is the case of precerebellar neurons, which migrate tangentially beneath the 
pial surface from the lower rombic lip to specific locations in the hindbrain. CXCL12 secreted 
from meningeal tissue regulates this migration, by acting as a short-range chemoattractant for 
precerebellar neurons and keeping the migratory stream close to the pial surface. In Cxcl12 
deficient mutants, marginal migration of precerebellar neurons is disrupted, and ectopic clusters 
are formed (Zhu et al., 2009).  An example in which CXCL12 is not expressed in meninges and 
is involved in radial migration by acting as a chemoatractant paracrine signal, are the 
gonadotropin-releasing hormone (GnRH) neurons, which migrate from the vomeronasal organ, 
along the nasal mesenchyme towards the hypothalamus. CXCL12 is expressed in a 
concentration gradient by different cells of the nasal mesenchyme. CXCR4 expressing GnRH 
neurons migrate along the mesenchyme expressing CXCL12, towards the increasing level of 
CXCL12 expression (Schwarting et al., 2007).  
However, a paracrine action of CXCL12 in migrating MbDA neurons seems unlikely. Even 
though Cxcl12 is expressed in the meninges, most CXCR4-expressing MbDA neurons are 
located within some distance of the pial surface. Moreover, in the CXCR4 deficient mice, many 
MbDA neurons reach the proper level, close to the pial surface, and appear to be properly 
distributed along the medial lateral extension of the ventralMb 
 
4.3.3.2 CXCL12 can act as a long-range chemoattractant signal 
Cxcl12 and Cxcr4 KO mice show an ectopic clustering of MbDA neurons in the dorsal aspect of 
the MbDA neuronal field. CXCL12 is expressed near the pial surface and CXCR4 expressing 
MbDA neurons are located between the VZ and the pial surface. Therefore, the ectopic 
clustering of MbDA neurons in Cxcl12 and Cxcr4 KO mice seems to suggest that CXCL12 
functions as a long-range chemoattractive signal for MbDA neurons.   
Evidence that CXCL12 can act as a long-range chemoattractant has been shown in other brain 
areas such as the hippocampus, where granule cells migrate radially, from the neuroepithelium 
towards the dendate anlage. CXCL12 is expressed in the anlage of the dendate gyrus, and 
CXCR4 is expressed within the granule cells migrating domain. When CXCL12 is expressed 
ectopically in hippocampal slices, the migratory stream of granule cells is disrupted, and they 
98 
 
migrate towards the ectopic CXCL12 source. This data suggests that CXCL12 acts as a long-
range attractant for radially migrating dentate gyrus granule cells (Bagri et al., 2002; 
Hesselgesser et al., 1997; Klein et al., 2001). 
In this study, the in situ hybridization used for detecting CXCL12 mRNA, does not allow for 
visualization of a concentration gradient of CXCL12 in the ventral midbrain.  
 
4.3.4 Possible mechanism of CXCL12 function  
The downstream mechanisms of CXCL12/CXCR 4 pathway are largely unknown. However, 
Lysco et al. (2011) found that CXCL12 controls the migration of interneurons by increasing their 
speed and reducing their branching frequency. Experiments performed by inhibiting CXCL12 
signaling in slice cultures showed that inducing branching is sufficient to cause cells to 
prematurely exit from the migratory stream. The suppression of branching by CXCL12 allows 
the neurons to maintain a simpler morphology that facilitates rapid migration in a defined 
stream. The authors suggest that the CXCL12 acts through a Gi coupled signal transduction 
pathway (Lazarini et al., 2000). By inhibiting adenyl cyclase, Gi protein subunit lowers cAMP 
levels and protein kinase A (PKA) activity. The branching and speed of migrating neurons can 
be regulated by cAMP, as it has been shown that exogenous cAMP added to neuronal cultures 
increases branching and decreases speed of laminin-induced neurites (Weeks et al., 1991). 
However in this study, the speed of radially migrating MbDA neurons was not found to be 
altered. Further analysis of branching should be performed in order to clarify if CXCL12 function 
in the ventral Mb through cAMP. 
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5. CONCLUSIONS 
 
This study demonstrates that MbDA neurons destined for the SN first migrate radially and then 
switch to tangential migration, while neurons destined for the VTA almost exclusively undergo 
radial migration. The tangential, but not the radial migration is Reelin mediated. Reelin signaling 
is mediated through Dab1 and regulates the polarity of MbDA neurons, their migration 
trajectories and speed of migration. CXCR4/CXCL12 signaling is likely important for radially 
migrating neurons, as the dorsoventral distribution of MbDA neurons is changed when this 
signaling pathway is inactivated. The current study provides the first direct monitoring of distinct 
migratory pathways of different MbDA neuronal populations and investigates two of the 
underlying molecular mechanisms (Figure 37). Insight into MbDA neuronal migration is 
important for enriching our knowledge of MbDA development and could also serve as a model 
for migration of other neuronal cell types in ventral brain areas, where the processes of 
migration are not well understood. 
Generation of MbDA neurons from pluripotent stem cells might become an important tool for 
cell-replacement therapy to substitute lost MbDA neurons in Parkinson’s disease, as well as for 
modeling of Parkinson’s disease in vitro. Molecules identified here, such as Dab1 that are 
particularly expressed in the SN subpopulation, can serve as markers to identify SN MbDA 
neurons during their generation from induced pluripotent stem cells.  
 
Figure 37. Reelin and CXCL12/CXCR4 signaling modulate distinct migratory behaviors of MbDA 
neurons. CXCL12 is expressed in meninges (yellow) and its receptor CXCR4 is expressed in 
differentiating MbDA neurons in the medial ventral midbrain (light yellow). CXCL12/CXC R4 signaling 
modulates the initial radial migration of all MbDA neurons. Reelin (purple) is expressed just above Dab1 -
expressing (light purple) MbDA neurons that migrate laterally. Reelin regulates the last step of tangential 
migration of MbDA neurons. 
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6. FUTURE DIRECTIONS 
 
This thesis presents a detailed analysis of the routes and mechanisms involved in the 
migration of MbDA neurons that form the SN and medial VTA. The results presented here 
provide the basis and are a prerequisite for further investigation of MbDA neuronal migration. 
The here presented analysis of the migratory behavior of MbDA neurons used a GIFM 
method to label MbDA progenitors that preferentially give rise to SN or medial VTA and to 
track their descendants during the period of migration. One caveat of this method is that the 
labeled precursors do not exclusively develop into MbDA neurons, but also give rise to other 
cells types (Blaess et al 2011). A more precise analysis could be performed by using GIFM 
in combination with a reporter line in which the reporter gene is under the control of 
regulatory elements of a MbDA neuron-specific gene, such as TH or Pitx3. Such a reporter 
construct could be used to specifically label differentiating (TH or Pitx3 expressing) MbDA 
neurons that are destined to contribute either to the VTA or SN. The TH and Pitx3 promoter 
constructs have been well characterized and previously used to generate transgenic or 
knock-in mice that express reporter genes in MbDA neurons (Matsushita et al., 2002; 
Sawamoto et al., 2001; Vives et al., 2008; Zhao et al., 2004). 
In the current study, MbDA migratory behavior was observed in real time, in organotypic 
slice cultures. This approach allowed for analysis of migratory trajectories and speed of 
migrating fate mapped MbDA neurons. To assess the radial versus tangential migration of 
MbDA neurons either sagittal or horizontal organotypic slices were prepared, respectively. 
However, the widefield microscope used for imaging only allowed visualization of migrating 
MbDA neurons in a 2D plane and a potential migration within the slice (Z direction) was not 
possible. Moreover, the poor resolution of imaged cells made it impossible to properly 
assess their morphology. Since migration is a process involving complex cytoskeleton 
dynamics, it will be interesting to further explore the mode of MbDA neuron migration by 
gaining more insights into their morphology, which allow to speculate about the underlying 
cytoskeleton dynamics during migration. To be able to properly visualize detailed 
morphological changes, a more sophisticated imaging set-up is required, such as 2-photon 
microscopy. This microscopy technique provides a long range tissue penetration with 
relatively low photo bleaching and a very good resolution, which would ensure an improved 
visualization of cellular processes in 3D time-lapse imaging of migrating MbDA neurons. 
Moreover, using this approach, further experiments could be conducted to shed light on the 
molecular mechanism involved in morphological changes linked to cytoskeleton dynamics 
during MbDA migration. Thus, Reeler mice and mice in which Dab1 was inactivated can be 
combined with SHH GIFM and migrating fate mapped MbDA neurons can be imaged 
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in organotypic slice cultures using 2-photon microscopy. Alternatively, the direct effect of 
Reelin overexpression or inhibition can be assessed by adding Reelin protein at ectopic 
locations or by using the CR50 function-blocking antibody in organotypic slice cultures. Such 
an approach could provide important information whether Reelin can directly or indirectly 
interfere with morphological changes linked to cytoskeleton dynamics. Additionally, other 
molecules potentially involved in MbDA polarization by interacting with Reelin can be tested. 
For example, it has been previously described that Reelin stabilizes the actin cytoskeleton of 
neuronal leading processes by inducing Cofilin phosphorylation (Chai et al., 2009a). Cofilin it 
is located at the leading edge of migrating neurons and binds to actin filaments (F-actin), 
promoting their disassembly. Thus Cofilin acts as an actin depolymerizing protein and by 
providing actin monomers, promotes lamellipodia formation (Jovceva et al., 2007; Kiuchi et 
al., 2007). It will be interesting to assess if Cofilin is involved in tangential migration of MbDA 
neurons by inactivating Cofilin in organotypic slice cultures and analysis of mutant mice. 
CDK5 (cyclin dependent kinase 5) is another potential molecule involved in MbDA neuronal 
migration. CDK5 has been showed to interact with the Reelin pathway and to play a role in 
migration of cortical and cerebellar neurons (Ayala et al., 2007; Kawauchi et al., 2006b; 
Kawauchi and Hoshino, 2008; Nishimura et al., 2009; Umeshima and Kengaku, 2013). 
CDK5 is a serine/threonine cyclin-dependent kinase known to modulate the extension of the 
leading process through phosphorylation of important actin regulators (Dhavan and Tsai, 
2001; Kawauchi et al., 2006a; Nikolic et al., 1998). In the cortex, Cdk5 null mice have 
defects similar defects to Reeler mutants: newly generated neurons fail to migrate past their 
predecessors, and accumulate progressively in deeper layers, resulting in an inverted 
“outside-in” cortex (Gilmore et al., 1998; Ohshima et al., 1996). Also, studies in cortex have 
shown that Cdk5 can phosphorylate Dab1. However, it is unclear if Cdk5 can modulate 
Reelin signaling through Dab1 phosphorylation (Beffert et al., 2004; Ohshima et al., 2007b). 
It is tempting to investigate whether Cdk5 also plays a role in MbDA neuronal migration. 
Inhibitors for Cdk5, such as olomoucine and roscovitine have been previously used to 
suppress CDK5 activity in slice culture (Nishimura (Nishimura et al., 2009; Umeshima and 
Kengaku, 2013)  and could be easily tested in organotypic slices of MbDA neurons. 
This thesis has shown for the first time that CXCR4 is specifically expressed in medially 
located MbDA neurons at the time of their migration and when CXCR4/CXCL12 signaling is 
inactivated some MbDA neurons accumulate more dorsally. These results suggest an 
involvement of in CXCR4/CXCL12 signaling in MbDA radial migration, but further 
experiments need to be performed in order to prove this hypothesis, especially since in 
cultures treated with the CXCR4 antagonist migrating MbDA neurons showed no change in 
their speed or trajectories. To assess whether other aspects of migration such as the timing 
of migration onset or cessation are affected, it would be interesting to analyze the migration 
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of MbDA neurons labeled with SN or VTA marking scheme on the background of the Cxcr4 
or Cxcl12 KO strains. Further analysis should be performed in slice cultures to assess how 
CXCR4/CXCL12 regulates MbDA migration. 
Furthermore, it will of interest to examine the effects of mis- or overexpression of Reelin and 
CXCL12 in slice cultures. A possible experiment is using hanging drops of cell lines 
expressing Reelin or CXCL12, embedded in agarose and sectioned and then placed as an 
overlay onto organotypic slices. Such an experiment provided important insights into the 
effect of Reelin on the polarity of different cortical neurons (Britto et al., 2013).  
Many aspects of the guidance of migrating neurons are shared with axonal guidance, such 
as chemotactic cues and substrate. These two processes occur in the same time frame 
during MbDA development and both require neuronal polarization. Leading processes of 
migrating neurons are morphological similar with the growth cones of migrating axons. It is 
unclear how migrating neurons polarized in their direction of migration at the same time start 
to form axonal projections. Therefore, it will be interesting to find out how the formation of 
axonal projections and migration are spatially and temporally integrated during migration of 
MbDA neurons. The fluorescence labeling method used in this study does not allow for a 
good visualization of cellular processes, because the expression of the reporter protein is not 
strong enough to label the entire axon. To improve the labeling a useful approach will be to 
use a reporter construct, which in conjunction with GIFM can result in a strong labeling of the 
processes of migrating MbDA neurons. (Madisen et al., 2009) previously described such a 
reporter construct. In this construct an exogenous strong CAG promotor is inserted in 
ubiquitously expressed Rosa26 locus to drive higher expression. A fluorescent marker gene 
(such as EYFP, dtTomato) is placed downstream of the CAG promotor and a floxed Stop 
cassette controls it. To image migration and axonal formation of MbDA neurons 
ultramicroscopy can be used. The advantage of using such a method is that ultramicrospy 
combines optical sectioning with fast multidimensional imaging of entire tissues with minimal 
photo bleaching and good optical resolution (Erturk et al., 2010; Niedworok et al., 2012). 
Imaging and 3D reconstructions of axons in fixed, cleared brains at different stages can 
provide information about MbDA axonal morphology at different stages. Additionally, time-
lapse imaging using ultramicroscopy in organotypic slice culture can provide a useful insight 
into how axonal development and migration are spatially and simultaneously coordinated. In 
principle, an organotypic slice can be imaged at any plane by being positioned relative to the 
stationary light sheet that uses a precise motorized translation and rotation stage. 3D time-
lapse of the migrating MbDA neurons can be generated and used to track the MbDA cellular 
processes during their migration and axonal formation (Ahrens et al., 2013). 
Altogether these experiments will help further address the molecular mechanism of MbDA 
neuronal migration during embryonic development.  
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